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Abstract 
 
Children with the onset of epilepsy under the age of two years are a heterogeneous 
group with particularly poor outcome reported by studies mostly originating from 
specialist hospital / clinic settings.  
 
A population based study was designed to determine the incidence of epilepsy onset 
under the age of two years and to ascertain a cohort for long-term follow up. This 
cohort observation aimed to determine usefulness of the current international 
classification of epilepsies in this age group, associated structural brain 
abnormalities, predictors of developmental function close to diagnosis; and factors 
that are associated with a longitudinal change of developmental scores after 12 
months.  
 
Cases were prospectively identified from residents in 15 boroughs of North London 
involving hospital and community based paediatricians. Information was obtained 
either by questionnaire anonymously or from clinical assessments of children 
enrolled in the observational cohort. 57 cases were enrolled giving a crude annual 
incidence of 54 (95% CI 41-69) /100.000 children under the age of 2 years. A two 
source capture recapture model determined an adjusted annual incidence of   56.3 – 
88.5 (95% CI) / 100.000 <= 2 years.   
 
Clinical assessment of children in the observational cohort at baseline and 12 months 
follow up included neurodevelopmental evaluation using standardised tools,  central 
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review of EEG’s and neuroimages. Data of all subjects enrolled were independently 
evaluated by two paediatric neurologists.  
Although most cases were classified under epilepsy syndrome groups, a specific 
epilepsy syndrome diagnosis could not be allocated in a third of cases and there was 
only moderate inter-rater agreement (kappa scores: 0.48, 0.5). 
 
Review of neuroimages of 52 children (91%) demonstrated a high yield of 
aetiologically relevant abnormalities in 26 (50%) with common occurrence of 
developmental malformations identified in 11 (43%).  
 
Multivariate regression analysis showed that 'abnormal neurological examination' 
and 'presence of interictal discharges on EEG' significantly and independently 
predicted lower developmental function close to diagnosis. There was no significant 
difference between initial and developmental function on follow up after adjusting 
for initial infantile spasms, normal or abnormal initial EEG, seizure status at follow 
up, structural brain abnormalities, and antiepileptic medication taken, suggesting that 
the initial status determined the function after 12 months follow up.   
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1 CHAPTER 1: INTRODUCTION 
1.1 Aims of the study 
Children with epilepsy onset under the age of two years are a heterogeneous group 
with respect to epilepsy syndromes and underlying aetiologies, whose prognosis with 
few exceptions has been widely reported to be poor. Previous research originating in 
the majority from hospital or specialist settings has commonly focused on subgroups 
to delineate specific electro-clinical syndromes, determine their aetiologies 
(including molecular genetic defects and developmental brain abnormalities) and 
investigate therapeutic interventions. 
 
The focus of this study was to collect information about the group of young children 
presenting with newly onset epilepsy (under the age of two years) from a population 
based setting.  In particular data were obtained relating to frequency of epilepsy 
onset in this age band, types of epilepsy, associated structural brain abnormalities 
and developmental status. The usefulness of the international classification system of 
epilepsy syndromes and epilepsies (Engel, Jr., 2001), applied at the time the work 
was carried out, was assessed. The relationships between clinical features, 
neuroimaging, neurophysiology and developmental function close to diagnosis and 
after short term follow up (approximately 12 months) were examined in order to 
identify predictors of adverse outcomes.   
 
Population based information is key for the generation of diagnostic strategies that 
will identify those most at risk early, improve management decisions on medical or 
surgical remediative interventions and help to allocate resources adequately.  
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1.2 Definitions 
For this observational study ‘epileptic seizure’ and ‘epilepsy’ have been defined in 
accordance with the report of the International League Against Epilepsy (ILAE) 
commission on epidemiology and prognosis (ILAE Commission, 1997): 
 Epileptic seizure: "A clinical manifestation presumed to result from an 
abnormal and excessive discharge of a set of neurons in the brain. The 
clinical manifestation consists of sudden and transitory abnormal phenomena 
which may include alterations of consciousness, motor, sensory, autonomic 
or psychic events perceived by the patient or an observer.”  (ILAE 
Commission, 1997) 
 Epilepsy: "A condition characterised by recurrent (two or more) epileptic 
seizures, unprovoked by any immediate identified cause. Multiple seizures 
occurring in a 24-hour period are considered a single event. Persons who 
have had only febrile seizures or only neonatal seizures as herein defined are 
excluded from this category." (ILAE Commission, 1997) 
 
More recent definitions for the term ‘epileptic seizure’ proposed by the ILAE task 
force on classification and terminology are very similar to the above quoted version 
in the 1997 commission report. They emphasise the specific pathomechanism of 
abnormal neuronal activity that results in the observevable clinical manifestations, 
whilst the 1997 ILAE definition contains a degree of ambiguity when using the term 
'presumed' in this context: 
 ILAE 2001 (Engel, Jr., 2001): “Manifestation(s) of epileptic (excessive and/or 
hypersynchronous), usually self-limited activity of neurons in the brain” ;  
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 ILAE 2005 (Fisher et al., 2005): “transient occurrence of signs and/or 
symptoms due to abnormal excessive or synchronous neuronal activity in the 
brain”.  
A different conceptual definition of ‘epilepsy’ has been recently proposed. The 
requirement of ‘recurrent unprovoked seizures’ has been abandoned and instead a 
history of a single seizure is sufficient in the presence of an ‘enduring alteration of 
the brain that increases the likelihood of future seizures associated with 
neurobiological, cognitive, psychosocial and social disturbances’ (Fisher et al., 
2005). This definition is however not practical for epidemiological research as the 
authors failed to specify what such an ‘enduring alteration of brain dysfunction’ 
constitutes and how to establish its presence especially following a first unprovoked 
seizure (Beghi et al., 2005). Only 40 to 50% of subjects may experience recurrence 
following a first unprovoked seizure as demonstrated in several observational and 
randomised interventional studies (FIR.S.T Group, 1993;Shinnar et al., 1996;Stroink 
et al., 1998;Marson et al., 2005;Berg, 2008). 
 
An ‘Epilepsy syndrome’ is ‘a complex of signs and symptoms that define a unique 
epilepsy condition. This must involve more than just the seizure type: thus frontal 
lobe seizures per se, for instance, do not constitute a syndrome’ (Engel, Jr., 2001). 
By further describing an epilepsy syndrome as ‘symptomatic’ a reference is made to 
underlying identifiable pathological disturbances in cerebral structure or 
metabolism’.  In ‘idiopathic’ epilepsy syndromes no structural or metabolic 
aetiology can be identified  and the primary cause is assumed to be genetic (Engel, 
Jr., 2001;Engel, Jr., 2006). In order to accommodate syndromes that cannot be 
classified under either of these categories the term ‘cryptogenic’ has been applied 
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with various meanings. In the context of epidemiological research ‘cryptogenic’ 
meant essentially absence of identifiable risk factors or unknown aetiology (ILAE 
Commission, 1997). The 1989 ILAE classification defines ‘cryptogenic epilepsies’ 
as ‘presumed to be symptomatic but with unknown aetiology’. In accordance with 
the proposal of the task force published in 2001 in this study the term ‘probably 
symptomatic’ has been applied synonymously with ‘cryptogenic’ as defined in the 
1989 ILAE  classification (Engel, Jr., 2001).  
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2 CHAPTER 2:  BACKGROUND AND RESEARCH QUESTIONS 
2.1 Classification of the epilepsies: 
2.1.1 Introduction 
Managing a chronic and diverse condition such as epilepsy with onset across the life 
span requires involvement of clinicians and professionals from multiple disciplines. 
Their clinical practice is informed by the increasing understanding and information 
provided through research. As such the need arose for a common framework that 
enables communication between clinicians and forms the basis for quantitative 
research in epilepsy. The ongoing process of developing a comprehensive 
classification system was started in 1985 by the ‘Commission on Classification and 
Terminology’ of the ILAE with a first proposal (ILAE, 1985). This and subsequent 
proposals were based on recognisable clinical patterns or epilepsy syndromes rather 
than on underlying conditions because of their heterogeneity and the fact that many 
have yet to be identified.  
 
It is now common clinical practice in developed countries including the UK to 
determine seizure type and epilepsy syndrome, which can than guide further 
decisions on investigations and treatment (National Institute for Clinical Excellence, 
2004). There is also an expectation of clinicians to be able to derive prognostic 
information through categorising of the epilepsy type.  
In the following paragraphs, the classification systems used at the time this study was 
designed are briefly described. Information in the literature about their applicability 
or usefulness of in childhood epilepsy was reviewed.  
For this purpose Medline (1966 to December 2007) was searched using the terms 
"epilepsy syndrome" in combination with "incidence" and "prevalence". The search 
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was repeated with "epilepsy classification"1. Studies in English were selected that 
applied the  1989 International Classification of Epilepsies and Epileptic Syndromes 
(ICE) or the diagnostic scheme published in 2001 and enrolled children (within age 
range 1 month up to 16 years) or children and adults (Commission on Classification 
and Terminology of the International League Against Epilepsy, 1989;Engel, Jr., 
2001). References of identified articles were examined for additional relevant 
studies. 
This information will set the background for the following chapter that reviews the 
literature with focus on children with epilepsy onset in infancy. 
 
2.1.2 Currently used classification systems 
At the time of writing two classification systems - the 1989 International 
Classification of Epilepsies and Epileptic Syndromes (ICE) (Commission on 
Classification and Terminology of the International League Against Epilepsy, 1989) 
and diagnostic scheme published in 2001(Engel, Jr., 2001) - were recognised by the 
ILAE for application in clinical practice and research until a superior classification 
system could be agreed on that satisfied the needs of both clinicians and researchers 
(Engel, Jr., 2006). 
 
The 1989 ICE (see table 2.1) supplements the 1981 International Classification of 
Epileptic Seizures (1981 ICES: (Commission on Classification and Terminology of 
the International League Against Epilepsy, 1981). Epilepsies and age specific 
                                                 
1 Translation  of search terms in Pubmed: epilepsy: "epilepsy"[MeSH Terms] OR "epilepsy"[All 
Fields], syndrome: "syndrome"[MeSH Terms] OR "syndrome"[All Fields],  classification: 
"classification"[Subheading] OR "classification"[All Fields] OR "classification"[MeSH Terms]; 
incidence: "epidemiology"[Subheading] OR "epidemiology"[All Fields] OR "incidence"[All Fields] 
OR "incidence"[MeSH Terms], prevalence: "epidemiology"[Subheading] OR "epidemiology"[All 
Fields] OR "prevalence"[All Fields] OR "prevalence"[MeSH Terms] 
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electro-clinical syndromes are grouped under two major hierarchical divisions:  
 
 Level 1 relates to seizure types (mode of seizure onset) and has 4 
categories: 1. Localisation-related (focal, local, partial), 2. 
Generalised epilepsies and syndromes, 3. Epilepsies and Syndromes 
undetermined if focal or generalised, 4. Special syndromes (situation 
related seizures, isolated seizures or status epilepticus) (Commission 
on Classification and Terminology of the International League 
Against Epilepsy, 1989).   
 
 Level 2 refers to aetiology and has three categories: idiopathic (no 
underlying cause other than a possible hereditary condition),  
symptomatic (consequences of known or suspected disorders of the 
central nervous system), cryptogenic (presumed to be symptomatic, 
but aetiology is unknown)(Commission on Classification and 
Terminology of the International League Against Epilepsy, 1989). 
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Table 2.1: Classification of epilepsies, epileptic syndromes and related seizure disorders 
(ILAE 1989) (Commission on Classification and Terminology of the International League 
Against Epilepsy, 1989)  
 
4. Special syndromes 
4.1. Situation-related seizures: 
Febrile convulsions 
Seizures occurring only in the context of acute metabolic or toxic events 
4.2. Isolated seizures or isolated status epilepticus
1. Localization-related (focal, local, partial) epilepsies and syndromes 
1.1. Idiopathic (with age-related onset): 
Benign childhood epilepsy with centro-temporal spikes 
Childhood epilepsy with occipital paroxysms  
Primary reading epilepsy 
1.2. Symptomatic: 
Chronic progressive epilepsia partialis continua of childhood (Kojewnikow syndrome) 
Seizures characterized by specific modes of precipitation 
Other epilepsies and syndromes based on localization or aetiology 
1.3. Cryptogenic 
2. Generalised epilepsies and syndromes 
2.1. Idiopathic (with age-related onset - listed in order of age): 
Benign neonatal familial convulsions 
Benign neonatal convulsions 
Benign myoclonic epilepsy in infancy 
Childhood absence epilepsy (pyknolepsy) 
Juvenile absence epilepsy 
Juvenile myoclonic epilepsy 
Epilepsy with generalized tonic-clonic seizures on awakening 
Other generalized idiopathic epilepsies not defined above 
Epilepsies with seizures characterized by specific modes of precipitation (e.g. 
photosensitive epilepsy) 
2.2. Cryptogenic and/or symptomatic (in order of age): 
West syndrome (infantile spasms) 
Lennox-Gastault syndrome 
Epilepsy with myocionic-astatic seizures 
Epilepsy with myoclonic absences 
2.3. Symptomatic: 
2.3.1. Non-specific aetiology: 
Early myoclonic encephalopathy 
Early infantile epileptic encephalopathy with suppression-bursts 
Other symptomatic generalized epilepsies not defined above 
2.3.2. Specific syndromes 
3. Epilepsies and syndromes undetermined whether local or generalized 
3.1. With both generalized and focal seizures: 
Neonatal seizures 
Severe myoclonic epilepsy in infancy 
Epilepsy with continuous spike-waves during slow wave sleep 
Acquired epileptic aphasia (Landau-Kleffner syndrome) Other 
undetermined epilepsies not defined above 
3.2. Without unequivocal generalized or focal features 
Application of the 1989 ICE in prospective population based studies enrolling both 
adults and children with newly diagnosed epilepsy demonstrated that although most 
cases could be classified up to two thirds of patients fell into less narrowly defined 
rather unspecific categories. Categories such as 3.2 (essentially unclassifiable cases), 
1.3 (cryptogenic localisation related epilepsies) and 2.1 (other generalised idiopathic 
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epilepsies not defined above) provide little information to guide management and 
predict the clinical course (see Table 2.1: categories of 1989 ICE). A defined 
syndromic diagnosis could only be achieved for a minority of cases (36 - 45%) 
(Manford et al., 1992;Olafsson et al., 2005).  
The lack of clear criteria on how to classify cases resulted in differences in 
interpretation and application of the 1989 ICE between studies. Cases for example 
with focal epileptiform EEG abnormalities, fulfilling criteria for localisation, and 
negative neuroimaging are classified by some authors under symptomatic by others 
under cryptogenic localisation related (Jallon et al., 2001). 
 
The multiaxial ‘diagnostic scheme for people with epileptic seizures and with 
epilepsy’ was proposed by the ILAE task force on classification and terminology in 
2001 and aimed to provide a more flexible individualised approach (Table 2.2) 
(Engel, Jr., 2001). The proposed diagnostic scheme combined description and 
categorisation of seizures using a glossary of descriptive terminology, epilepsy 
syndrome, aetiologies and impairment in a system of 5 axes (see also Table 2.2). 
It was recognised that a syndrome diagnosis cannot be made for each patient. 
The seizure type (axis 2) was therefore ‘promoted’ to a diagnostic entity rather than a 
description of the ictal clinical and electrophysiological manifestations (as in the 
1981 seizure classification) (Commission on Classification and Terminology of the 
International League Against Epilepsy, 1981).  A ‘seizure type diagnosis’ should 
include reference to pathomechanisms and anatomical structures involved with 
implications for diagnostic evaluation, treatment and prognosis. Thus it would 
provide an alternative for cases where a syndromic epilepsy diagnosis cannot be 
made (Engel, Jr., 2006). However seizures are difficult to categorize in many patients 
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especially young children. In addition seizure types (especially ‘generalised’ seizure 
types) still await delineation and the processes as well anatomical cerebral structures 
involved in seizure generation are not yet completely understood (Engel, Jr., 2006).  
Axis 3 provides the place for a syndrome diagnosis that should be selected if 
appropriate from an updated list in the 2001 report that also includes epilepsy 
syndromes “under development”.  
 
The definitions for ‘epileptic syndrome’ in the 2001 proposal of the ILAE task 
force (table 2.3) and in the 1989 ICE2 are in principal very similar.  Whilst some 
of the epilepsy syndromes listed in the 1989 ICE are, however, predominantly 
defined by seizure type (e.g. temporal lobe epilepsies, frontal lobe epilepsies), the 
definition in the 2001 proposal requires additional clinical and 
electrophysiological characteristics. This appears to contradict the idea in the 
2001 proposal that seizure type could be used as diagnostic entity when an 
electro-clinical syndrome diagnosis is not achievable (Seino, 2006). 
 
A list of definitions of key terms specifies proposed changes in terminology 
(compared to 1989 ICE) and introduces new concepts (see Table 2.3). This includes 
abolition of the distinction between simple and complex partial seizures, change of 
the term 'localisation related' to 'focal' with the added explanation that the 
epileptogenic zone may not be restricted to a small cortical area but often can involve 
a wide area in one or both hemispheres diffusely (multifocal).  
                                                 
2 “An epileptic syndrome is an epileptic disorder characterised by a cluster of signs and 
symptoms customarily occurring together; these include such items as type of seizure, aetiology, 
anatomy, precipitating factors […] and sometimes prognosis. However, in contradiction to a 
disease, a syndrome does not necessarily have a common aetiology and prognosis.” (Commission 
on Classification and Terminology of the International League Against Epilepsy, 1989) 
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One of the new concepts, ‘epileptic encephalopathy’, has particular relevance to 
infancy and childhood onset epilepsies. It is hypothesised that epileptiform 
abnormalities contribute significantly to progressive cerebral dysfunction in addition 
to the underlying aetiology. According to this concept epileptic activity in the 
immature brain interferes with brain maturation resulting in impairment of 
neurodevelopment and cognitive function in later life. "The epileptic 
encephalopathies" is one of the categories suggested in the 2001 task force report 
under which age dependent specific electroclinical syndromes are further organised. 
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Table 2.2: Proposed multiaxial diagnostic scheme for people with epileptic seizures 
and epilepsy, 2001 (adapted and modified from (Engel, Jr., 2001)) 
 
Epileptic seizures and epilepsy syndromes are to be described and categorized according to a 
system that utilizes standardized terminology, and that is sufficiently flexible to take into 
account the following practical and dynamic aspects of epilepsy diagnosis:  
1. Some patients cannot be given a recognized syndromic diagnosis.  
2. Seizure types and syndromes change as new information is obtained.  
3. Complete and detailed descriptions of ictal phenomenology are not always 
necessary.  
Multiple classification schemes can, and should, be designed for specific purposes (e.g. 
communication and teaching; therapeutic trials; epidemiological investigations; selection of 
surgical candidates; basic research; genetic characterizations).  
 
Axis 1 Ictal phenomenology - from the Glossary of Descriptive Ictal Terminology can be 
used to describe ictal events with any degree of detail needed. 
Axis 2 Seizure type - from the List of Epileptic Seizures. Localization within the brain 
and precipitating stimuli for reflex seizures should be specified when appropriate. 
Axis 3 Syndrome - from the List of Epilepsy Syndromes, with the understanding that a 
syndromic diagnosis may not always be possible. 
Axis 4 Aetiology - from a Classification of Diseases Frequently Associated with 
Epileptic Seizures or epilepsy syndromes when possible, genetic defects, or 
specific pathological substrates for symptomatic focal epilepsies 
Axis 5 Impairment - this optional, but often useful, additional diagnostic parameter can 
be derived from an impairment classification adapted from the WHO ICIDH-2. 
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Table 2.3: Definitions of key terms (down loaded from www.ilae-epilepsy.org, 
accessed in November 2007,  adapted from (Engel, Jr., 2001) 
 
Epileptic Seizure Type: An ictal event believed to represent a unique 
pathophysiological mechanism and anatomical substrate. This is a diagnostic entity 
with etiological, therapeutic, and prognostic implications. (new concept)  
 
Epilepsy Syndrome: A complex of signs and symptoms that define a unique epilepsy 
condition with different etiologies. This must involve more than just the seizure type; 
thus frontal lobe seizures per se, for instance, do not constitute a syndrome. 
(changed concept)  
 
Epilepsy Disease: A pathological condition with a single specific, well-defined 
etiology. Thus Progressive myoclonus epilepsy is a syndrome, but Unverricht-
Lundborg is a disease. (new concept)  
 
Epileptic encephalopathy: A condition in which the epileptiform abnormalities 
themselves are believed to contribute to the progressive disturbance in cerebral 
function. (new concept)  
 
Benign epilepsy syndrome: A syndrome characterized by epileptic seizures that are 
easily treated, or require no treatment, and remit without sequelae. (clarified concept) 
 
Reflex epilepsy syndrome: A syndrome in which all epileptic seizures are precipitated 
by sensory stimuli. Reflex seizures that occur in focal and generalized epilepsy 
syndromes that are also associated with spontaneous seizures, are listed as seizure 
types. Isolated reflex seizures can also occur in situations that do not necessarily 
require diagnosis of epilepsy. Seizures precipitated by other special circumstances, 
such as fever or alcohol withdrawal, are not reflex seizures. (changed concept)  
 
Focal seizures and syndromes: Replaces the terms partial seizures and localization-
related syndromes. (changed concept)  
 
Simple and complex partial epileptic seizures: These terms are no longer 
recommended, nor will they be replaced. Ictal impairment of consciousness will be 
described when appropriate for the individual seizures, but will not be used to 
classify specific seizure types. (new concept)  
 
Idiopathic epilepsy syndrome: A syndrome that is only epilepsy, with no underlying 
structural brain lesion or other neurological signs or symptoms. These are presumed 
to be genetic and are usually age-dependent. (unchanged term)  
 
Symptomatic epilepsy syndrome: A syndrome in which the epileptic seizures are the 
result of one or more identifiable structural lesions of the brain. (unchanged term)  
 
Probably symptomatic epilepsy syndrome: Synonymous with, but preferred to, the 
term cryptogenic, used to define syndromes that are believed to be symptomatic, but 
no etiology has been identified. (new term)  
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2.1.3 Identification of epilepsy syndromes in childhood  
Most population based studies in the literature describing epilepsy prevalence and 
incidence cohorts applied the 1989 ICE  (see table 2.4) and only two studies referred 
to the relative recently published 2001 ILAE proposal for the classification of 
epilepsy syndromes (Larsson and Eeg-Olofsson, 2006;Akiyama et al., 2006). 
Table 2.4 lists population based studies that applied the 1989 ICE with the 
proportions of subjects that were categorised under specific epilepsy syndromes 
(electro-clinical syndromes, that are more narrowly defined) and those that were 
essentially unclassifiable (including category 3.2 – ‘without unequivocal generalised 
or focal features’). The proportion of specific epilepsy syndromes listed in table 2.3 
does not include cases that were classified under the following vague categories of 
the 1989 ICE: 1.3 – cryptogenic localisation-related epilepsies and syndromes, 2.1 – 
‘other generalised idiopathic epilepsies not defined above’, and   2.3 ‘other 
symptomatic generalised epilepsies not defined above’.  
 
In population based settings the proportion of subjects with specific epilepsy 
syndrome diagnoses are larger in most childhood cohorts (51 - 67%) (Eriksson and 
Koivikko, 1997;Callenbach et al., 1998;Beilmann and Talvik, 1999;Berg et al., 
1999c;Waaler et al., 2000;Freitag et al., 2001;Kwong et al., 2001), with the exception 
of one Japanese study (22%) (Oka et al., 2006), compared to cohorts of  adults and 
children (36-45%) (Manford et al., 1992;Jallon et al., 2001;Olafsson et al., 2005) [see 
table 2.3 for details]. This is not surprising as the majority of specific epilepsy 
syndromes are delineated in childhood and adolescence. In addition some paediatric 
studies involve child neurologists in the recruitment of cases (Berg et al., 1999c). 
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Whilst the majority of children can be classified using the 1989 ICE, the proportion 
of subjects that are essentially unclassified varies between 1 and 12% in the reviewed 
childhood cohorts, usually because of a lack of information (see table 2.4: (Eriksson 
and Koivikko, 1997;Callenbach et al., 1998;Beilmann and Talvik, 1999;Berg et al., 
1999c;Waaler et al., 2000;Oka et al., 2006) ). Variations in distribution of the 
epilepsy syndromes and the proportion of cases falling into specific epilepsy 
syndrome categories (51%-67% of children enrolled in North American and 
European studies (Eriksson and Koivikko, 1997;Callenbach et al., 1998;Beilmann 
and Talvik, 1999;Berg et al., 1999c;Waaler et al., 2000;Freitag et al., 2001), 22% in a 
Japanese prevalence cohort (Oka et al., 2006)) are compounded by differences in 
study design, availability of investigation results and most importantly the 
interpretation of the ICE criteria. Only two papers specified that cases were 
independently classified by several raters with subsequent consensus agreements 
when necessary (Berg et al., 1999c;Jallon et al., 2001). Taking methodological 
differences between the quoted studies into consideration, in at least a third of 
children a more narrowly defined epilepsy syndrome diagnosis cannot be achieved 
and the seizure disorder is rather vaguely described as 'localisation-related', 
'generalised' or 'undetermined' epilepsy. 
High inter-rater agreement can be achieved when investigators agree ‘rules’ for 
application of the ICE a priori as demonstrated in a community based cohort 
recruited through child neurology practices in the state of Connecticut (Berg et al., 
1999a). Berg et al showed also that the initial syndrome diagnosis was stable over 
time in the majority of cases (Berg et al., 2000a). After two years the initial 
syndrome diagnosis was revised in only 84 of 613 of cases (∼14%). Two thirds of the 
revised diagnoses came form the group of children who were essentially unclassified 
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(category 3.2 of the 1989 ICE:  'without unequivical generalised or focal features', 
see alo table 2.1) or partially classified (category 1.3 'cryptogenic localisation 
related'). In 16 cases (< 3 % of the entire cohort) more major revisions were made 
which included changes from non-idiopathic localisation related to idiopathic 
generalised. The initial diagnosis was most commonly changed when new 
information of subsequent EEG’s or neuroimaging became available. Evolution of 
the initial syndrome occurred in approximately 4 % of cases (e.g. from West 
syndrome to Lennox-Gastaut). 
 
The 2001 proposal of diagnostic scheme was applied by Akiyama et al, who 
reclassified a prevalence cohort that was originally classified according to the 1989 
ICE (Akiyama et al., 2006). Specific epilepsy syndromes were identified in only 269 
(12%) cases, whilst the remaining 1761 patients were described by seizure type only. 
Although EEG information was accessible for the majority of patients the authors did 
not specify the availability of other information such as neuroimaging data that 
would have impacted their ability to classify cases.  
 
In summary review of the literature shows that the ILAE syndrome classification 
(1989 ICE) is applicable for a majority of children presenting with epilepsy. Specific 
syndrome diagnoses are more commonly made in childhood. However a significant 
proportion of children fall in unspecific categories. Few data are available to evaluate 
the diagnostic scheme proposed in 2001. 
 
   
Table 2.4: Application of 1989 ICE in population based studies (proportion of specific epilepsy syndromes and unclassifiable cases) 
Authors, 
Year of 
publication Country Cohort Ascertainment  n age [years] Inclusion criteria 
3.2 or 
unclassified 
Specific 
Epilepsy 
Syndromes 
Manford et al, 
1992 
UK 
‘The National 
General 
Practice Study 
of Epilepsy’ 
population 
based 
prospective 
275 GP practices - in urban + rural 
areas of UK   
594 (139 < 
15 years) 
1 months 
onwards 
unprovoked seizures 
or epilepsy (recurrent 
unprovoked seizures) 190 (32%) 36% 
Oka et al, 1995 Japan Prevalence 
survey in geographical area, medical 
records of hospitals 2378 < 10 
children with epilepsy 
(single seizures + 
febrile convulsions) 506 (21%) 12.6% 
Eriksson KJ, 
Koivikko MJ, 
1997 Finland Prevalence  
catchment area of university 
hospital, hospital patient's register, 
PICU admissions,  EEG department 
@ University Hospital 329 0-15 
recurrent unprovoked 
seizures, single 
prolonged seizure or  
single SE with EEG 
confirming epilepsy 32 (10%) 52% 
Callenbach et 
al, 1998 
Netherlands 
‘Dutch Study of 
Epilepsy in 
Childhood’ 
hospital based 
prospective  
University hospitals Rotterdam, 
Leiden; Westeinde Hospital (The 
Hague), Juliana Children's Hospital, 462 
1 month - 16 
years 
recurrent unprovoked 
seizures 5 (1.1%) 52% 
Berg A et al, 
1999 
USA, 
Connecticut 
population 
based 
prospective  
through child neurologists (16/17 
practices) in state 
613/770 
(79.6%) 1month-15 
recurrent unprovoked 
seizures 71 (11.6%) 67% 
Beilmann A, 
Talvik T, 1999 Estonia 
Prevalence + 
Incidence 
catchment area of university 
hospital, annually letters to 
Paediatricians/Neurologists/ EEG 
department @ university hospital 560 0-19 
recurrent unprovoked 
seizures 10 (1.8%) 65% 
Waaler et al, 
2000 Norway Prevalence 
Catchment area, university  hospital 
patient register, EEG department, 
contact to GP + other institutions 198 6-12 
recurrent unprovoked 
seizures 22(10.6%) 64% 
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Authors, 
Year of 
publication Country Cohort Ascertainment  n age [years] Inclusion criteria 
3.2 or 
unclassified 
Specific 
Epilepsy 
Syndromes 
Kwong et al, 
2001 Hong Kong 
Prevalence 
(hospital 
based) 
catchment area of hospital, 
attendees register 309 1month-15 
recurrent unprovoked 
seizures 7 (2%) 51% 
Freitag et al, 
2001 Germany Incidence 
Mannheim, Heidelberg, hospital 
medical records, EEG attendees, 
regular contact to private 
paediatricians (letters, visits etc) 36 1month-15 
recurrent unprovoked 
seizures 0 61% 
Jallon et al, 
2001 
France 
‘CAROLE 
Study’ 
population 
based 
prospective 
242 of 430 Child and adult 
neurologists throughout France and 
one in Geneva participated (majority 
hospital based)  
1016 (543 < 
15 years) 
1 months 
onwards 
recurrent unprovoked 
seizures 187 (18%) 43% 
Olafsson et al, 
2005 Iceland Incidence 
country wide surveillance system - 
of all healthcare facilities (hospitals, 
A&E's, EEG departments, 
Radiology departments etc), 
verification by review of synopsis 
by neurologist 
294 (72 < 15 
years) 
1 months 
onwards 
unprovoked seizure or 
epilepsy (recurrent 
unprovoked seizures) 77(26.2%) 45% 
Larson, Eeg-
Olafsson et al 
2006∗ Sweden Prevalence 
catchment area of university 
hospital - Uppsala + rehabilitation 
centre, patient's register, 
questionnaire to GP's 205 1 months - 16 
recurrent unprovoked 
seizures 8 (3.9%) 49% 
Oka et al, 2006 Japan Prevalence 
survey in geographical area, medical 
records of institutions 1337 <13 
recurrent unprovoked 
seizures 146 (11%) 22.5% 
SE = Status epilepticus; ∗ICES 1989 modified according to  2001(updated syndrome list )
   
2.2 Epilepsy under the age of two years  
2.2.1 Introduction 
Within in the childhood epilepsy group infants are often considered separately 
because of the high incidence of seizures and epilepsy in the first year of life, the 
heterogeneity of clinical presentations (with age specific seizure manifestations), the 
diversity of outcomes and underlying aetiologies (Arzimanoglou et al., 2004b).  As 
discussed in the following paragraphs a number of early studies focused on outcomes 
of infants with seizures in the first 12 months, whilst some of the later studies 
included children with epilepsy onset in the first 24 months (Rantala and Ingalsuo, 
1999;Altunbasak et al., 2007) . Febrile convulsions are especially common in the 
first year of life and only a proportion of infants may go on to develop afebrile 
seizures in the second year of life as part of the natural evolution of an epileptic 
disorder, e.g. severe myoclonic epilepsy in infancy (Verity et al., 1985;Dravet et al., 
2005a;Sillanpaa et al., 2008). In order to ensure inclusion of such early epilepsy 
presentations the extension of the age band for an infancy epilepsy cohort from 12 to 
24 for months appears justified.  The candidate has taken this view when reviewing 
the literature and designing inclusion criteria for this work. The candidate, however, 
acknowledges that the choice of such age limits to form subgroups is arbitrary. 
Despite of the documented typical peak ages of onset in the majority of cases with 
delineated electroclinical syndromes, for example, the age of onset in some of the 
typical and atypical syndromic presentations can be wider reaching across such age 
bands.   
The following sections review information available in the literature of infancy 
epilepsy series or cohorts (onset in the first 12 to 24 months) including distribution 
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of the specific epilepsy syndromes listed in the current international classification 
systems. Data relating to the clinical characterisation and outcome of this age group 
are contrasted with those obtained from childhood epilepsy cohorts that are 
composed of infants and older children (epilepsy onset 1 month to 16 years). 
Medline (Pubmed) was searched (1966 to January 2008) with the term "infant" 
combined with "recurrent seizures" or "convulsive disorders" 3,  repeated with 
"recurrent seizures" or "epilepsy" and "prognosis". The searches were limited to 
articles in English. Selected were studies that enrolled all infants (aged 1 month to 12 
or 24 months) with recurrent seizures. Additional relevant articles were identified 
from references of selected papers.   
Studies identified in the Medline search described in section 2.2.1 were examined for 
information about frequency and distribution of infancy onset epilepsy syndromes. 
References of a published systematic review of incidence studies were examined in 
order to identify all articles that provided incidence estimates of epilepsy under one 
or two years (Kotsopoulos et al., 2002). The Medline search in this paper (1966 to 
1999) was updated (Jan 2000 to December 2006) using search terms: "recurrent 
seizures" or "epilepsy" and "incidence" (limits: "age 0-23 months", articles in 
English and human studies)4.  
 
                                                 
3 Translation of query: (recurrent[All Fields] AND ("seizures"[MeSH Terms] OR "seizures"[All 
Fields])) OR (convulsive[All Fields] AND ("disease"[MeSH Terms] OR "disease"[All Fields] OR 
"disorders"[All Fields])) AND ("humans"[MeSH Terms] AND English[lang] AND "infant"[MeSH 
Terms] 
4 Translation of query: ((recurrent[All Fields] AND ("seizures"[MeSH Terms] OR "seizures"[All 
Fields])) OR ("epilepsy"[MeSH Terms] OR "epilepsy"[All Fields])) AND 
("epidemiology"[Subheading] OR "epidemiology"[All Fields] OR "incidence"[All Fields] OR 
"incidence"[MeSH Terms]) AND ("humans"[MeSH Terms] AND English[lang] AND "infant"[MeSH 
Terms] 
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2.2.2 Incidence of epilepsy in infancy  
Annual incidence estimates of epilepsy onset in childhood in developed countries 
vary between 38 to 60/100,000 in recent publications (Camfield et al., 1996;Olafsson 
et al., 1996;Freitag et al., 2001;Sillanpaa, 2003;Olafsson et al., 2005;Larsson and 
Eeg-Olofsson, 2006). The age specific incidence curve of epilepsy in developed 
countries demonstrates a peak in the first year of life followed by a sharp decline in 
early childhood and a second increase in the elderly forming an U-shaped appearance 
(Hauser et al., 1993;Camfield et al., 1996;Olafsson et al., 2005;Banerjee and Hauser, 
2008). The age specific incidence rates of first unprovoked seizures form a similar 
curve further supporting the impression that the brain is especially susceptible to 
seizures in very young and old age: “Epilepsy is a disease with onset at the extremes 
of life” (Banerjee and Hauser, 2008).  
 
Although the onset of childhood epilepsy is most frequent in infancy the age specific 
incidence estimates show great variability between studies (79 – 256/100.000/year, 
see table 2.5). Both geographical and methodological differences including 
prospective or retrospective study design, ascertainment methods, and case 
definitions contribute to these variations. A number of studies recruit cases from the 
population living in the catchment area of a hospital and/or EEG department using 
attendance registers as the single source of ascertainment. This may result in case 
under-ascertainment in certain settings. Ascertainment adjustment methods such as 
capture-recapture methodology were not applied.  
 
The impact of different case definitions becomes especially apparent when 
comparing the figures obtained from the two UK birth cohort studies (see table 2.5). 
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Not surprisingly, the study that ascertained all infants with one o more afebrile 
seizures (Verity et al., 1992) estimated a much higher incidence rate for the first year 
of life when compared to a cohort that included cases with recurrent unprovoked 
seizures ((Verity et al., 1992;Kurtz et al., 1998).  
 
In some studies the incidence estimates for the first year of life are based on small 
case numbers and confidence intervals are rather wide (Blom et al., 1978;Olafsson et 
al., 1996;Freitag et al., 2001); see also table 2.5).  
 
Few data are available in the literature with respect to the incidence of epilepsy in 
children under the age of two years because most epilepsy incidence studies provide 
age specific data only for the age group less than 1 year and summarize data in larger 
age bands (eg 1-4 years, 5-9 years etc). 
   
Table 2.5: Studies providing incidence estimates of epilepsy in children under the age of one or two years 
Author, year of 
publication Ascertainment period Country Case definition Case ascertainment 
Age specific 
incidence < 1 year 
per 100.000 95% CI 
Blom et al, 
1978 1973 - 1974 Sweden 
1 or more unprovoked 
seizures 
retrospective - catchment area approach,  
using data/records from hospital EEG 
department, single EEG -service provider 
in area , follow up of cohort, letter + 
phone contact,  
95.7 (n=3) 32.5 - 281 
Doose et 
al,1983  
children born 1957-
1966 Germany, Kiel > 1 unprovoked seizure 
catchment area approach, information 
obtained retrospectively from  hospital 
records (epilepsy centre),  
201.6 (n=76) Not available 
Verity et al, 
1992 
Birth cohort one 
week 1970 United Kingdom 1 or more afebrile seizures 
prospective follow up of birth cohort, 
screening questionnaire with 
subsequently obtained from GP's and 
hospital records 
160 (n=23 first 
seizure) 107 - 240 
Hauser et al, 
1993 1935 -1984 USA, Rochester   >1 unprovoked seizure 
retrospectively, information form 
diagnostic record system,  86 (n=36) 62 - 119 
Braathen et al, 
1995 1990 - 1992 Sweden > 1 unprovoked seizure 
prospective, catchment area of hospital, 
epilepsy team 0-2 years: 70 (n=14) 
Not 
available 
Camfield et al, 
1996 1977 - 1985 
Canada, Nova 
Scotia >1 unprovoked seizures 
retrospective, catchment area of hospital  
EEG department/  118 (n=112) 98 - 143 
Olafsson et al, 
1996 1993 Iceland > 1unprovoked seizure 
retrospective, records of healthcare 
centres, local hospitals,  contact of  
Paediatricians + Neurologists  
256.5 (n=4) 99.7- 657 
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Author, year of 
publication Ascertainment period Country Case definition Case ascertainment 
Age specific 
incidence < 1 year 
per 100.000 95% CI 
Kurtz et al, 
1998 
Birth cohort one 
week 1958 
England/Scotland/
Wales 
> 1 disturbances of 
consciousness, not 
associated with acute fever 
prospective follow up of birth cohort, 
screening questionnaire with 
subsequently obtained from GP's and 
hospital records 
90 (n=14) 43 -138 
Freitag et al, 
2001 1999 
Germany, 
Heidelberg + 
Manheim 
>1 unprovoked seizure 
prospective, involving EEG departments, 
2  University hospitals and Office 
Paediatricians (contacted by letters and 
phone calls) 
146 (n=5) 47.4 - 340.1 
Olafsson et al, 
2005 1995 -1999 Iceland > 1 unprovoked seizure 
prospective, country wide surveillance 
system - of all healthcare facilities 
(hospitals, A&E's, EEG departments, 
Radiology departments etc) 
79.5 (n=11)  44 -132 
 
   
2.2.3 Epilepsy syndromes in the neonatal period and infancy 
The number of ‘specific epilepsy syndromes’ with onset in the first two years of life 
that have been included in the ILAE lists of epilepsy syndromes has been increasing 
over the last two decades.  Table 2.6 lists the syndromes according to the grouping 
suggested in the 2001 proposal and table 2.7 a) and b) summarise the main clinical 
features.  
 
In a simplistic way neonatal / infancy onset epilepsies can be categorised under two 
main groups. One represents syndromes with poor prognosis for seizure control and 
cognitive outcome in the majority of patients (Table 2.7 b). With the exception of 
‘migrating partial seizures in infancy’ these have been grouped under ‘epileptic 
encephalopathies’ in the 2001 proposal.  A broad spectrum of underlying aetiologies 
is commonly represented. This includes developmental and acquired brain lesions as 
well as genetic and metabolic disorders. In ‘migrating partial seizures in infancy’ 
commonly no underlying aetiology can be recognised.  
 
One of the electroclinical syndromes of the 'poor outcome group'- severe myoclonic 
epilepsy in Infancy (SMEI) or Dravet's syndrome - is here discussed in more detail 
because of the recent discovery of an associated ion channel mutation with 
implications for diagnosis and classification. In typical cases, developmentally 
normal infants present with atypical febrile convulsions (hemiconvulsions and/or 
prolonged febrile seizures) and episodes of febrile as well as afebrile status 
epilepticus in the first year of life.  In the further evolution of this syndrome afebrile 
multiple seizures types including focal seizures, atypical absences, non-convulsive 
status epilepticus like states and myoclonus occur, frequently accompanied by 
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developmental plateauing or regression. Although the initial EEG may  be normal a 
range of characteristic abnormalities evolve later including generalised spike wave 
discharges and photosensitivity (Dravet et al., 2005b). Atypical or SMEI borderline 
(SMEB) presentations share many characteristics of typical presentations but 
myoclonic seizures or generalised spike wave discharges may be absent and the 
predominant seizure type can be generalised tonic clonic convulsions (Oguni et al., 
1994;Doose et al., 1998). The association between 'increase in body temperature' and 
seizures, a marker that has been observed in another previously identified genetic 
epilepsy syndrome: 'Genetic (Generalised) Epilepsy with Febrile Seizures plus +' 
(GEFS+) lead to the discovery of de novo sodium channel subunit mutations in 
patients with SMEI (SCN1A,  one of the ion channel mutations previously identified 
in GEFS+ families) (Claes et al., 2001). Subsequently other groups confirmed 
SCN1A mutations  with high prevalence in patients with typical and borderline  
SMEI presentaions ranging from 33 - 82% (Ohmori et al., 2002;Wallace et al., 
2003;Nabbout et al., 2003;Fukuma et al., 2004;Harkin et al., 2007). In the largest 
series (SMEI: n=66, SMEB: n = 36) a higher proportion of patients with SMEI 
(79%) tested positive for the SCN1A mutation compared to the borderline cases 
(69% of SMEB) (Harkin et al., 2007).  Whilst the majority of SCN1A mutations in 
typical and borderline SMEI arise de novo, 5 % of the reported series (mostly 
missense, but also truncation mutations) have familial mutations (Scheffer et al., 
2009). In addition a number of families with 2 affected siblings with SMEI have 
been reported due to somatic or germline mosaicisms (Marini et al., 2006;Morimoto 
et al., 2006). 
GEFS+ is a phenotypically very heterogeneous syndrome with presentations in large 
autosomal dominant pedigrees ranging from febrile seizures (a proportion occurring  
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after the age of 6 years) in isolation or in combination with mild to severe types of 
epilepsy (including myoclonic astatic epilepsy, SMEI and focal epilepsies) (Scheffer 
and Berkovic, 1997;Scheffer et al., 2007). Although five genes have been identified, 
encoding sodium channel subunits (SCN1A, SCN2A, SCN2B ) and GABA receptor 
subunits (GABR2, GABRD), monogenetic inheritance is less relevant for the 
majority of GEFS+ cases that arise from small families  or occur sporadic (Baulac et 
al., 2001;Wallace et al., 2002;Ito et al., 2002;Harkin et al., 2002;Scheffer et al., 
2005). In one series of patients with GEFS+ eleven percent of patients with SCN1A 
mutations have been identified (Marini et al., 2007). The phenotypical and genetic 
heterogeneity within GEFS+ and familiar SMEI cases as well as the overlap between 
both suggests that additional genetic modifiers may play an important role in the 
expression of clinical features (Scheffer et al., 2009;Singh et al., 2009). GEFS+ could 
be understood as an accumulation of clinically delineated epilepsy syndromes that 
broadly share genetically determined pathomechanisms resulting in susceptibility to 
seizures with sensitivity to increased body temperature. SMEI lies within this 
spectrum at the severer end (Arzimanoglou, 2009).  
 
Spontaneously remitting seizures or pharmacologically responsive epilepsy and 
normal cognitive outcome in the majority of patients is characteristic for the 
idiopathic syndromes in the second group.  The underlying aetiology of these 
idiopathic forms is most likely genetic. Mutations in genes encoding ion channels 
have been found in some syndromes (Table 2.7 a). Benign familial (BFIS) and non 
familial infantile seizures (BIS) have been newly included in the 2001 proposal. 
Watanabe et al first described infants with focal or secondarily generalised seizures 
and good outcome (Watanabe et al., 1993;Watanabe and Okumura, 2000). Familial 
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occurrence in autosomal dominant pedigrees was subsequently recognised by 
Vigevano et al (Vigevano et al., 1992;Vigevano, 2005). Infants present between 3 
and 20 month of age. Seizures occur often in brief clusters over one or several days. 
The interictal EEG outside of a seizure cluster is typically normal and there are no 
structural abnormalities on neuroimaging. Despite some of the common features this 
group of infants is phenotypically and genetically very heterogeneous. Several 
chromosomal loci have been identified in linkage studies of BFIS: 19p13; 2q24; 
16p12- q12 (Guipponi et al., 1997;Malacarne et al., 2001;Caraballo et al., 2001). An 
association with other neurological conditions such as paroxysmal dyskinesias has 
been described in families that map to the locus on Chromosome 16 and with 
‘Familial Hemiplegic Migraine’ in two families linked to 1q23 (Caraballo et al., 
2001;Vanmolkot et al., 2003). Family members affected by ‘Familial Hemiplegic 
Migraine’ and/or BFIS carried a missense mutation in the ATP1A2 (Na+, K+-
ATPase) gene. Sodium channel mutations (SCNA2 gene) have been identified in 
families whose affected members had their seizure onset in the neonatal period or in 
early infancy (0-6 months) (Berkovic et al., 2004;Herlenius et al., 2007). The authors 
suggested delineation of a new syndrome: ‘Benign Infantile Neonatal Seizures’ 
(Berkovic et al., 2004). Other phenotypical presentations of the ‘BIS spectrum’ are:  
 ‘Benign infantile focal seizures with midline spikes and waves during 
sleep (high voltage diphasic spikes followed by slow wave in sleep 
EEG): A wider age range of seizure onset has been reported in this 
subgroup (4-30 months) and developmental progress was normal at 
follow up (Capovilla and Beccaria, 2000);  
 BIS in relation with gastroenteritis (especially rotavirus): Infants in 
this subgroup present with situation related seizures and do not 
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require a diagnosis of epilepsy (Specchio and Vigevano, 
2006;Okumura et al., 2006).  
  
Some patients that have been diagnosed with idiopathic infantile or familial neonatal 
syndromes experience a more severe course. Familial neonatal seizures with 
confirmed potassium channel mutation can present with epileptic encephalopathy 
(Dedek et al., 2003). A proportion of patients with ‘Benign Myoclonic Epilepsy in 
Infancy’ (BME) have long-term cognitive impairment: 15% in a hospital based series 
(Auvin et al., 2006) and 32% (25/77) of cases with information available on 
cognitive outcome from a literature review (Zuberi and O'Regan, 2006). The word 
‘benign’ was therefore removed in the most recent ILAE task force report and the 
syndrome is now called ‘Myoclonic Epilepsy in Infancy ’ (Engel, Jr., 2006).  
 
2.2.3.1 Distribution specific epilepsy syndromes with onset under two years 
in the general population   
Population based studies enrolling patients presenting with recurrent unprovoked 
seizures provide limited information. Childhood prevalence studies of active epilepsy 
are biased towards severe types of epilepsy and may under report ‘benign’ 
syndromes in which seizures go into remission. The numbers of infants enrolled into 
prospective studies vary and tend to be rather small in cohorts that enrol children and 
adults (see also table 2.8 under ‘comments '). Sixty one or 10% of the children 
enrolled in the Connecticut study were under 1 year at diagnosis (Berg et al., 1999c). 
Data specifically relating to the group of patients with epilepsy onset under the age 
of 2 years are not provided in the majority of publications. 
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West syndrome (Infantile Spasms) is most commonly represented. The proportion of 
infants with West syndrome varies (0.5 - 8%, see table 2.8) and tends to be higher in 
prevalence cohorts as well as studies that involve child neurologists in the 
recruitment. ‘The National General Practice Study of Epilepsy’ (NGPSE, conducted 
in the 1980's) is a community based study in which patients with a suspected new 
diagnosis of epilepsy older than 1 month were prospectively registered by 275 
general practitioners based in surgeries around the UK over a 3 year period (Sander 
et al., 1990). It is surprising that amongst the 39 children enrolled in the age group 0-
4 years none was identified with West syndrome (Manford et al., 1992). Whilst 
idiopathic syndromes’ including childhood absence epilepsy (CAE, 1.6%), juvenile 
myoclonic epilepsy (JME, 1.1%) were recognised amongst 594 cases with a definite 
diagnosis of epilepsy (including 139 children age 0-14 years), other syndromes listed 
under the category 2.2 “cryptogenic or symptomatic generalised epilepsies” of the 
1989 classification (e.g. Lennox – Gastaut syndrome, Epilepsy with myoclonic 
astatic seizures) were not identified (Manford et al., 1992).  The authors interpret this 
observation with the infrequent representation of some specific epilepsy syndromes 
in the general population. In support of this statement a recent epidemiological study 
from Iceland reported an incidence of West syndrome of  0.7 per 1000 person years, 
whilst figures for JME and CAE were 70 and 80 per 1000 person-years respectively  
(Olafsson et al., 2005). Other incidence figures for  infantile spasms available in the 
literature range from 2.9 to 4.5 per 10.000 live births (Riikonen and Donner, 
1979;Sidenvall and Eeg-Olofsson, 1995;Trevathan et al., 1999).  Because the study 
design of the NGPSE does not allow relating of case numbers to the population at 
risk it is difficult to compare the quoted incidence figures. Under reporting of 
children with more severe epilepsies including West syndrome, that are in the UK 
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commonly managed by hospital or community based paediatricians cannot be 
excluded. 
 
Other neonatal / infantile syndromes listed in the 1989 ICE, which has been applied 
in the majority of studies are extremely rare (see table 2.8). Patients with milder 
types of epilepsy may not present to a specialist setting which explains the different 
proportions of BME in the ‘Dutch Study of Epilepsy in Childhood’ (2.4%) and the 
Connecticut study by Berg et al (0.2%) that recruited cases through child neurology 
practices (Callenbach et al., 1998;Berg et al., 1999c). Thus, the data from population 
based cohorts suggest that a large proportion of infants may be either unclassifiable 
(category 3.2) or fall into categories that are defined by aetiology (symptomatic, 
cryptogenic). 
 
Two retrospective specialist hospital based studies report the distribution of epilepsy 
syndromes in children with seizure onset in the first year of life. In a large cohort 
from Argentina (n=471) the majority of patients were classified as West syndrome 
(47%) and symptomatic localisation related epilepsy (28%) (Caraballo et al., 1997). 
Seventy three children (15%) fell into non specific categories and 15 infants (3.8%) 
were diagnosed with benign syndromes (6 BME, 12 BFIS). Of the severe epilepsy 
syndromes SMEI was the second commonest (15/471, 3.2%).  
 
West syndrome (39%), symptomatic localisation-related epilepsies (13%) and 
symptomatic specific syndromes [2.3.2 (11%)] were also the commonest syndromic 
diagnoses in the second smaller hospital based series from Italy (n=150) (Battaglia et 
al., 1999). Neuroimaging data were available for all children (MRI in 49%). Only 2 
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cases (1.3 %) were identified as idiopathic generalised epilepsy and 23 % of the 
cohort were categorised in non-specific categories. Infants presenting with BIS/BFIS 
may have been categorized under cryptogenic partial as the authors applied the 1989 
ICE. 
 
Sarisjulis et al investigated if and when a syndromic diagnosis can be made in infants 
with epilepsy of unknown cause that did not have infantile spasms as the first seizure 
type. Their retrospective cohort was derived from a specialist hospital setting 
(n=140) (Sarisjulis et al., 2000). A specific syndrome diagnosis could be made in 
half of the patients in the first months after presentation. In 28 % of cases no 
syndromic diagnosis could be allocated and a further 23 % of patients fell under the 
non-specific category ‘cryptogenic localisation related’ epilepsy. The latter group 
included 9 (of 32) patients who later presented with infantile spasms. Only 8 patients 
(5.7%) with benign syndromes were identified (1.8 % of the entire retrospective 
cohort of patients with seizure onset in the first year of life). Forty two patients 
(30%) were clinically diagnosed as having SMEI (9.7% of the entire infancy onset 
epilepsy group), reflecting the special interest of this epilepsy centre, where this 
syndrome was first described.  At the time this paper was published the high 
prevalence of SCN1A mutations in patients with typical clinical presentation of 
SMEI had not jet been discovered and results for this genetic investigation were 
unlikely to be available for this cohort at the time. The investigators had most 
difficulties in distinguishing between cryptogenic localisation related epilepsies and 
SMEI as both syndromes can present with focal seizures and normal EEG at onset. In 
75% of patients with cryptogenic localisation related epilepsy the time lag between 
first seizure and first abnormal EEG recording was < 3 months. The initial 
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presentation of typical SMEI cases with febrile seizures can delay the recognition of 
this syndrome. In this retrospective cohort the first afebrile seizure occurred between 
2 and 20 months (mean 7.6 months) and the syndrome was identified between 3 and 
24 months of age (mean age 8.4 months, 88% recognised before the age of one year 
and 95% by 18 months of age).  
 
Taken together there is a lack of data pertaining to the distribution of infancy onset 
epilepsy syndromes in the general population. Limited data available from 
population based studies suggest that the benign syndromes may be especially 
underreported. West syndrome that is characterised by a specific seizure type is most 
easily recognised.  
Data from hospital based series are biased towards identification of the refractory 
types and also may reflect the special interest of the epilepsy centre in one particular 
syndrome. There is also a suggestion that a significant proportion of infancy onset 
epilepsies cannot be classified under the current classification systems. In the context 
of current clinical practice that applies syndromic diagnoses to guide patient 
management this results in uncertainty with respect to the most appropriate 
investigation and therapeutic strategies.  
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Table 2.6: Epilepsy Syndromes with onset in Neonatal period and Infancy (Engel, 
Jr., 2001;Engel, Jr., 2006) 
 
Group of Syndromes Specific Syndromes 
Idiopathic Focal Epilepsies  Benign Infantile Seizures (Non-Familial) [BIS] 
 
Familial (Autosomal Dominant) Focal 
Epilepsies 
Benign Familial Neonatal Seizures 
 
Benign Familial Infantile Seizures [BFIS] 
Symptomatic (or Probably 
Symptomatic) Focal Epilepsies 
Limbic Epilepsies  
  
Neocortical Epilepsies:  
• Hemiconvulsion - Hemiplegia Syndrome 
• Other Types Defined by Location and 
Etiology  
• Migrating Partial Seizures of Early 
Infancy *  
Idiopathic Generalized Epilepsies (Benign) Myoclonic Epilepsy in Infancy [BME]
Epileptic Encephalopathies   Early Myoclonic Encephalopathy [EME]
 Ohtahara Syndrome [EIEE] 
 West Syndrome 
 Dravet Syndrome [SMEI] 
 Myoclonic Status in Non-Progressive 
Encephalopathies 
Seizures Not Necessarily Requiring a 
Diagnosis of Epilepsy 
 Benign Neonatal Seizures,  
 Febrile Seizures 
 Single Seizures or Isolated Clusters of 
Seizures 
  Rarely Repeated Seizures (Oligo-
Epilepsy)  
   
Table 2.7 a):  Epilepsy syndromes with onset in first the 2 years of life (clinical features):  Syndromes with good outcome in majority of patients 
 Age of onset Seizure types Interictal EEG 
 
Chromosomal loci; Genes 
 
Benign neonatal seizures1 
− Non familial 
 
 
− Familial 
(autosomal dominant) 
1-7 days 
 
 
2-3 days 
 
Focal clonic / 
apnoeas 
 
Diffuse tonic 
probable focal 
 
Normal or focal/multifocal 
abnormalities,  
 
discontinuous, ‘theta pointu 
alternant’ pattern 
 
 
 
20q13.3; KCNQ2 
8q24;  KCNQ3 
Benign neonatal infantile 
seizures∗ 
(autosomal dominant) 
Mean 11 weeks +/- 9 
weeks∗∗ 
Focal, secondarily 
generalised 
Normal or focal 
abnormalities 2q24; SCN2A
2 
Benign infantile seizures3 
− Non familial 
 
 
− Familial  
(autosomal  dominant) 
 
3-20 months 
(majority < 12 months) 
 
4-8 months 
 
 
 
Focal 
 
 
Normal 
 
 
 
 
16p12-q124, 19q5 
1q23 ( ATP1A2)6 
(Benign) myoclonic epilepsy in 
infancy7 
6 months - 3 years 
 
Myoclonic 
Reflex myoclonus 
Normal, 
Ictal EEG: generalised 
spike  or  polyspike and 
wave discharges 
unknown 
∗ not included in recent  ILAE classification proposal (Engel, Jr., 2001); ∗∗onset from neonatal period up to 13 months (Herlenius et al., 2007); 1(Plouin and 
Anderson, 2005); 2(Heron et al., 2002) ; 3(Vigevano, 2005;Specchio and Vigevano, 2006;Okumura et al., 2006); 4(Caraballo et al., 2001); 5(Guipponi et al., 
1997); 6(Vanmolkot et al., 2003); 7(Dravet and Bureau, 2005;Auvin et al., 2006)
 53 
   
Table 2.7 b): Epilepsy syndromes with onset in first the 2 years of life (clinical features): Syndromes with poor outcome  
 Age of onset 
 
Seizure types Interictal EEG Other characteristics 
Early infantile epileptic 
encephalopathy (Ohtahara 
syndrome)1  
 
birth – 3 months tonic spasms, focal, 
rarely myoclonus 
suppression – burst 
pattern (in waking and 
sleep) 
 
Aetiology; predominantly acquired structural brain lesions 
or developmental brain malformations; 
 
Severe myoclonic 
encephalopathy1 
birth – 28 days myoclonic, focal, tonic 
spasms (later) 
suppression-burst 
pattern (enhanced or 
only in sleep) 
Aetiology: unknown or metabolic disorders 
Migrating partial seizures 
in infancy2 
First year of life,  
Birth – 7 months 
Focal (large variety of 
motor and autonomic 
manifestations), occur 
in clusters 
Multifocal spikes 
Ictal: continuous but 
shifting epileptiform 
activity from one region 
to another from one 
hemisphere to another 
No structural brain abnormalities 
West syndrome3 birth – 2 years, 
majority in 1rst 12 
months (peak 3 – 7 
months) 
spasms, focal seizures 
antecedent or 
concomitantly in 1/3 
Hypsarrhythmia (absent 
in up to 33%) 
Aetiology – wide spectrum: acquired brain lesions, 
developmental brain malformations, metabolic disorders, 
chromosomal abnormalities, genetic (e.g. ARX4, 
CDKL55) or unknown; 
 
Severe myoclonic 
epilepsy in infancy 
(Dravet’s syndrome)6 
Within first year Initially: atypical 
febrile convulsions 
(prolonged, unilateral 
clonic seizures) 
 
Subsequently: tonic, 
tonic-clonic, 
myoclonus, focal 
Initially: normal 
Subsequently: 
generalised, focal and 
multifocal 
abnormalities 
 
Genetic aetiology:  
Chromosome 5q31-q33, SCN1A7; ~ 80% of patients8, 
Chromosome 2q24, GABR2, γ2 subunit of GABA 
receptor9 
 
1(Aicardi and Ohtahara, 2005;Ohtahara and Yamatogi, 2006), 2(Dulac, 2005), 3 (Lux and Osborne, 2004;Dulac and Tuxhorn, 2005), 4(Kato et al., 2003), 
5(Archer et al., 2006), 6 (Dravet et al., 2005b), 7(Claes et al., 2001),8(Harkin et al., 2007), 9(Harkin et al., 2002;Jansen et al., 2006)
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Table 2.8: Application of 1989 ICE in population based studies: Specific Neonatal / Infancy onset Syndromes  
Authors, Year of 
publication Country Cohort n age [years] 
West 
syndrome 
Other specific 
neonatal/infancy 
onset syndromes Comments 
Manford et al, 
1992 UK 
Prospective 
population 
based cohort 
594  1 months onwards 0  
139 < 15 years, 0-4 years: 
n=39 
Oka et al, 1995 Japan Prevalence 2378 < 10 40 (2.1%) EIEE 1 (0.1%)  
Eriksson, 
Koivikko, 1997 Finland Prevalence  329 0-15 25 (8%) 
BNC 2(1%), BFNC 
2(1%) 
91 (27%) < 12 months at 
onset  
Callenbach et al, 
1998 
Netherlands 
Dutch Study of 
Childhood 
onset Epilepsy 
Prospective 
multi-centre 
hospital 
based cohort 
462 1 months – 16 years 17 (3.7%) 
BME 11 (2.4%), 
BFNC 1 (0.2%)  
Beilman A, 
Talvik T, 1999 Estonia 
Prevalence + 
Incidence 560 0-19 years 8 (1.4%) 
BME 5 (0.9%), 
EME 1 (0.2%)   
Berg et al, 1999 USA, Connecticut 
Prospective 
community 
based cohort 
613 1 month – 15 years 24 (3.9%) 
BME 1 (0.2%), 
SMEI 1 (0.2%) 
85 < 1 year at seizure onset, 
61 < 1 year at diagnosis 
Waaler et al, 
2000 Norway Prevalence 198 6-12 years 1 (0.5%)  
infantile syndromes under-
reported due to mortality + 
evolution of syndromes, and 
benign syndromes not any 
more active 
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Authors, Year of 
publication Country Cohort n age [years] 
West 
syndrome 
Other specific 
neonatal/infancy 
onset syndromes Comments 
Kwong et al, 
2001 Hong Kong 
Prevalence 
(hospital 
based) 
309 1month-15 years 16 (5%) BNFC 1, BME 1 
61 (20%) onset < 12 months 
(15 idiopathic, 4 cryptogenic, 
38 symptomatic) 
Freitag et al, 
2001 Germany Incidence 36 
1month-15 
years 0 SMEI 1(2.8%) 5 < 12 months (14%) 
Jallon et al, 2001 France 
Prospective 
population 
based cohort 
1016  1 months onwards 25 (2.5%) BME 9 (0.9%) 543 < 15 years 
Olafsson et al, 
2005 Iceland Incidence 294  
1 months 
onwards 6 (1%)  
72 < 15 years,  
11 (3.7%) < 12 months ,  
10 in age group 1-4 years  
Larson, Eeg-
Olofson et al 
2006 
Sweden Prevalence 205  1 months - 16 years 4 (2%) 
BFIS 1 (0.5%), 
BME 1(0.5%), 
EME 1 (0.5%), 
SMEI 6 (2.9%) 
44 (21%) onset < 12 months, 
neuroimaging in 75% (MRI : 
85%,  CT: 54%) 
Oka et al, 2006 Japan Prevalence 1337 <13 59 (4.3%) EIEE 11 (0.9%)  
EIEE = Early Infantile Epileptic Encephalopathy, EME= Early Myoclonic Encephalopathy, BNC=Benign Neonatal Convulsions (Seizures), 
BFNC=Benign Familial Neonatal Convulsions (Seizures),  BME=Benign Myoclonic Epilepsy in Infancy, BFIS=Benign Familial Infantile Seizures, 
SMIE=Severe Myoclonic Epilepsy in Inancy, MRI=Magnetic Resonance Imaging 
   
2.2.4 Seizure types 
Clinical manifestations of epileptic seizures in infancy can be subtle and difficult to 
recognise. They differ from those observed in later childhood and adult age reflecting 
an age dependent evolution of clinical manifestations. Typical manifestations in 
infancy include behavioural change with arrest of movements, hypotonia, 
asymmetric or symmetric clonic movements, tonic posturing (symmetric or 
asymmetric), version of head and eyes, as well as autonomic features such as 
flushing, pallor, and peri-oral cyanosis. Auras, elaborate automatisms, dystonic 
posturing and secondarily generalisations occur with increasing age whilst other 
features such as asymmetric clonus and symmetric posturing observed in infantile 
seizures disappear with advancing age (Nordli, Jr. et al., 2001). 
Following the first description by West, who observed epileptic spasms in his infant 
son, these were initially recognised as major defining feature of an age dependent 
syndromic epilepsy presentation with poor outcome (West syndrome / Infantile 
spasms) rather than a seizure type (West W, 1841;Commission on Classification and 
Terminology of the International League Against Epilepsy, 1989). Although the 
onset of spasms, typically in clusters, is frequently observed in infancy (peak 
presentation between 3 and 7 months) it was subsequently recognised that spasms 
may persist beyond 2 years of age, may occur at any age throughout childhood and 
are a feature of several different syndromes (Gobbi et al., 1987;Ohtsuka et al., 
2001;Eisermann et al., 2006;Vigevano et al., 2007;Goldstein and Slomski, 2008). 
Thus epileptic spasms were included in the seizure type classification of the 2001 
ILAE ICE proposal defined as  "A sudden flexion, extension or mixed extension-
flexion of predominantly proximal and truncal muscles which is usually more 
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sustained than a myoclonic movement but not as sustained as a tonic seizure i.e. 
about 1 second" (Engel, Jr., 2001;Blume et al., 2001). EEG as well as polygraphic 
features have been well described and include a generalised high amplitude slow 
wave (or sharp slow wave complex)  coinciding with the motor manifestation 
(associated with a diamond shaped EMG pattern of 1-2 second duration), commonly 
followed by attenuation and fast activity (either preceding or following the slow 
wave complex)(Vigevano et al., 2001).  Subcortical structures especially the brain 
stem have been proposed as generator for spasms because of their association with 
various diffuse and focal brain abnormalities as well as hydrancephaly (Neville, 
1972;Dulac et al., 1999). However, neocortical epileptogenic mechanisms also 
contribute to  generation of spasms as evident from neurophysiology, functional 
neuroimaging and the reported seizure free outcome following surgical cortical 
resections or disconnection procedures (Chugani et al., 1990;Jonas et al., 2005;Kang 
et al., 2006). According to one prominent hypothesis spasms are the result of a 
failure in the complex interplay between brainstem and neocortical structures 
involving two possible scenarios: a) enhanced cortical excitability (as a normal 
developmental stage or result of a pathological process) is insufficiently modulated 
(inhibited) by brain stem structures or b) increased excitability in brain stem 
structures is inefficiently modulated (inhibited) by descending cortical regulation ( 
due to structural cortical abnormalities or epileptiform activity or both) (Dulac et al., 
1999;Lado and Moshe, 2002).  
Several investigators found that the 1981 International Classification of Epileptic 
Seizures could not be sensibly applied for infantile seizures (Nordli, Jr. et al., 
1997;Acharya et al., 1997;Nordli, Jr. et al., 2001). The main difficulty was the 
determination of altered consciousness in preverbal stage of development required to 
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categorise partial seizures under ‘simple’ or ‘complex’. Categories describing 
sensory motor manifestation cannot be applied in infants for the same reason. 
Although the division of focal seizures in ‘simple’ and ‘complex’ has been 
abandoned in more recent proposals of the task force, the nature of most seizure 
types is based on manifestations observed in older ages. Some investigators have 
proposed modified seizure type classifications for infantile seizures that are based 
solely on clinically observable manifestations (Nordli, Jr. et al., 1997;Hamer et al., 
1999;Korff and Nordli, Jr., 2006). 
 
Analysis of video telemetry data from hospital based cohorts of infants with 
medically refractory seizures has shown that the repertoire of clinical manifestations 
in infants is relatively small. The majority of seizures were categorised as spasms, 
(focal) clonic, (focal) tonic, or hypomotor / behavioural arrest with version) (Hamer 
et al., 1999;Korff and Nordli, Jr., 2006). Automatisms when observed were simple 
and consisted mainly of oroalimentary manifestations (sucking, chewing).  Typical 
tonic clonic seizures were not observed in this age group. Epileptic spasms that are 
categorised under generalised seizures can present both clinically and 
electrographically with focal features. 
 
Clinical features that help to discriminate between focal and generalised seizures in 
older children and adults, such as symmetrical or asymmetrical tonic posturing, head 
and eye version do not reliably predict a focal or generalised ictal EEG onset in 
infants (Dravet et al., 1989;Nordli, Jr. et al., 1997;Acharya et al., 1997;Hamer et al., 
1999). Unilateral clonic and bilateral asymmetric clonic seizures are however 
commonly associated with focal electrographic findings (frequently involving contra 
 59
   
lateral central / rolandic areas). Other seizure types with predictable ictal EEG 
pattern included generalised spasms, e.g. symmetrical spasms that are not associated 
with focal seizures, generalised clonic and atonic seizures.  Thus with few exceptions 
clinical observation alone may not be sufficient to classify a significant proportion of 
infantile seizures.  
 
Korff and Nordli observed in their cohort of infants with medication resistant 
seizures (n=69, 1-24 months) that 98 % (94 of 96) of seizures were commonly short, 
lasting less than 5 minutes (Korff and Nordli, Jr., 2006).  Two seizures  were 
significantly longer: a generalised clonic-tonic- clonic seizure lasting for 25 minutes 
presented in a patient diagnosed with Dravet’s syndrome and a seizure with 
behavioural arrest, eye deviation and focal hypotonia, that ceased after 15 minutes. 
When spasms were excluded the median duration was 49 seconds (range 0.02 - 25 
minutes).  They also identified trends in the relation between age and seizure 
manifestations. Generalised seizures other than epileptic spasms presented at a later 
age (median age 12.5 months) than focal seizures (median age 9 months). 
Generalised clonic and atonic seizures were recorded only in infants older than 7 
months. Focal clonic seizures and behavioural arrest with version were observed 
early but not recorded in patients older than 18 months. 
 
There is currently no population based information in the literature about the 
distribution of seizure types in infants. Limited data are available from hospital and 
specialist clinic based series of children with seizure onset in the first year of life. In 
early series infantile seizures were classified based on clinical features into large 
categories such as infantile spasms, status epilepticus, ‘others – partial‘ or ‘others 
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generalised’ (Chevrie and Aicardi, 1978;Cavazzuti et al., 1984). Infantile spasms 
were the commonest seizure type seen in 47- 68% of infants, partial or secondarily 
generalised seizures in 12-14% and generalised seizures in up to 25% (Chevrie and 
Aicardi, 1978;Cavazzuti et al., 1984;Czochanska et al., 1994). Twelve to 17% of 
infants presented with status epilepticus. A different distribution was reported from a 
large retrospective hospital based series in Japan (n = 512) (Matsumoto et al., 
1983a). Generalised motor seizures were more frequent (50.5%) compared to 
infantile spasms (31%). Eighteen percent of infants in this series presented partial, 
secondarily generalised or hemiconvulsive seizures. Bias towards more severe forms 
of epilepsy in some series based in a specialist setting as well as the previously 
discussed difficulties to classify infantile seizures with the exception of infantile 
spasms may contribute to these variations.    
 
2.2.5 Aetiologies  
A wide and heterogeneous spectrum of aetiologies is associated with seizure onset in 
the first year of life. The long list of conditions includes various types of 
developmental cortical malformations, chromosomal abnormalities, ion channel gene 
mutations, metabolic disorders, as well as pre-, peri- and post-natally acquired brain 
lesions (Kuzniecky and Barkovich, 2001;Nabbout et al., 2003;Weaving et al., 
2004;Arzimanoglou et al., 2004b;Ferrari et al., 2005;Guerrini et al., 2007). Cortical 
malformations, especially if diffusely involving one or both hemispheres, are 
frequently associated with seizure onset in the neonatal period or early infancy 
(Vigevano, 1999). 
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The notion that infancy onset epilepsies are dominated by brain pathology has been 
derived form early hospital / specialist clinic based series of children with seizure 
onset in the first year of life. The proportion of infants that have symptomatic 
epilepsy or significant predisposing antecedent conditions (including developmental 
delay) is high and varies between 52 - 80% in these studies. Less than half (17-48%) 
of infants fall into the cryptogenic  / idiopathic group, i.e. no underlying cause is 
identified and patients are developmentally as well as neurologically normal at the 
time of seizure onset (Chevrie and Aicardi, 1977;Matsumoto et al., 1983a;Cavazzuti 
et al., 1984;Czochanska et al., 1994;Battaglia et al., 1999;Altunbasak et al., 2007). 
The considerable variations in the observed proportions of symptomatic and non-
symptomatic epilepsies may be related to differences of inclusion criteria (some 
studies included febrile seizures and children with a single seizure: (Matsumoto et 
al., 1983a;Cavazzuti et al., 1984) and the degree of bias in various settings.  
 
The most significant aetiological categories are prenatal and perinatal aetiological 
factors (up to 40%), that include developmental brain abnormalities as well as 
acquired lesions through infection and/or hypoxia (Chevrie and Aicardi, 
1977;Matsumoto et al., 1983a;Matsumoto et al., 1983c;Czochanska et al., 1994).  
Although the availability of neuroimaging methods was limited at the time the data 
for most studies were obtained, 13-19% of infants with developmental brain 
malformations, most commonly tuberous sclerosis, were identified (Chevrie and 
Aicardi, 1977;Czochanska et al., 1994;Battaglia et al., 1999). More detailed 
documentation of the various types of malformation is not available from these 
series. The proportion of children with structural brain lesions may be even higher as 
subtle cortical abnormalities would have escaped recognition.   
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Population based data are available from a single study that was conducted in 
Finland (Rantala and Ingalsuo, 1999). Cases were ascertained through the hospital 
discharge diagnoses and EEG database of the University of Oulu. This institution 
provides the only paediatric service in its catchment area. The investigators identified 
all children diagnosed with epilepsy (recurrent unprovoked seizures) under the age of 
2 years, excluding neonates that were born between January 1, 1976 and December 
31, 1986 (n=72). Thirty four infants (47%) were classified as cryptogenic/idiopathic 
and 37 (51%) as symptomatic. The latter group included 16 patients with progressive 
encephalopathies with unknown aetiology and normal CT and/or MRI. Brain 
anomalies identified in 11 (15%) and chromosomal abnormalities (6 cases, 8.3%) 
were the most common aetiologies in this cohort. This study supports the impression 
that the proportion of symptomatic epilepsies in infancy is high compared to 
childhood epilepsy cohorts that enrol infants and older children (up to the age of 16 
years). Eighteen to 22% of children were classified with symptomatic epilepsies in 
two large childhood epilepsy cohorts of which one was community based  (Berg et 
al., 1999c) and the other conducted in a multicenter hospital setting (Arts, 2003).  
 
2.2.6 Role of neuroimaging and EEG in infancy onset epilepsies 
2.2.6.1  Neuroimaging [magnetic resonance (MR) imaging] 
MRI is unsurpassed as a technique for investigating brain structure in-vivo in 
humans. It is widely used to investigate the spectrum of acquired and developmental 
brain abnormalities that has been recognised in patients with epilepsy. 
Developmental lesions include malformations of cortical development (MCD) with 
uni-hemispheric focal, multifocal or diffuse bi-hemispheric distribution. MCDs have 
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been classified based on MR imaging features and  histological appearances (of 
surgical / post mortem specimens) by relating these to various stages of brain 
development (Barkovich et al., 2005). The number of gene defects underlying 
specific types of MCDs is steadily increasing and based on this information the 
understanding of mechanisms involved in brain development (Kato and Dobyns, 
2003;Guerrini et al., 2008). Advances in MR imaging technology have also been 
driven in part by the search for surgical targets to treat patients with medication 
resistant epilepsy. MR imaging has been recommended as the mode of neuroimaging 
of first choice in patients with epilepsy especially if seizures are resistant to 
medication (Commission on Neuroimaging of the International League Against 
Epilepsy, 1997;Commission on Neuroimaging of the International League Against 
Epilepsy, 1998).   
 
As discussed previously (paragraph 2.2.5) data from infants with new onset epilepsy 
in hospital and specialist settings suggest a significant proportion of underlying brain 
abnormalities. Therefore MR imaging is an essential tool to guide further diagnostic 
work up (for example targeted metabolic and genetic investigations) and also 
therapeutic management (consideration of epilepsy surgery) in the group of children 
presenting to this setting. Identification of structural brain abnormalities would also 
permit investigation of their relationship to developmental impairment in this early 
onset group. 
  
National guidelines  in the United Kingdom (UK) and more  recently published 
ILAE guidelines for paediatric patients with epilepsy recommend MR imaging early 
in the course of the disorder for certain  subgroups of paediatric patients (National 
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Institute for Clinical Excellence, 2004;Gaillard et al., 2009). Both guidelines suggest 
MR imaging for children with focal epilepsies, those with generalised epilepsies that 
cannot be categorised under the defined idiopathic electro-clinical syndromes and  
young children under the age of 2 years (Gaillard et al., 2009). Although a number of 
studies report neuroimaging findings in children following a first epileptic seizure 
only a proportion of subjects enrolled underwent imaging often using brain 
Computer Tomography as there was limited access to MR technology (see also 
literature review by Gaillard et al (Gaillard et al., 2009)). As in the infancy age group 
there is a lack neuroimaging data from community based setting. One recently 
published study provides data from a large community based childhood epilepsy 
cohort. Berg et al reported positive MRI findings relevant to epilepsy in 82 (~ 16%) 
of 518 children with available MRI data enrolled in the Connecticut cohort (85% of 
the entire cohort, children with newly diagnosed epilepsy from 1 month to 16 years 
of age) (Berg et al., 2009). Significantly more children with non-idiopathic epilepsy 
syndromes had positive MR scans compared to cases diagnosed with  one of the 
delineated idiopathic electro-clinical syndromes (22% vs. 3%) confirming that the 
classification was appropriate in the majority of cases. Not surprising in this context 
multiple logistic regression revealed a diagnosis of a non-idiopathic epilepsy 
syndrome and abnormal neurological examination as significant predictors of a 
positive MR scan. If the classification of cases into epilepsy syndromes that was 
based on clinical, EEG and MRI data according to the information given by the 
authors, was carried out prior to the above analysis a major bias would have been 
introduced. 
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Acquisition of high quality MR images is challenging in children especially in the 
infancy age group. Adequate sedation including general anaesthetic is required in 
infants and most children under the age of 7 years with associated safety risks and 
costs.  Thus the above mentioned guidelines raise the question if there is a 
justification for early MR imaging of all infants with newly diagnosed epilepsy in a 
community setting.  
  
2.2.6.2  EEG 
 
The role of the EEG (standard waking record with activation procedures and/or sleep 
record) in  childhood epilepsy management as stated  in National guidelines (for 
England & Wales) is essentially to support (not to exclude) a diagnosis of epilepsy 
and to help to determine the type  epilepsy (National Institute for Clinical 
Excellence, 2004;Berg et al., 2009). A  number of studies investigating the course 
after the first convulsive seizure showed an increased risk of seizure recurrence with 
abnormal EEG recording, but demonstrated also seizure recurrence in a proportion of 
cases with normal EEG findings (Shinnar et al., 1996;Pohlmann-Eden and Newton, 
2008). The international epilepsy classifications, as already discussed above,  are 
based on epilepsy syndromes that have been defined  by a combination of clinical 
features and typical EEG appearances (Arzimanoglou et al., 2004a). Although there 
are  EEG patterns that are quite specific for certain syndromes e.g. hypsarrhythmia in 
West syndrome/infantile spasms, suppression burst in  EIEE/EME, normal interictal 
EEG in benign infantile seizures, ictal EEG appearances of malignant migrating 
seizures in infancy other syndromes such as Dravet's syndrome (SMEI) can be 
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associated with a  range of EEG features in various stages of the disorder (Dulac and 
Tuxhorn, 2005;Dulac, 2005;Aicardi and Ohtahara, 2005;Dravet et al., 2005b).  
 
Interictal EEG appearances in developmental cortical lesions (MCDs) are generally 
non-specific. However, some patterns have been recognised that may provide 
'diagnostic clues' to further pursue magnetic resonance imaging. High amplitude 
rhythmic fast activity, for example, can be seen in recordings of infants and young 
children with diffuse bilateral malformations (Lissencephaly) (Dalla et al., 1996). 
With  hemispheric lesions this pattern may be lateralised or localised (Dalla et al., 
1996). Localised or focal cortical abnormalities, however, appear to be associated 
with more heterogeneous EEG appearances that can change over time from initially 
normal recordings with later evolution of abnormalities, or initially localised changes 
that become generalised (Guerrini et al., 1992;Raymond et al., 1995). Interictal 
patterns seen on scalp EEG recordings of variable proportions of children and adults 
with focal or lateralised cortical lesions (mostly patients undergoing pre-surgical 
evaluation and/or epilepsy surgery) include rhythmic (fast),  repetitive or continuous 
epileptiform discharges and localised slow activity (Raymond et al., 
1995;Gambardella et al., 1996). In infants with focal cortical dysplasia the initial 
EEG appearances are even more variable and include focal discharges, 
hypsarrhythmia  and burst suppression pattern (Lortie et al., 2002). Variations of the 
typically described interictal and ictal EEG patterns are commonly observed in 
infantile spasms /West syndrome with underlying cortical abnormalities (Fusco and 
Vigevano, 1993;Dulac and Tuxhorn, 2005). Such EEG appearances include presence 
of focal discharges during clusters of spasms, fast activity seen concomitantly with 
spasms, or variant forms of hypsarrhythmia especially with marked asymmetry 
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(hemi-hypsarrhythmia) (Dulac et al., 1999;Kobayashi et al., 2004;Dalla et al., 2007). 
Specialised functional imaging techniques including ictal single photon computer 
tomography (SPECT) and [18] fluoro deoxyglucose positron emission tomography 
(FDG-PET) may be considered when conventional MR images fails to detect a 
lesion, that may be a target for epilepsy surgery (Chugani et al., 1990;Hwang et al., 
1996;Mori et al., 2007;Kakisaka et al., 2009).  
 
The role of the EEG for prediction of outcome in infancy onset epilepsy has been 
investigated in several hospital/specialist setting based studies. Cavazzuti et al report 
a significant correlation between epileptiform interictal EEG and poor seizure as well 
as developmental outcome in a large cohort of infants (n=482) presenting with 
convulsive seizures (including febrile and acute symptomatic seizures) in the first 
year of life (Cavazzuti et al., 1984). Similar findings have been reported by Datta and 
Wirrel from a smaller infancy cohort (n=40) that included unprovoked and acute 
symptomatic seizures with the exception of febrile convulsions (Datta and Wirrell, 
2000). In a subgroup of infants presenting with focal seizures abnormalities on the 
initial EEG (abnormal background activities and/or epileptiform discharges) were 
also correlated with poor developmental and seizure outcome at 5 year follow up 
(Okumura et al., 2001). The three mentioned studies investigated the impact of 
several factors on outcome in separate analyses and none applied multivariate 
regression statistics. Multivariate logistic regression analysis was applied in one 
already quoted study investigating children diagnosed with epilepsy under the age of 
2 years in a hospital setting (n=75) (Altunbasak et al., 2007). The authors examined 
the impact of various clinical factors including EEG in 3 separate multivariate 
models on a) neurological abnormality at last visit, b) developmental retardation and 
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c) 1 year - seizure free outcome at follow up.  Epileptiform activity on EEG was a 
significant factor together with use of > 1 antiepileptic drug in only one model that 
predicted neurological abnormality at last clinic visit. Overlapping effects between 
the factor 'epileptic activity on EEG' and other factors as well as the number of 
factors included into the models with a relative small sample size are possible 
explanations for this result.  
 
Several studies have looked at the relationship between the profound interictal 
EEG abnormalities seen in infantile spasms/West syndrome and developmental 
outcome. Kramer et al could not demonstrate a relationship between the 
various patterns of hypsarrhythmia to developmental outcome (Kramer et al., 
1997). The same authors applied a hypsarrhythmia scoring system that 
quantified the degree of pre‐treatment EEG abnormality of various 
characteristics such as disorganisation, amount of slow activity, amplitude and 
frequency of discharges. The correlation between higher hypsarrhythmia scores 
and worse developmental outcome was statistically significant. However, the 
developmental function of subjects with a particular hypsarrhythmia score 
showed wide variation from mild to profound developmental impairment 
suggesting impact of other confounding factors including aetiology, treatment 
lag and response to treatment. Persistence of hypsarrhythmia beyond 3 weeks, 
correlated in a logistic regression model with worse developmental outcome in 
another study (n=48, 38% cryptogenic infantile spasms) (Rener‐Primec et al., 
2006). As discussed by the authors persistence of hypsarrhythmia may be a 
marker for treatment resistance associated with worse brain pathology or the 
result of a longer treatment lag.   
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Recurrence of hypsarrhythmia between consecutive spasms within a cluster was 
initially reported to be associated with more favourable outcome (Fusco and 
Vigevano, 1993;Dulac et al., 1993). This was subsequently not confirmed by other 
groups (Haga et al., 1995;Gaily et al., 2001).  
 
Information provided by the EEG is rarely diagnostically specific and interpretation 
requires consideration of the clinical context as well as results of other investigations. 
The EEG (especially video EEG) contributes to diagnosis of seizure types and 
epilepsy syndromes. In addition EEG appearances can also influence decisions on 
further diagnostic work up. Lateralised or focal ictal or interictal eletrographical 
features, for example,  may give rise to consideration of more specialised 
neuroimaging techniques (such as FDG -PET scans, ictal SPECT scan) especially 
when 'standard' MR imaging does not demonstrate a lesion. 
 EEG appearances may also have a role in the prediction of outcome in infancy onset 
epilepsy although current data are sparse and in the majority originate from specialist 
settings. 
2.2.7 Outcome 
Several studies published in the last thirty years, report the outcome of children 
presenting with recurrent seizures in the first 12 and 24 months of life (Chevrie and 
Aicardi, 1978;Chevrie and Aicardi, 1979;Matsumoto et al., 1983c;Cavazzuti et al., 
1984;Czochanska et al., 1994;Battaglia et al., 1999;Rantala and Ingalsuo, 
1999;Altunbasak et al., 2007).  The majority of patients have been followed up for 
more than 3 years in most series. Several are retrospective and most studies with the 
exception of one (Rantala and Ingalsuo, 1999) are hospital and specialist clinic 
based. There are limitations to the comparability of outcome data between studies as 
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inclusion criteria vary (single or recurrent seizures) and some investigators enrol also 
infants presenting with acute symptomatic and febrile seizures (Cavazzuti et al., 
1984). Several authors state that they include all children that were diagnosed with 
epilepsy in the first 12 or 24 months of life without detailing the criteria that 
constitute such a diagnosis (Czochanska et al., 1994;Altunbasak et al., 2007). In the 
following paragraphs the outcome data reported in these studies are summarized 
under 3 different aspects: epilepsy, morbidity/mortality and neurodevelopment.  
2.2.7.1 Epilepsy 
The first data relating to the seizure outcome of infancy onset epilepsy were 
published by Chevrie and Aicardi in the late 1970's (Chevrie and Aicardi, 1979). 
They reported outcomes of a large hospital based retrospective cohort of children 
with seizure onset between 1 and 12 months of age (n=293). The median follow up 
period was 3 years and 6 months (range 1- 24 years). The cumulative percentage of 
children with persistent seizures was 70% at 2 years and 56% at 6 years following 
the first seizure. Persisting seizures were significantly more common in children with 
symptomatic aetiologies, infants presenting with status epilepticus or partial seizures 
compared to generalised seizures and infantile spasms. Epilepsy was less common in 
infants with normal developmental and neurological status at follow up. Matsumoto 
et al documented a slightly better seizure outcome from their retrospective hospital 
based infancy onset epilepsy cohort (n=251) (Matsumoto et al., 1983c). At follow up, 
at age 6 years and older (average age 144 months), 56% were seizure free for more 
than 3 years. Seizure outcome in the subgroups with symptomatic aetiology 
(cumulative percentage of patients > 3 years seizure free at 6 years: < 30%), infantile 
spasms (33% > 3 years seizure free) or secondarily generalised seizures (34% seizure 
free > 3 years) was worse compared to infants presenting with cryptogenic aetiology 
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(cumulative percentage of patients > 3 years seizure free at 6 years: > 60%), initially 
generalised motor seizures other than spasms (81% seizure free for > 3 years at 
follow up) or partial seizures (57% seizure free).  
 
Other studies of hospital/specialist clinic based infancy cohorts showed similar 
proportions of children that had persisting seizures (44-47%) or were seizure free 
(53-56%) at follow-up. Minimum time periods without seizures necessary to classify 
a case as seizure free were either not further specified or relative short,  defined as 6 
or 12 months (Czochanska et al., 1994;Battaglia et al., 1999;Altunbasak et al., 2007).  
 
In comparison with data from childhood epilepsy cohorts (composed of infants and 
older children up to the age of 16 years) the seizure outcome of infants with epilepsy 
presenting to hospital / specialist settings is worse. Sixty four percent of children 
with epilepsy onset between 1 month and 16 years enrolled in the Dutch study of 
childhood epilepsy (multicentre hospital based ) were more than 2 years seizure free 
at five year follow-up (Arts et al., 2004). This proportion remains relatively stable 
after long term follow  up over several decades according to data from a Finnish 
cohort with  64-67% of patients with childhood onset epilepsy (under the age of 15 
years ) reported to be in seizure remission (> 5 years) on or off antiepileptic 
medication (Sillanpaa et al., 1998;Sillanpaa and Schmidt, 2006). 
 
Seizure outcome in population based infancy epilepsy cohorts may be better as 
suggested by findings of Rantala et al (Rantala and Ingalsuo, 1999). The already 
above mentioned retrospective population based study of infants with seizure onset 
in the first two years of life documented seizure remission for a mean period of 13 
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years (antiepileptic medication was withdrawn after 2 years being seizure free) in 
60% (37/65) of children.  However, the majority of the infants who became seizure 
free had cryptogenic epilepsy (32 of 37) apart from five with symptomatic aetiology.  
 
2.2.7.2 Morbidity and Mortality 
A significant proportion of children varying between 31 and 67% have neurological 
abnormalities on long-term follow-up(Chevrie and Aicardi, 1978;Matsumoto et al., 
1983c;Czochanska et al., 1994;Datta and Wirrell, 2000;Altunbasak et al., 2007). This 
proportion was slightly lower in the series reported by Matsumoto et al (80/304, 
26%)  that also includes infants presenting with febrile seizures (Matsumoto et al., 
1983c). Not surprisingly neurological abnormalities were more common in infants 
with symptomatic aetiology which is reflecting brain pathology (Chevrie and 
Aicardi, 1978;Matsumoto et al., 1983a;Datta and Wirrell, 2000). In the early studies 
presence of neurological abnormality at presentation was however used to categorize 
cases as symptomatic, creating a circular argument.  
 
Seizure type at presentation and age at onset may also be relevant factors. Chevrie 
and Aicardi observed a higher proportion of children with gross neurological 
abnormalities (defined as presence of hemiplegia, bilateral pyramidal signs, 
pseudobulbar syndrome, major hypotonia ) at follow up in the subgroups with status 
epilepticus ( 43%)  and partial seizures (45%) compared with infantile spasms (27%) 
or generalised seizures (27%) (Chevrie and Aicardi, 1978). Nearly twice as many 
children that were less than 6 months old at seizure onset (38%) compared with 
infants older than 6 months presenting with seizures had neurological impairment at 
follow up (20%). This could be interpreted in two ways: a) certain brain 
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abnormalities associated with neurological impairment manifest with earlier seizure 
onset or b) early seizures especially if prolonged (status epilepticus) may result in 
brain injuries with subsequent neurological impairment.  
 
Mortality of infants presenting with seizures / epilepsy in the first 12 or 24 months of 
life ranged from 4 -12%  (Chevrie and Aicardi, 1978;Cavazzuti et al., 
1984;Czochanska et al., 1994;Battaglia et al., 1999;Rantala and Ingalsuo, 1999). 
Causes were specified in 3 series (Matsumoto et al., 1983c;Czochanska et al., 
1994;Rantala and Ingalsuo, 1999). Infection was the commonest cause. Most of the 
deaths in the series followed by Czochanska et al (15 of 133) occurred in children 
with neurological impairment (Czochanska et al., 1994). A relationship with status 
epilepticus was observed by Matsumoto et al in 11of 45 deaths (24%) and 1 of 6 
deaths by Rantala et al (Matsumoto et al., 1983c), (Rantala and Ingalsuo, 1999). In 
the large retrospective cohort described by Chevrie and Aicardi mortality was higher 
in the subgroups of infants with symptomatic epilepsy, early seizure onset (< 6 
months), status epilepticus or partial seizures (Chevrie and Aicardi, 1978).   
 
Although the proportion of deaths in childhood epilepsy cohorts is smaller (1.9 -
3.7%) similar factors are associated with increased mortality (Callenbach et al., 
2001;Camfield et al., 2002;Berg et al., 2004b). Most deaths occurred in 
neurologically abnormal children and were rarely attributable to seizures themselves. 
Conducting chi squared tests for bivariate analyses Berg et al found in their 
community based cohort that aetiology, epilepsy syndrome diagnosis (epileptic 
encephalopathy versus all other syndrome diagnoses combined), seizure control and 
seizure onset under 2 years were significantly associated with mortality (Berg et al., 
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2004b). In a multivariable Cox proportional hazards model only symptomatic 
aetiology and epileptic encephalopathy syndromes were independently associated 
with mortality.  These factors however overlap. Of the 13 deaths reported from the 
Connecticut childhood epilepsy cohort by Berg et al. 10 children were diagnosed 
with an epileptic encephalopathy syndrome (the majority with Lennox-Gastaut 
syndrome, one West syndrome, one Othahara syndrome and one SMEI). Nine of 
these cases had a symptomatic aetiology (structural brain abnormality or metabolic 
disorders).  These findings merely confirm that death in childhood epilepsy is mostly 
confined to children diagnosed with severe types of epilepsy, commonly with onset 
in early age and with serious underlying disorders. 
 
2.2.7.3 Neurodevelopmental status  
The proportion of children with normal developmental outcome following epilepsy 
onset in the first year of life varied between 21 and 38 % in early hospital based 
retrospective studies (Chevrie and Aicardi, 1978;Matsumoto et al., 1983c). 
Differences in the composition of these infancy epilepsy cohorts and possible under-
reporting of developmental impairments because standardised neurodevelopmental 
assessment tools were not applied (the developmental status was classified under 
gross categories, such as “normal” versus “severe retardation”) may explain this 
variability. Significant factors that related to poor outcome included early seizure 
onset (< 6 months), pre or peri-natal abnormalities, seizure type (infantile spasms, 
partial and secondarily generalised seizures) and symptomatic aetiology. There was a 
subgroup of children with better seizure and developmental outcome. These infants 
presented with generalised seizures, cryptogenic or unknown aetiology and had more 
commonly a family history of febrile or afebrile seizures suggesting aetiological 
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relevance of genetic factors (Chevrie and Aicardi, 1979). Later publications 
delineating benign familial and non familial infantile seizures focused on this 
subgroup in detail (Vigevano et al., 1992;Watanabe and Okumura, 2000).  
 
Standardised assessment tools, such as Brunet-Lezine scales for infants/young 
children, Terman –Merill scales, Stanford Binet and Wechsler Intelligence Scales for 
Children were applied in more recently published specialist setting based prospective 
infancy epilepsy cohorts (Czochanska et al., 1994;Battaglia et al., 1999;Altunbasak 
et al., 2007). The primary outcome measure in these papers was full scale IQ and 
further details are often not provided. Thirty three to 42% of children had IQ’s in 
normal or borderline range (IQ > 70 or 75) and a significant proportion (46 - 48%) 
had profound cognitive impairment on follow up (IQ’s < 50). In keeping with the 
observations made in the initial studies symptomatic aetiology, early seizure onset 
(<6 months) and early abnormal development were related to poor outcome 
(Battaglia et al., 1999). Altunbasak et al found significant risk ratios for 
“developmental retardation” at the last follow up for the following factors: mental 
retardation at initial presentation, abnormal neurology, initial infantile spasms, use of 
> 1 anti-epileptic drug, history of neonatal seizures, symptomatic aetiology and 
perinatal anoxia. It is very likely that several of these factors are correlated. 
Therefore in a multivariate logistic regression analysis only two factors: ‘abnormal 
neurology’ and ‘use of > 1 antiepileptic medication’ were significant and 
independently associated with developmental impairment (Altunbasak et al., 2007).  
  
These data originating from hospital and specialist based settings indicate that up to 
two thirds of children with epilepsy onset in the first 12-24 months of life have 
significant developmental impairment on follow up.  Because of the bias associated 
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with the setting this observation may not be applicable to community and population 
based settings. Only 26.4% of children enrolled in the Connecticut community based 
childhood epilepsy cohort (epilepsy onset 1 month to 15 years) had some degree of 
global cognitive impairment, defined as IQ< 80, on follow up (Berg et al., 2008a).   
In this cohort, however, younger age at epilepsy onset (< 5years) was significantly 
and independently associated with a risk of global cognitive impairment. This would 
further support the notion that children with very early onset epilepsy are at high risk 
for developmental/cognitive impairment. It remains uncertain if seizure activity itself 
has a causal role or whether the impairments are a manifestation of the underlying 
brain disorder. 
 
2.3  Conclusions and Research questions 
 Frequency of epilepsy with onset under the age of two years:  
The fact that the incidence of childhood epilepsy peaks in the first year of life 
has been well documented and replicated in several studies as outlined in 
section 2.2.2.. Incidence estimates for the first year of life however show 
great variability. Factors that may be accountable include differences in study 
design (ascertainment methods), case definitions and populations in various 
geographical areas. Although children under the age of two are regarded as a 
separate vulnerable group amongst children with epilepsy there is a lack of 
data pertaining to the frequency of epilepsy onset in this age group. 
 
 Classification of epilepsy syndromes in the first 2 years of life:  
As reviewed in section 2.1.3 the majority of children with epilepsy can be 
classified using the 1989 ILAE ICE. However at least a third of children 
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cannot be classified or fall into unspecific categories, that provide little 
information. Few data are available with respect to the usefulness of the 2001 
diagnostic scheme. The distribution of epilepsy syndromes in the first 2 years 
of life in a population based setting is poorly documented in the literature as 
discussed in section 2.2.3.  Available data give the impression that specific 
syndromes apart from West syndrome /infantile spasms are rare. This 
includes electro-clinical syndromes with good outcome. 'Benign infantile 
seizures', however, have only been included in the syndrome list in the 2001 
ILAE proposal and may have therefore not been identified in population or 
community based studies using the 1989 ICE.  Less severe types of epilepsy 
are likely to be under-represented in the discussed mostly hospital based 
infancy epilepsy series. There is also a suggestion that a significant 
proportion of children with epilepsy onset under the age of 2 years, especially 
when the aetiology is unknown, cannot be classified in a meaningful way 
using the international epilepsy syndrome classification systems that were 
recognised at the time this study was carried out (Sarisjulis et al., 2000). This 
raises the question how useful the syndromic classification suggested in the 
2001 ILAE proposal is in the population of children with newly onset 
epilepsy under the age of 2 years at initial presentation and if diagnoses are 
stable after a time interval.   
 
 Outcome: 
Review of the published in the majority hospital and specialist clinic based 
series of children with epilepsy onset in the first 12 or 24 months of life 
(section 2.2.7) supports the view that patients in this age group are at high 
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risk of poor outcome . Symptomatic aetiologies (especially structural brain 
abnormalities) are more common, chances of seizure remission are smaller, 
and mortality is higher in this age group compared to later childhood-onset 
epilepsies. A significant proportion of children have motor impairment and 
the majority have long-term neurodevelopmental and cognitive deficits. The 
series do however also implicate a subgroup of children that have better 
seizure and developmental outcome. This group may be under represented in 
the hospital and specialist setting. Thus the published outcome data may not 
truly be representative of the general population.  
 
 Neuroimaging and structural brain abnormalities: 
 At the time the data for some of the infancy epilepsy onset series have been 
obtained, available neuroimaging techniques were limited and thus subtle 
structural brain abnormalities especially may have been incompletely 
documented. Considering the wide spectrum of presentations and outcomes 
in this age group population based information on spectrum of structural 
brain abnormalities and the relation to seizure as well as neurodevelopmental 
outcomes is important. Information regarding the yield of neuroimaging (MR 
imaging) as currently applied in clinical practice in a population based setting 
may contribute to justification of local and national guidelines. 
 
 Role of EEG:  
The EEG as reviewed in section 2.2.6.2 contributes to diagnosis and 
classification of epilepsy types in the infancy age group. The information on 
its role in prediction of developmental function at presentation and follow up 
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in a population based setting is very limited. 
 
 Based on the above points the following research questions were proposed for 
this study: 
1. What is the incidence of new onset epilepsy in children aged between 4 
weeks and 2 years? 
 
2. What proportion of children with epilepsy onset under age of two years in a 
population based setting can be categorised using the diagnostic scheme,  in 
particular seizure types and syndrome list, as suggested in the 2001 ILAE 
proposal at diagnosis (Engel, Jr., 2001) ?  
Is there consistency between raters? 
Are diagnoses reliable over time (reclassification after 12 months with 
additional information) 
 What is the distribution of seizure types and syndromes in this population 
based cohort? 
 
3. Which aetiologies and structural brain abnormalities can be identified in this 
cohort?  
 
4. What are the predictors of the neurodevelopmental status close to diagnosis? 
 
5. What are the predictors of longitudinal changes of the neurodevelopmental 
status at 12 months follow up? 
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2.4 Epilepsy in Infancy study: A population based collaborative study on 
epilepsies with onset under the age of 2 years in North London 
 
In order to address research question 1, a defined population was required in which 
the occurrence rate of epilepsy in children under the age of 2 years could be 
estimated. Further descriptive information of such an incidence cohort was needed to 
address questions 2 to 5. Therefore a study was designed to combine population 
survey and cohort observation. The surveyed infancy population was defined 
according to the place of residence in a defined geographical area.  Ascertainment 
and data collection methods were set up as described in the following chapter. The 
cases were intercepted and recruited into an observational cohort for evaluation as 
outlined below to address research questions 4 and 5. By combining surveillance and 
cohort observation cases could be recruited from a population/community setting 
with the aim to minimize referral bias.  
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3 CHAPTER 3: METHODS 
 
3.1 Population survey 
In the UK it is common and good medical practice that children presenting with 
seizures or new onset epilepsy to primary care physicians and accident & emergency 
units are referred to a paediatrician. The National Institute for Health and Clinical 
Excellence (NICE), an independent organisation in the UK responsible for providing 
national guidance on the promotion of good health, has also identified this practice as 
key priority for implementation: “All children with a recent-onset or suspected 
seizure should be seen urgently by a specialist (defined as a paediatrician with 
training and expertise in the epilepsies)” (National Institute for Clinical Excellence, 
2004). Thus the candidate assumed that all children under the age of 2 years with 
new onset epilepsy would be seen by a paediatrician soon after initial diagnosis and 
decided to conduct a survey involving consultant paediatricians and paediatric junior 
doctors but not general practitioners.  
The British Paediatric Surveillance Unit (BPSU, a collaboration between the Royal 
College of Paediatrics and Child Health, UCL-Institute of Child Health, Health 
Protection Agency, Health Protection Scotland and the Faculty of Paediatrics of the 
Royal College of Physicians of Ireland) has established a postal reporting system 
through consultant paediatricians in order to survey rare childhood conditions on 
national level. Epilepsy however is the commonest chronic neurological condition in 
childhood and the frequency is expected to be especially high in the first year of life. 
Thus, conducting the population survey for this study through the BPSU on national 
level would have been inappropriate. 
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A surveillance study in a geographically defined area of North London was set up 
considering the following practical aspects: 
i. the area is densely populated (see section 3.1.1) 
ii. the North Central London Epilepsy Network (see  section 3.1.2) could 
be  used as a forum to promote the survey 
iii. a surveillance study investigating childhood status epilepticus has 
been previously conducted in the same geographical area of North 
London and the established referral network of collaborating  
hospitals as well as notification systems could be adapted for this 
study (Chin et al., 2005;Chin, 2005).  
 
3.1.1 Geographical area in North London and target population   
The target population was defined as residents in the geographical area outlined 
in Figure 3.1. This area consisted of 15 boroughs of North London. Residents 
were identified by the postal code of their home address during the period of 
ascertainment.  
 
Authoritative data about the residential population are based on the Census that is 
conducted every 10 years in the UK. The last Census took place in April 2001. 
Information on accommodation, relationship, demographic characteristics (e.g. 
sex, age, and marital status), cultural characteristics, health and provision of care, 
qualifications and employment were obtained from every household. These data 
are updated by the Office for National Statistics (ONS) annually in order to 
produce “mid-year population estimates” for the years in between the Censuses. 
Mid-year estimates are made with reference to the residents on the 30th June with 
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the population on 30th June of the previous year as starting point. The cohort 
component method is used whereby the previous mid-year population is aged-on 
by one year and the population change is estimated by accounting for the births 
and deaths in the previous 12 months as well as migration to and from the area. 
Further adjustments are made for mobile groups that are not captured by the 
migration estimates.  Plausibility checks of these estimates are carried out 
including calculation of demographic rates and ratios (National Statistics, 
2004;Jefferies and Fulton, 2005). 
  
According to the mid - 2006 estimates 3,218,810 residents live in the defined 
geographical area of North London. Of these 609,287 (19%) are children (under 
the age of 16 years) and 98,090 (3 %) are under the age of 2 years (Office for 
National Statistics, 2008). Compared to the 2001 census data the population has 
increased (see appendix 1: Resident population of surveyed geographical area in 
North London). This can be in part be explained by increased immigration 
numbers over recent years. Figures published by the National Office for Statistics 
based on several sources (International Passenger Survey, Labour Force Survey) 
demonstrated that London has the highest immigration figures compared to other 
destinations within the UK. Twenty nine percent of immigrants state their intend 
to be resident in London (The National Office for Statistics, 2008).  
Table 3.1 lists the population density by borough in the target geographical area. 
The highest childhood population density is in Hackney and the lowest in the 
City of London. 
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As a large metropolitan population the composition of ethic groups is different in 
North London compared to England and Wales (see also appendix 2 for distribution 
of ethnic groups in childhood population 0-15 years in North London and England 
and Wales).   
 
 
Figure 3.1: Surveyed geographical area in North London  
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Table 3.1: Population density in the surveyed geographical are of North 
London ( based on Mid -2006 population estimates, Population Estimates 
Unit, Office For National Statistics) 
BOROUGHS Childhood 
Population 
 <= 2 years 
Land Area 
(km) 
Population 
density children 
<=2 years 
per sq km 
Density 
children aged 
< 16 years per 
sq km 
CITY OF 
LONDON 
104 3 36 254 
BARNET 9,357 87 108 812 
BRENT 8,514 43 197 1,245 
CAMDEN 5,668 22 260 1,716 
ENFIELD 8,748 81 109 782 
HACKNEY 8,171 19 429 2,555 
HAMMERSMITH 
& FULHAM 
4,822 16 294 1,763 
HARINGEY 7,460 30 252 1,564 
HARROW 5,758 50 114 891 
ISLINGTON 4,937 15 332 2,151 
KENSINGTON & 
CHELSEA 
4,149 12 342 2,368 
NEWHAM 10,050 36 277 1,717 
TOWER 
HAMLETS 
7,427 20 376 2,355 
WALTHAM 
FOREST 
7,755 39 200 1,273 
WESTMINSTER 
5,141 21 239 1,469 
3.1.2 The North Central London Epilepsy Network 
The North Central London Epilepsy Network, established in 2003, represents a 
partnership of paediatricians, paediatric neurologists and other health professionals 
involved in the management of children with epilepsy that work together across 
organisational boundaries. The aim is to create better integrated services for children 
with epilepsy in North London, this includes sharing of resources (information for 
patients, families, teachers etc.), training, regional guidelines, audit and research. 
Although the network has been primarily established with health professionals caring 
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for the population in North Central London (Enfield, Barnet, Islington, Haringey, 
Camden) the network meetings, held 3 monthly are also attended by consultant 
paediatricians from other hospital / primary care trusts in North East and North West 
London (that do not have their own epilepsy networks). Members of the network 
were approached to support and collaborate with the survey. The study was promoted 
on network meetings and the members were provided with updates about the 
progress.  
3.1.3 Ascertainment 
3.1.3.1 Notification systems 
Identifying cases through a single source may result in under-ascertainment or bias. 
Thus, a multi-tiered notification system that was successfully applied in a 
prospective paediatric study on convulsive status epilepticus conducted in the same 
geographical area of North London (North London Status Epilepticus in Childhood 
Surveillance Study, NLSTEPSS) was adopted (Chin et al., 2005). This combined 
passive method (24 hour telephone line) and active notification methods (regional 
BPSU like regional postal survey). As outlined by Chin re-call bias may occur, 
because responders are asked at the end of each month to report cases in the 
preceding month; under-ascertainment and delayed notification of cases are 
additional weaknesses of the postal survey (Chin, 2005). Chin also discusses 
strategies that have been identified to increase the response to postal surveys which 
include design of a short questionnaire, first class outward mailing and postal follow 
up (reminder) that includes a questionnaire (Chin, 2005).  
The regional BPSU like postal survey and the telephone system used in NLSTEPSS 
have been adapted for this study in such a way that cases could be either notified 
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anonymously and anonymised information was obtained subsequently or registered  
with name as well as contact details after consent of the patient’s parents / carers was 
obtained to be contacted by the researcher. The latter was necessary in order to 
intercept cases and enrol these in the observational cohort: 
 
Telephone hotline:  
A telephone line was set up to notify cases at the time these were seen. This 
notification method was similar to that used in NLSTEPSS and was primarily 
directed to paediatric junior medical staff and nursing staff involved in the care of 
patients with epilepsy. Messages could be left 24 hours by using an automated 
system that requested the following information: contact details of the caller, 
patient’s initials, date of birth, postal code or name, address or patient’s name as well 
as contact details when consent of the parents/carers to be contacted subsequently by 
the research team was obtained. The system was checked for messages daily during 
the working week. The telephone number was displayed on posters and in hospital 
wards, outpatients and admission units of collaborating hospitals. In addition “study 
promotion cards” in business-card format displaying telephone number and 
“Epilepsy in Infancy Study” website address were distributed to paediatric junior and 
consultant staff.  
 
Monthly postal survey:  
A regional postal survey was directed to hospital and community based consultant 
paediatricians that provide services to the residents in the surveyed geographical 
area.  Case notification forms and self addressed envelopes were sent out by first 
class mail at the end of each month during the ascertainment period. The forms were 
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designed in a way to achieve optimal response on a single A4 page, orange coloured 
paper (see appendix 3). Simply by ticking a box the recipient could indicate ‘No 
cases seen’ in the previous month. Cases were notified on the form either by giving 
identifiers (patient’s initials, date of birth, postal code) or name, contact number and 
address with consent of the parents/carers that were informed about the study by the 
paediatrician. Reminder letters were sent out if a response was not received within 4-
6 weeks. 
 
A list of all consultant paediatricians regardless of subspecialty was generated by 
contacting all hospital paediatric departments and community services in the 
surveyed area. The information obtained was compared to the list of paediatricians 
published annually in the handbook of the Royal College of Paediatrics and Child 
Health. From Great Ormond Hospital for Children (GOSH) only Paediatric 
Neurologists were included in the mailing list. It is practice at GOSH that provides 
highly specialised tertiary and quaternary paediatric services to refer all patients with 
newly diagnosed epilepsy to the paediatric neurology team. In addition the care for 
the patients admitted to GOSH is usually shared with a consultant paediatrician 
based in the local hospital. The latter would have been included in the postal survey. 
Similar to the BPSU system a list of positive responders was generated.  Posting of 
monthly questionnaires was omitted for consultant paediatricians with 
subspecialisation in a field, in which they were unlikely to be involved in the primary 
management of infants with newly presenting epilepsy (such as paediatric 
endocrinologists, paediatric haematologists) either on their own request or if they 
failed to return questionnaires for more than 3 months, despite of reminders.  These 
subspecialty paediatricians were informed in a letter that they were excluded from 
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the monthly mailing list and unless they inform the researcher otherwise the 
researcher assumed their agreement to notify any cases meeting including criteria for 
the study.  
 
Consultant paediatric neonatologists of one hospital department (Homerton Hospital) 
requested to be excluded from the postal survey stating that all eligible patients 
would be referred to consultant paediatricians in their department or paediatric 
neurologists. During the 13 months ascertainment period the mailing list was updated 
according to information sent to the researcher with return of notification forms and 
also when in contact with paediatric departments in the surveyed area whilst 
promoting the study or collecting data.  
 
Other sources: 
A number of cases were directly notified to the candidate, who was based at UCL-
Institute of Child Health /Great Ormond Street Hospital by paediatric neurology team 
members, through telephone calls (not using the study phone number) or by 
electronic-mail. This was especially the case for infants that were referred by the 
general paediatricians directly to the 'Rapid Neurology Assessment Unit' based at 
Great Ormond Street Hospital. Medical and nursing staff notified the researcher 
directly (verbally or by e-mail) about such cases.  As in the methodology described 
by Chin these cases were considered as passive notifications and categorised as being 
identified by “Telephone” (Chin, 2005).  
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3.1.4 Case definition and ascertainment period 
Inclusion criteria: 
Infants and young children who met the following criteria were eligible for 
enrolment: 
− Age between 4 weeks and 24 months 
− newly diagnosed epilepsy, history of 2 or more unprovoked seizures 
− seizure onset in the first 4 weeks of life but continuing beyond this age  
Exclusion criteria: 
Patients with seizures provoked by acute conditions such as fever, infections, trauma, 
electrolyte disturbances, transient metabolic or endocrine disorders as well as 
neonates with seizures that did not recur after 28 days of age were excluded. 
 
Cases were ascertained over 13 months (1st September 2005 until 1st October 2006).  
 
3.1.5 Promotion of the study  
Information about the plan to conduct the survey was posted 3 months prior to the 
start of the ascertainment period to all hospital and community based paediatricians 
providing services to the target population. This information letter contained a reply 
section for the recipient to request further information about the planned study (a 
telephone call or visit from the researcher to the paediatric department). In each 
participating hospital a consultant paediatrician agreed to be the local collaborator for 
this study. The collaborators took local Research & Development responsibility, 
helped to promote the study in their departments and also served as a link to the 
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research team.  
 
The researcher presented the study at departmental meetings in participating 
hospitals that were attended by consultant and junior staff. Information sheets for 
paediatricians and parents were distributed on these occasions. In addition the study 
was also presented on regional RCPCH study days and the regional monthly 
neurodisability training meetings. The latter were attended by community 
paediatricians.  
The study was also promoted through posters that were displayed in the paediatric 
wards, A&E units and outpatient departments of collaborating hospitals.  
A website (www.epilepsyininfancy.ich.ucl.ac.uk) provided information about the 
study, and also had links to download information leaflets for parents and medical 
staff. The website address and study telephone number were displayed on promotion 
cards in business card format that were distributed to consultant and junior medical 
staff. 
 
Newsletters providing updates and information about progress of the study were 
posted approximately 6 monthly during the 13 months ascertainment period to 
consultant paediatricians in order to maintain awareness (see Appendix 4: 
Newsletters).   
 
3.1.6 Data collection 
Data were collected using a standard epilepsy history proforma, which was generated 
with input of the local collaborators in the participating hospitals (see Appendix 5: 
Standard History Proforma). Epilepsy history proformas that where in clinical use at 
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the time (Great Ormond Street Hospital, Nottingham University Hospital) served as 
model for the initial draft. The following information was requested: seizure history 
(age at onset, description of manifestations of first, subsequent and current seizures, 
frequency), details of antiepileptic medication, birth and neonatal complications, 
other medical or genetic diagnoses, family history, information about previous and 
current developmental progress, ethnic background, investigations results.  
The proforma was designed for prospective completion at the time a patient with 
suspected epilepsy was seen (e.g. in outpatients or admission units) and could be 
filed as part of the hospital notes. Tick boxes were included wherever possible in 
order to make completion easier. The section requesting information about the 
developmental progress for example included milestones based on the Denver 
screening questionnaire, with answers to be circled as appropriate (“yes”, “no”, 
“don’t know”).  
 The epilepsy history proforma was distributed in all participating hospitals and 
could also be downloaded from the “Epilepsy in Infancy Study” website. 
Anonymised copies of the epilepsy history proforma (identifiers: patient’s initial’s, 
date of birth, first part of postal code of home address) were requested with the 
notification of a case by the researcher. When the proforma was not available 
anonymised clinical documents including clinic letters, discharge summaries and 
investigation reports were obtained.   
 
3.1.7 Case verification 
The clinical information obtained was reviewed by two paediatric neurologists 
independently. Cases were enrolled if both assessors agreed that inclusion criteria 
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were met. Where disagreement occurred cases were discussed and consensus 
obtained.  
3.1.8  Two Source capture-recapture method 
The capture-recapture methodology has been originally developed in wildlife 
research for the estimation of the size of animal populations. Animals are captured, 
tagged, released and recaptured again. The population size is estimated from 
information provided by multiple overlapping samples (e.g. the proportion of 
recaptured animals identified by their tags) (International Working Group for 
Disease Monitoring and Forecasting, 1995b). 
 
In human epidemiology and disease monitoring samples are represented by 
information from multiple incomplete sources (lists / registries of cases). Typically 
cases are ‘recaptured’ by matching unique identifiers of cases on several lists. 
Capture-recapture methods have been increasingly applied in disease surveillance 
over the past 60 years. Because information from incomplete registries is combined, 
such methods can be more cost effective. More importantly they provide a means to 
assess completeness of ascertainment. However application of capture-recapture 
methods requires some caution as assumptions are being made for estimates to be 
valid (International Working Group for Disease Monitoring and Forecasting, 
1995a;Chao et al., 2001). This is especially the case for the simplest model using 
only two sources of information: 
a) There should be no change of the population through migration or loss of 
cases during the study period (‘closed’ population). An assumption that is 
difficult to meet in practice for human as well as some wildlife studies. 
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b) Unique identifiers are required to match individuals on each list. The 
accuracy, with which cases are correctly diagnosed and enrolled, should be 
the same for each list. 
c) Each individual should have the same chance to be ‘caught’ on each list 
(homogeneity). Severity of the condition, age or geographical location (for 
example case resident at boundaries of the surveyed area) may influence 
whether cases are registered.  
d) Both sources are independent, e.g.  enrolment in list A should not make it 
more likely to be included in list B. For example if cases are notified by 
the same specialised clinician to a register, who also requests specific 
investigations (if surveillance of laboratories, EEG or radiology 
departments are used as second source).   
   
Case homogeneity (c) and independence (d) are difficult to achieve completely in 
human studies. Stratification of the analysis by variables which may be related to 
enrolment such as ‘case severity’ is one of the methods to adjust for case 
heterogeneity.  If 3 or more sources are available log linear models can be applied to 
assess source dependency as well as case heterogeneity and incorporate these aspects 
into the final model (Chao et al., 2001). The process of fitting log-linear models can 
be complex and requires the scientist to decide on the optimal model or set of 
models. 
 
A two source capture recapture model was applied in this study to calculate an 
ascertainment adjusted estimate (source 1: cases enrolled through 'postal survey', 
source 2: all cases notified by 'telephone' and other sources of passive notification as 
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described in section 3.1.3.1.).  A disadvantage of this approach was that correction 
for list dependency and case heterogeneity was not possible. The candidate explored 
the option to use EEG departments providing services to residents in the surveyed 
geographical area as 3rd source in the initial phases of the study. Several departments 
were visited and searched for EEG request forms and EEG reports of children in the 
age range of interest. The clinical information on the request forms, EEG reports or 
on documents completed by EEG technicians, when patients attended for recordings, 
was however very variable and frequently insufficient to decide whether cases would 
meet inclusion criteria. Considering also the time required for regular visits and 
searches of electronical data bases or through request forms in several EEG 
departments a decision was made no longer to pursue this 3rd source of 
ascertainment.  
 
Although use of at least three sources / registers has been recommended if capture-
recapture techniques are applied, in practice (as also experienced in this study) 
limitations on time, resources and availability of sources meeting criteria of similar 
diagnostic accuracy are reasons to consider the advantages of a two source model 
against a traditional case registration approach.  Capture – recapture techniques tend 
to underestimate the true number of cases (overestimation of completeness of 
ascertainment) if there is positive dependency between two lists (caused by list 
dependency or/and case heterogeneity, which make case enrolled in list A more 
likely to be included in list B).   In the case of negative dependence (enrolment on 
list A makes is less likely to be included on list B) the reverse is the case; capture-
recapture techniques overestimate the number of true cases (Brenner, 1995). Brenner 
demonstrates that in the case of positive dependence the two source capture recapture 
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technique can help to reduce the underestimation of the true case number by 
traditional case registration, especially if the sources have low rates of completeness 
(Brenner, 1995). In the case of negative case dependency application of the capture-
recapture method has no benefits or can be even disadvantageous compared to the 
traditional case registration method. The direction of the source dependence cannot 
be inferred from the data of a two source surveillance model, instead the specific 
circumstances of case registration need to be taken into consideration.  
 
In this study positive dependence between the two sources of case ascertainment 
(‘postal survey’ and ‘telephone’) was expected. Consultant paediatricians could use 
the ‘telephone hotline’ to notify eligible children or instruct the junior doctors in their 
team to call at the time cases are seen. The same consultants could also return the 
monthly posted notification form notifying the case at a later time point. Based on 
the above argument the two source capture recapture method was applied in this 
study to reduce the underestimation of the traditional case registration approach. 
 
3.2 Cohort observation 
3.2.1 Recruitment of subjects 
The parents / carers of eligible patients were initially informed by their paediatricians 
about the study. With their consent the paediatrician forwarded contact details to the 
researcher using the above described notification systems (telephone hot line, 
monthly postal survey). The families were approached by the researcher either 
directly if patients attended appointments at GOSH or by phone and a meeting was 
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arranged subsequently. At the first meeting written consent from parents/carers was 
obtained and the children were enrolled in the observational cohort. 
 
3.2.2 Evaluation 
3.2.2.1 Clinical assessment at baseline 
All patients in the observational cohort underwent clinical assessment at the time of 
enrolment (baseline assessment). A detailed patient history was obtained from the 
parents /carers during an interview and documented on an evaluation proforma (see 
Appendix 6: Evaluation proforma). The following information was recorded:  
− age of seizure onset,  
− seizure history (description of manifestations during first, 
subsequent and current seizures; duration; frequency, seizure 
free periods, status epilepticus, history of febrile seizures) 
− antiepileptic medication, including side effects and response  
− birth history and complications in the neonatal period 
− other medical and genetic diagnoses and their treatments, 
− family history (febrile seizures, epilepsy, neurological 
conditions, genetic diagnoses) 
− developmental progress prior and following onset of 
seizures, 
− concerns about visual and hearing impairment 
− investigations 
− ethnic background 
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Patients were examined by the researcher and the findings were also documented on 
the evaluation proforma. Copies of previous investigation results 
(blood/urine/cerebrospinal fluid) were requested from the paediatrician who notified 
the patient. 
 
3.2.2.2 Assessment of Neurodevelopmental Status (Baseline): 
The neurodevelopmental assessment using the standardised methods described below 
was conducted by a psychology assistant, who was supervised by a psychologist. The 
psychology assistant was not aware of the clinical details of the infants and 
conducted the tests either during the same session when subjects and parents/carers 
were seen by the candidate or during a separate appointment (home visits, or if 
children were seen at Great Ormond Street Hospital combined with other clinical 
attendances).  
 
In order to determine the developmental status close to diagnosis of epilepsy and 12 
months later the  Bayley Scales of Infant and Toddler Development 3rd edition 
[Bayley III] were administered (Bayley N, 2006a;Bayley N, 2006b). 
The Bayley Scales of Infant and Toddler Development are a standardised, widely 
applied and comprehensive assessment battery for infants and young children 
between 1 and 42 months of age (Bayley and N, 1993). The scales have recently 
been revised to include the following scales:  
- Cognitive Scale: These items assess sensory-motor development, exploration 
and manipulation, object relatedness, concept formation, memory, and other 
aspects of cognitive processing. For this revised version of the Bayley II 
(1993) items were rewritten to decrease the impact of motor ability.  
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- Language Scale: Items are separated in two subscales measuring receptive 
and expressive communication. The subscales also include items to assess 
preverbal behaviours, vocabulary development and social referencing. 
- Motor Scale: This includes two subscales:  
Fine Motor: items measure skills related to visual tracking, reaching, object 
manipulation and response to tactile information. 
Gross Motor: - measures static positioning (e.g. sitting, standing); dynamic 
movement, including locomotion and coordination as well as motor planning. 
 
 The Bayley III provides norm referenced scores including: scale and composite 
scores (Cognition, Language, Motor).  
 
‘Social-Emotional’ and ‘Adaptive Behaviour’ domains are also assessed by the 
Bayley III using a questionnaire for completion by the primary care givers:  
- Social-Emotional Scale: 
skills and functions assessed include self-regulation and interest in the world, 
communication needs, engaging others and establishing relationships, use of 
emotions in interactive, purposeful manner, use of emotional signals or 
gestures to solve problems. 
- Adaptive behaviour scale: skills assessed include the following areas: 
Communication, Community Use, Health and Safety (showing caution 
keeping out of danger, Leisure (playing, following rules), Self-Care (eating, 
toileting, bathing), Self-Direction (self-control, following directions), 
Functional Pre-academics (letter recognition, counting, drawing of simple 
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shapes) Home –Living (helping adults with household tasks etc), Social and 
Motor. The scores form the General Adaptive Composite.  
 
Following the assessment the questionnaire was given to the parents for completion 
together with a self addressed stamped envelope.  
 
The developmental state prior to seizure onset was determined by using the Vineland 
Adaptive Behavior Scales Survey Form (VABS) (Sparrow S.S. et al., 1984). The 
Survey Form questionnaire is administered to the primary caregiver by an 
interviewer and measures personal as well as social sufficiency of an individual form 
birth to 18 years 11 months old. The following domains are assessed: 
communication, daily living skills, socialisation and motor skills. The composite of 
these scales forms the Adaptive Behavior Composite.  
 
Prior to administration of the Survey Form by the psychology assistant (following 
the Bayley III assessment) or by the candidate the purpose of the interview was 
explained to parents / carers. They were asked to describe activities that their child 
usually performed just prior to onset of the first seizure. Also during the interview 
they were reminded to consider only behaviours demonstrated prior to seizure onset. 
Because of the small number of items in the VABS that apply to the neonatal age and 
limitations of carers to give accurate information about skills in this age 
retrospectively the Survey Form was only administered when epilepsy onset 
occurred after the neonatal period.  
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3.2.2.3 12 months review assessment 
Twelve months after the initial evaluation the carers were contacted to arrange 
follow up assessments. When carers and patients were unable to attend appointments 
at UCL-Wolfson Centre / Great Ormond Street Hospital for Children the psychology 
assistant visited the families at home to administer the Bayley III. A member of the 
research team conducted interviews with the family either over the phone or when 
patients for attended developmental assessments. A standard follow up proforma was 
used to record the following information:  
−  seizure status since last evaluation, seizure manifestations, frequency, 
duration 
− anti epileptic medication (changes, current, reasons for withdrawal) 
− investigations  performed since baseline evaluation 
− general health and other medical / genetic diagnoses made since baseline 
evaluation 
− developmental progress since baseline evaluation 
− general and neurological examination results (if this could be performed) 
 
3.2.2.4  Review of neuroimaging and EEGs 
Neuroimages, which were requested by the physicians responsible for the care of the 
patients as part of the initial investigations, were obtained. Two collaborating 
consultant neuroradiologists, who were unaware of the clinical details of cases apart 
from inclusion criteria, reviewed the images independently. A proforma was 
completed to document imaging sequences and planes (e.g. axial T2 weighted), 
signal abnormalities according to anatomical area and interpretation of findings. On 
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the proforma the neuroradiologists were also asked to make a subjective judgement 
about the quality of the images (graded “good”, “acceptable” and “insufficient”). 
This referred to their ability to extract sufficient information to come to a diagnostic 
conclusion with a certain level of confidence. In addition they commented if further 
repeat MR imaging should be performed (see Appendix 7: Proformas for review of 
Neuroimaging and EEG). Disagreements were resolved by discussing the individual 
cases. 
 
Digitised recordings of the EEGs requested by the physician responsible for the care 
of the patients were obtained. The recordings were reviewed by the candidate 
together with consultant neurophysiologists using a universal software program 
(Persyst). Information relating to the following points was documented on a 
proforma: type of recording, state of patient, background activities, interictal and 
ictal epileptiform activities, description and type of seizures if indicated (see 
Appendix 7).  
 
3.2.2.5 Feed back to parents and physicians 
The results of the Bayley III assessment were summarised in a short report and send 
to the notifying physician with an extra copy to be forwarded to the parents. If the 
review of neuroimaging and /or EEG recordings revealed different findings form the 
reports issued at the local hospital this information was shared with the notifying 
physician.  
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3.2.3   Classification of seizures and epilepsy syndromes 
In order to test if seizures and epilepsy syndromes in children with epilepsy onset 
under the age of two years can be determined according to 2001 ILAE task force 
proposal (research question two, chapter 2) two paediatric neurologists 
independently evaluated the clinical information including description of seizure 
manifestations, investigation results (EEG and neuroimaging data, other 
investigations) and results of the Bayley III assessments.  Both paediatric 
neurologists, who managed predominantly patients with epilepsy in their clinical 
practice,  applied the 2001 proposal with the definitions of key terms according to 
their own clinical judgement without prior agreement on ‘rules’. Cases were firstly 
categorised under one of the epilepsy syndrome groups that were suggested in the 
2001 commission report (table 5 in (Engel, Jr., 2001) and than allocated a specific 
epilepsy syndrome diagnosis if possible. 
 
In order to classify an infant under the ‘idiopathic focal or generalised epilepsy 
syndrome group’ for example,  in accordance with the definition given in the 2001 
proposal absence of structural brain abnormalities, other neurological signs / 
symptoms and any other underlying aetiology was required. In addition in keeping 
with the descriptions of the specific syndromes with onset in infancy in the idiopathic 
group the developmental status prior and after epilepsy onset was age appropriate 
and seizures usually responded to first line medication.  
 
Seizure types (axis 2) and epilepsy syndromes (axis 3) were classified at two time 
points:  following the initial (baseline) assessment and after the 12 months review. 
The reclassification following the 12 months review was conducted in two steps: in 
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step one the raters were asked to consider only information that was available 
following the baseline evaluation (intra-rater reliability); in step 2 the raters were 
also provided with additional data available after the 12 months-review (e.g. 
manifestations of continuing seizures, results of further investigations). The purpose 
of the latter was to assess change or evolution of the initial syndromic diagnosis.  
Seizures were classified according to the list of seizure types provided in the 2001 
proposal that was also published on the ILAE website at the time the study was 
conducted (see table 3 in (Engel, Jr., 2001). The 2001 task force proposal suggested 
organizing epilepsy syndromes under syndrome groups (see table 5 in (Engel, Jr., 
2001). Thus the raters were asked to determine the epilepsy syndrome group (level 1: 
e.g. idiopathic generalised, idiopathic focal, symptomatic or probable symptomatic 
focal, epileptic encephalopathies) and specific epilepsy syndrome (level 2: e.g. West 
syndrome, benign myoclonic epilepsy in infancy).   
 
3.2.4 Handling of data 
Clinical information of patients that were notified but not enrolled in the in the 
observational cohort was obtained and anonymised using identifiers (Initials, DoB) 
as described above. Non- anonymised data of patients enrolled in the observational 
cohort were collected in individual files that were stored safely at the institution this 
project was based (UCL-Institute of Child health, Neurosciences Unit). 
Two electronic password protected databases were created in Microsoft Access 2003. 
One database contained names and addresses of all consultant paediatricians 
involved in the survey, information about returns of the monthly posted notification 
forms and number of cases notified. The second database held information about 
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cases that were notified to the study, patients enrolled in the observational cohort 
including clinical, EEG, neuroimaging and psychometric data. 
  
3.2.5 Statistical Analysis 
Statistical analysis of the data was performed using the following statistical 
programmes: SPSS version 15, R version 2.6.1, Stata Version 9.  
3.2.5.1 Incidence estimates 
As denominator for the calculation of the incidence of epilepsy in children to the age 
of 2 years per year the mid-year population estimates 2006 (obtained from Office for 
National Statistics) for each of the 15 boroughs in the surveyed geographical area 
was used. The method applied to generate mid-year population estimates has been 
described in section 3.1.1.1. The 95% confidence intervals were calculated by 
applying the exact method for a single proportion. Poisson regression analysis was 
applied to investigate influence of sex and age bands (age band 0: < 12 months, age 
band 1: 12-24 months). A poisson regression model using case numbers and 
population risk for the appropriate age bands (0 and 1) from other studies identified 
in the literature as well as data from this project was fitted in order to determine the 
risk of epilepsy in the first compared to the second year of life. Poisson regression 
analysis was also applied to estimate the relative risk of ethnic group. The white 
ethnic group was used as reference group and odds ratios as well as 95% confidence 
intervals were requested. 
 
The ascertainment adjusted incidence estimate was calculated using a two source 
capture-recapture method.  
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3.2.5.2 Inter-rater agreement 
Inter-rater agreement between the two paediatric neurologists that classified seizures 
and epilepsy syndromes was assessed by calculating Kappa (κ). Kappa is a measure 
for inter-rater agreement that is corrected for agreement occurring by chance ('chance 
corrected proportional agreement'). If there is complete perfect agreement the value 
of kappa obtains +1 and it becomes 0 when there is no agreement beyond chance. 
Commonly suggested categories for the interpretation of Kappa are:  
< 0.20 - poor, 0.21- 0.40 fair, 0.41 - 0.6 moderate, 0.61 - 0.8 good, 0.81-1 very good 
(Landis and Koch, 1977). The choice of such benchmarks however may be to a 
degree arbitrary and interpretation should take clinical circumstances into 
consideration. For a circumstance in which highest possible agreement is desired the 
difference between kappa and 1 indicates the unachieved agreement beyond chance. 
In the case of agreement on a clinical diagnosis for example a view could be taken 
that a value of kappa significantly below 0.5 indicates poor agreement (Altman D, 
1991). The magnitude of kappa is affected by the prevalence in the categories (e.g. 
common conditions versus rarer conditions) and also by the number of available 
categories. Comparison of kappa values between different studies is therefore 
limited.  
 
3.2.5.3 Predictors of neurodevelopmental status close to diagnosis: 
A principal component analysis was applied to generate a 'Developmental raw-score 
Factor (DF)' from language, cognitive and motor raw scores at baseline evaluation. 
Raw scores were used to generate the DF as the distribution of composite and scale 
scores was not normal. Exploratory analyses were conducted using Analysis of 
Covariance (ANCOVA) entering the DF with ‘age at testing as covariate’ in order to 
 107
   
determine relevant factors. Stepwise multivariable linear regression was 
subsequently carried out to determine significant independent predictors of the 
developmental function close to diagnosis.  
3.2.5.4  Longitudinal change of neurodevelopmental status and predictors: 
By entering Bayley III composite factors (cognitive, language and motor) in a 
principal component analyses a 'Developmental Composite Factor' was generated 
and further analysis carried out using repeated measures ANOVA.    
 
3.2.6 Approval of the study 
The study was approved by the UCL-Institute of Child Health / Great Ormond Street 
Hospital for Children joint Ethics Committee as non local investigator study. The 
project was then registered with the ‘Research & Development’ departments of all 
acute Hospital and relevant PCTs in the surveyed geographical area. 
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4 CHAPTER 4:  RESULTS AND DISCUSSION 
This chapter is organised in sections according to the research questions.  Following 
each section the findings are discussed in the context of existing literature. 
  
4.1 Population Survey and incidence estimate of newly diagnosed epilepsy under 
the age of two years 
 
4.1.1 Cases ascertained and notification systems: 
 
Fifty seven cases met inclusion criteria and were enrolled. Thirty five cases were 
notified through the postal survey (returning of notification form), 41 by ‘phone’, 
and 19 by both systems. Figure 4.1 shows the distribution of the cases according to 
residence in the geographical target area (the legend lists only 14 sections as ‘City’ 
and ‘Hackney’ on the map are combined in one). Cases from all 15 boroughs have 
been ascertained. The mean monthly responder rate (responders / notification forms 
sent out) of the postal survey was 77%. 
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 Figure 4.1: Distribution of cases ascertained in the geographical target area 
 
 
 
 
 
 
4.1.2 Incidence of epilepsy in children under the age of 2 years 
4.1.3 Age-specific incidence of epilepsy (first and second year of life) and 
The incidence of newly diagnosed epilepsy in the first year of life with 82.1 / 
age bands (see also table 4.2 & figure 4.2.). Poisson regression models were fitted 
calculation of incidence rates directly from the model. Main effect terms for sex and 
 
The crude incidence of epilepsy under the age of 2 years in North London was 53.6 
(95% CI 41.4 - 69.5) / 100.000 children < = 2 years/year (see also table 4.1). 
sex 
100.000 / year was higher compared to the second year of life (23.4 / 100.000 / year, 
see also table 4.1). The incidence figures for males and females were similar in both 
using R version 2.6.1 with log (Population at risk) as an offset term, allowing the 
age group (“< 12 months”, “12 – 24 months”) and their interaction terms were fitted.  
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Likelihood ratio tests confirmed that only the main effect for age group was 
significant; the difference in risk for epilepsy between the “< 12 months” and “12-24 
onths” group was 3.52 (95% Confidence interval: 1.86 – 6.65; p < 0.0001). 
 to 
 
el 
 
 
ova 
the 1958 national child development 
study cohort (Risk ratio = 0.93, p = 0.7949). 
m
 
Table 4.3 shows the incidence figures from the North London study in comparison
the incidence estimates from other studies, which provide cases and population at 
risk for the first and second year of life (Camfield et al., 1996;Kurtz et al., 1998). 
Poisson regression models with log (population at risk) as offset term with main 
effects on “age group” and “study”, and their interaction term were fitted. Including
the interaction term did not significantly improve the goodness of fit of the mod
(likelihood ratio test p = 0.77). This means that age dependence of the risk for 
epilepsy in the first two years of life is similar in the three studies. Thus the final 
model comprised main effects of age and studies only. The estimate for the risk ratio
of epilepsy between the first and second year of life adjusted by study is 2.88 (95%
CI 2.15-3.9; p < 0.0001). Looking at the age-adjusted incidence of epilepsy in the 
first two years the risk was significantly lower in the London study than in the N
Scotia study (Risk ratio = 0.71, p = 0.026) . There was no difference in the age-
adjusted incidences of the North London and 
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Table 4.1: Incidence of epilepsy in the first and second year of life 
Age Population at 
risk* 
N Incidence per 
100.000/yr 
95% CI 
< 12 months 54,810 45 82.1 61.4 – 109.8 
12 - 24 months 51,423 12 23.4 13.3 - 40.8 
All (<= 2 years) 106,233 57 53.6 41.4 – 69.5 
* over 13 months , CI = Confidence Interval 
 
 
Table 4.2: Incidence and sex (Epilepsy onset under the age of 2 years) 
Age groups Male Female 
 N I 
Population 
at Risk* N I 
Population at 
Risk* 
< 12months 24 85.7 28,006 21 78.3 26,804 
12-24 months 7 26.6 26,335 5 20 25,088 
All  (<=2 years) 31 57.05 54,341 26 51.05 51,892 
N = number of cases, I = incidence per 1000,000, * over 13 months  
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 Figure 4.2: Age specific incidence rates of epilepsy by sex (bars illustrate 95% CI) 
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Table 4.3: Comparison of incidence estimates of North London Epilepsy in Infancy 
                 Study with other studies 
Study  Age 
group 
 [months] 
Cases Population 
at Risk 
Incidence1 95% CI 
North London < 12 m 45 54,8102 82 61-110 
 12-24 m 12 51,4232 23 13 - 41 
Nova Scotia ♣ < 12 m 112 94,800 118 98 -143 
 12-24 m 42 96400 42 30-57 
1958 NCD cohort♣♣ < 12 m 14 15,496 90 43 -138 
 12-24 m 5 15,482 31 14 -76 
CI = Confidence Interval, 
1 Incidence per 100.000/year, 
2over 13 months 
♣ Nova Scotia (1977-1985)(Camfield et al., 1996) 
♣♣1958 National child development study cohort (Kurtz et al., 1998) 
   
 
4.1.4 Ascertainment adjusted incidence estimate 
The adjusted (‘true’) number of cases according to a two source capture recapture 
model (see also table 4.4 for details of the estimates) was 75 over the 13 months 
period. Thus under-ascertainment was 24%. Completeness of ascertainment 
according to sources was:  46.7% for the postal survey and 54.7% for the passive 
notification system ‘telephone’. The ascertainment adjusted estimate for the 
incidence of newly diagnosed epilepsy under the age of 2 years is 56.3 – 88.5 (95% 
CI) / 100.000 <= 2 years/ year.   
 
Table 4.4:  Capture-recapture estimates  
 Postal Survey  
Telephone Registered Not registered Total 
Registered 19 22  41 
Not registered 16 18* 34 
Total   35 40 75** 
 
*calculated: d = n – 19 – 22 – 16 
**n = 35× 41/19; 95%CI n +/- 1.96 √ (35×41×16×22/193) = 58-92 
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4.1.5 Ethnic composition of the incidence cohort 
 
Information on ethnicity was grouped in the following categories: 'White' (British, 
Irish, other White), 'Asian' (Indian, Pakistani, Bangladeshi, other Asian), 'Black' 
(African, Caribbean, other black), 'Other' (Chinese or other ethnic group), ' Mixed' 
(White and black Caribbean, White and black African, White and Asian, White and 
other non-white, other non-white). 
Figures 4.3 and 4.4 illustrate the distribution of ethnic groups in the incidence cohort 
of children with epilepsy onset under the age of 2 years and the resident population 
under the age of 2 yeas in the surveyed area of North London. Sixty percent of cases 
in the incidence cohort belonged to the non-white groups and of these the Asian 
group was the largest with 38% of the total cohort. Poisson regression analysis 
showed that the risk of presenting with epilepsy under the age of 2 years was higher 
for infants belonging to one of the non-white groups compared to the white group: 
risk ratio 2.5, 95% CI 1.4 - 4.3, p = 0.0001.  
 
A second poisson regression analysis with white ethnic group as reference 
demonstrated a significant higher risk only for the Asian group: risk ratio 3, 95%CI 
1.6 – 5.4, p < 0.001 (‘Black’ group: 1.9, 95%CI 0.9 – 4, p = 0.09; ‘Other’ group 1.9, 
95%CI 0.5 – 8.3, p=0.4).  
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Figure 4.3: Ethnic composition of the North London infancy epilepsy cohort 
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Figure 4.4: Ethnic composition of resident population under two years of age in 
                   surveyed geographical area of North London (mid-year 2006, Population  
                   Estimates by Ethnic Group; National Office for Statistics, 2008) 
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12,932 (13%) 
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4.1.6 Discussion of incidence estimate in the context of other studies 
The paucity of age specific incidence estimates for epilepsy with onset under the age 
of two years in the literature has been already highlighted in section 2.2.2. However, 
incidence estimates for comparison can be calculated from two studies that provide 
case numbers and population at risk in the appropriate age bands: 
- a population based study in Nova Scotia, Canada:  81 (95% CI 67-93)/ 
100.000 person years (children < 2 years) (Camfield et al., 1996). 
- the UK 1958 National Child Development Study Cohort: 61 (95% CI 39-95) 
/100.000 children < 2 years /year (Kurtz et al., 1998).  
A third childhood incidence study ascertained form a hospital catchment area in 
Sweden states a mean annual incidence of epilepsy in children under the age of 2 
years of 70/100.000 based on 14 cases (total number of cases under the age of 16 
years with newly diagnosed epilepsy ascertained over 2 years: n =79) (Braathen and 
Theorell, 1995). The authors do not provide information about the age specific 
population at risk. Hence the confidence interval cannot be calculated. The case 
definitions are similar in the three studies (see also table 2.5 in section 2.2.2). 
The ascertainment adjusted incidence determined in the North London Epilepsy in 
Infancy Study  (56.3 – 88.5 (95% CI) / 100.000 <=2 years/ year) overlaps with the 
confidence intervals estimates of the incidence estimates calculated from the data of 
the Novo Scotian study and the 1958 national child development study cohort. 
However the confidence interval of the incidence estimate from the data of the UK 
1958 national child development study based on only 14 cases is wide compared to 
the study by Camfield et al. (Camfield et al., 1996). The latter authors ascertained 
152 cases under the age of 2 years over an 8 year period.  For the Nova Scotian study 
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the denominator for each age group was estimated by averaging data from the 
Canadian Tax Office available for year 4 and 6 of the ascertainment period assuming 
that there was little change in the population of this Canadian province during the 
period of ascertainment. Different methods of case ascertainment were used in the 
three quoted studies. Two of the studies ascertained cases from the resident 
population in a catchment area using either a single source (records of the only EEG 
department in the province (Camfield et al., 1996)) or several sources (hospital 
attendances, district general paediatricians (Braathen and Theorell, 1995)) whilst the 
in the third a birth cohort was surveyed using a screening questionnaire at several 
time points (Kurtz et al., 1998). Because a traditional case registration approach was 
applied in the three studies, information with respect to completeness of 
ascertainment cannot be derived. This information is important to assess the quality 
of registers (notification systems) used and helps to interpret data correctly.  
 
According to the two source capture-recapture model applied in this study 
completeness of ascertainment was relatively high at 76%. This is however likely to 
be an overestimate as positive dependence between the two sources can be assumed. 
As already discussed in the method section (3.1.8) the lack of a third source in the 
'Epilepsy in Infancy Study' meant that a log linear model could not be applied to 
correct for this. Underascertainment could have occurred due to lack of cooperation 
of some paediatricians to notify eligible cases despite of all efforts to promote the 
study in the collaborating paediatric departments regularly and availability of several 
notification methods. Other reasons for a failure to notify cases could be a delay in 
recognition of paroxysmal events as seizures, which can be especially difficult in 
infants and young children, by paediatricians, general practioners or parents. The 
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discrepancy in numbers between infants with seizure onset under 12 months 
compared to those with onset between 12-24 months enrolled in the 'Epilepsy in 
Infancy Study' may suggest that underascertainment of children in the second year of 
life was higher. Stratification of the 2 source capture-recapture model according to 
age, by calculating the model for each age band separately (age < 12 months, and age 
12-24 months) could have been considered. The small case number in the 12-24 
months age band would have resulted in a larger confidence interval of the estimated 
number of true cases with greater impact of classification errors on the model 
considering the small numbers in each cell. Most of all, however, the finding of 
several other epidemiological studies, as discussed in more detail in the next section 
(4.1.6.1), demonstrating a similar pattern with sharp decrease of the age specific 
incidence after the first year of life could explain the discrepancy in case numbers 
between the age band < 12 months and 12-24 months in the 'Epilepsy in Infancy 
Study' and would count against the notion of higher underascertainment in the 
second year of life.  
 
One hundert percent complete ascertainment is difficult to achieve in 
epedimeiological studies. Chin et al report overall completeness of ascertainment in 
NLSTEPSS (North London Convulsive Status Epilepticus in Childhood Surveillance 
Study) of 74-81% (95%CI 62-84%), which is similar to the figure estimated in the 
'Epilepsy in Infancy Study' using a two source capture-recapture model (Chin, 
2005;Chin et al., 2006). As mentioned in the methods chapter (sections 3.1.1 & 
3.1.3.1) in NLSTEPSS the same geographical area in North London was surveyed 
and very similar notification systems were applied (BPSU like postal survey, 
telephone hotline). Because a third source based on information of ICD 10 codes 
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obtained in 6 hospitals was available a log-linear model could be applied to adjust for 
source dependence.  The ascertainment in NLSTEPSS between the two sources 
(‘postal survey’ and ‘phone’) was more heterogeneous compared to the 'Epilepsy in 
Infancy Study'. Case ascertainment in NLSTEPSS by postal survey was slightly 
lower (39-43%), whilst the proportion of cases ascertained by the passive system 
‘phone’ was higher (62-68%). Completeness of ascertainment by the BPSU like 
regional postal survey used in NLSTEPSS and in this study was in the range reported 
by other researchers using the BPSU scheme to ascertain cases nationally (45-56%) 
(Rahi and Dezateux, 1999;Heath et al., 2004). 
 
4.1.6.1 Age specific risk of epilepsy in the first two years of life 
Data from the ‘Epilepsy in Infancy study’ show the same pattern of age specific 
incidences of epilepsy in early childhood previously documented by other authors: 
the incidence is highest in the first year of life followed by a sharp drop in the second 
year (Hauser et al., 1993;Camfield et al., 1996;Kurtz et al., 1998). This is illustrated 
by Figure 4.3 which is based on data from the 1958 UK birth cohort and the Novo 
Scotian childhood epilepsy cohort (Camfield et al., 1996;Kurtz et al., 1998). The age 
specific incidence rates remain stable during the first decade and fall again in 
adolescence. A poisson regression model based on data of these two studies for the 
first two years of life and the North London ‘Epilepsy in Infancy study’ demonstrates 
that there is no difference in the age dependent risk of epilepsy between males and 
females (see section 4.1.3). This model shows also that the risk of epilepsy onset in 
the first year is almost three times as high compared to the second year of life.  
Age dependent seizure susceptibility has also been demonstrated in various animal 
models (Holopainen, 2008). Status epilepticus and recurrent seizure rodent models 
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show that the immature brain has propensity for seizures but is more resistant to 
seizure induced damage (Haut et al., 2004). The mechanisms for this phenomenon 
are poorly understood. Shift of GABA receptor function from initially excitatory to 
inhibitory is one concept that may explain seizure susceptibility in the early neonatal 
period (Dzhala et al., 2005;Ben-Ari and Holmes, 2006). There is also emerging 
evidence that seizure activity in the immature brain triggers numerous sequential and 
overlapping plastic and regenerative processes including changes of neurotransmitter 
receptors and formation of synaptic connections. Such alterations of neuronal circuits 
facilitate further seizure generation and have negative impact on long-term cognitive 
function (Holmes, 2005). It is difficult to separate the effect of seizures from the 
consequences of brain pathologies such as developmental malformations, molecular 
genetic defects and inborn errors of metabolism that are diagnosed in a significant 
proportion of infants (as shown in the following paragraphs). However because of 
the propensity of the immature brain for seizures brain pathologies may be more 
likely manifest with epilepsy in this young age.  
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Figure 4.5: Age specific incidence rates of childhood epilepsy 
                   Based on data  from (Camfield et al., 1996;Kurtz et al., 1998) 
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4.1.6.2 Multi-ethnic composition of North London epilepsy in infancy 
incidence cohort  
The Epilepsy in infancy study ascertained cases from an urban multi-ethnic 
population. This offered also the opportunity to investigate differences in the 
occurrence of epilepsy under the age of two years in different ethnic groups.  
With the white group taken as reference, children belonging to the non-white groups 
were over 2 times more likely to present with epilepsy under the age of 2 years. 
Separate analysis demonstrated that only Asian children had a 3 times higher risk 
presenting with epilepsy, whilst the risk was not significantly higher in the ‘black’ 
and ‘other’ ethnic groups (The latter includes Chinese and other ethnic groups). 
Information about socioeconomic background that may be a relevant factor has 
however, has not been considered in this analysis.  
 
Little information is available in the literature with respect to the interaction of 
ethnicity and incidence of epilepsy. Most epilepsy incidence studies were conducted 
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in white European populations or populations with European ancestry whilst studies 
based in Asia and Africa were looking at relatively homogeneous groups. Some US 
based studies suggest higher epilepsy prevalence and incidence in the black 
compared to the white population (Shamansky and Glaser, 1979;Haerer et al., 1986). 
There is also a suggestion of an age specific relationship between unprovoked 
seizures and ethnicity. Annegers at al determined the incidence of epilepsy and 
unprovoked seizures in members of a multiethnic Heath Maintenance Organizations 
(Annegers et al., 1999). Because information about ethnicity was not included in the 
membership records they evaluated the impact of ethnicity as part of a nested case-
control study. The authors calculated odds ratios for an initial unprovoked seizure 
using the non-Hispanic white population as reference. Whilst the overall odds ratios 
for African-American and Hispanic ethnicity were very similar, in young children 
under 5 years the ratios were 1.69 (0.73-3.94) for African-Americans and 1.81 (0.76-
4.32) for Hispanics. Interpretation of these data is difficult because of the relatively 
small case number in the age band < 5 years (n=38) and wide confidence intervals.  
Chin et al demonstrated in NLSTEPSS an independent association of ethnicity and 
socioeconomic status to the risk of status epilepticus (SE) (Chin et al., 2009). The 
incidence of SE was higher in Asian children compared to white and other ethnic 
groups. Further analysis with respect to association to epilepsy and aetiologies of SE 
showed that the risk of SE caused by prolonged febrile convulsions was almost 3 
times higher in Asian children compared to other ethnic groups. The association to 
epilepsy and ethnicity was less apparent because of the small number of incidence 
cases related to an underlying diagnosis of epilepsy (21 of176, 12%, of these two 
thirds (n=13) had a previous diagnosis of epilepsy) enrolled in NLSTEPSS (Chin et 
al., 2006;Chin et al., 2009). The NLSTEPSS data cannot be extrapolated to 
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demonstrate a relationship between epilepsy and ethnicity; they do however support 
the concept of population genetic factors influencing susceptibility for seizures. 
 
4.2 Cohort observation: North London infancy epilepsy cohort (children with 
newly diagnosed epilepsy under 2 years)  
4.2.1 Description of cohort  
4.2.1.1 Data obtained 
Of the 57 cases that met inclusion criteria 50 patients underwent clinical baseline 
assessment conducted by the researcher. Children were clinically evaluated (n=50) 
after a median time interval of 7 weeks (interquartile range 4 - 11 weeks) following 
the diagnosis of epilepsy.  Anonymised clinical information was obtained for 7 cases 
that were not enrolled in the observational cohort.  
 
4.2.1.2 Clinical features  
Clinical details of the cohort are summarised in table 4.5.  Abnormalities on 
neurological examination at enrolment (observed in 46% including 19% with 
pyramidal signs, hemiplegia or hemidystonia) and developmental impairment 
preceding seizure onset (39%) were common in this infancy epilepsy cohort. The 
time interval from first to second seizure was short; 79% of infants experienced the 
second seizure within 1 week and 97 % within 1 month.  Seizure onset was in the 
neonatal period in 8 cases (14% of the total cohort). Thirty seven percent of the 
North London infancy epilepsy cohort reported daily seizures whilst the majority 
(57%) experienced seizure free periods of more than one week at the time of 
enrolment. Forty nine percent were on their first anti-epileptic drug at enrolment.  
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Table 4.5: Clinical features of North London infancy epilepsy cohort (n=57) 
  Range sd 
Sex M/F 
 
31/26   
Mean age of epilepsy onset [months]  
 
6.9 0.1 - 22 5.8 
 N (%)   
Time interval: first to second seizure  
         <= 1 week 
         >1- 4 weeks 
         > 4 weeks 
 
 
45 (79) 
10 (17.5) 
2 (3.5) 
  
Neonatal seizures:  
 
14 (25)   
Febrile convulsions:  
 
12 (21)   
Status epilepticus (SE), one or more 
episodes: 
        SE preceding diagnosis 
        SE at diagnosis (second seizures) 
        Recurrent episodes  
 
 
7 (12) 
3 
1 
3 
  
Neurology at time of enrolment:  
   Normal 
   Unspecific abnormalities:  Hypotonia /   
   Posturing  
   Focal signs   
 
31 (54) 
14 (25) 
 
11(19) 
  
Abnormal development prior to epilepsy 
onset  
(when onset after neonatal period, N=48) 
 
 
19 (39) 
  
Consanguinity:  
 
9 (16)   
Severity of seizures at baseline:  
Daily 
Weekly 
Monthly (< 12 weeks seizure free) 
Seizure free for > 12 weeks 
 
21 (37) 
2 (3.5) 
29 (57) 
3 (5) 
  
Number of antiepileptic drugs trialled:  
0 
1 
2 
3  
>3 
 
3 (5) 
28 (49) 
12 (21) 
7 (12) 
7 (12) 
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4.2.2 Axis 2: Seizure types at initial assessment 
 
Initial seizure types [first seizure(s)] were most commonly focal (53%, 95% CI 40 -
65%) followed by nearly equal proportions of spasms (23%, 95% CI 14 - 35%) and 
other generalised seizures (21%, 95% CI 12 - 33%; see also figure 4.6). Details of 
classification of the initial seizures are provided in Table 4.6. Evolution to different 
seizure types in subsequent seizures was reported in 20 cases (35%, see table 4.8). 
This included the emergence of spasms with initially focal or undetermined seizures 
(n=5), secondarily generalised seizures with initially focal seizures (n=6) as well as 
multiple seizure types (n=3). Most common subsequent seizure types were focal 
seizures (47%, 95% CI 35 - 60%) and spasms (32%, 95% CI 21 - 44%) see also 
figure 4.7 and table 4.7 with details of the classification. 
 
Kappa (κ) as a measure of inter-rater agreement was calculated based on  gross 
categories ‘generalised’, ‘focal’ (included secondarily generalised seizures), ‘focal 
and generalised’, ‘spasms’ and ‘not able to classify’. For the classification of the 
initial seizure types and subsequent seizure types  Kappa  was 0.64 (95%CI 0.48 – 
0.8) and 0.62 (95% 0.46-0.78)  respectively indicating good agreement between the 
two paediatric neurologists (Altman D, 1991). 
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Figure 4.6: 
 
Seizure types - initial seizure
n (%)
13 (23%)
12 (21%)
2 (4%)
30 (53%)
Spasms
Focal (incl secondarily
generalised)
Generalised
Undetermined*
 
 
Figure 4.7: 
 
Seizure types - subsequent seizures 
n (%)
1 (2%)
27 (47%)
18 (32%)
9 (16%)
2 (4%)
Spasms
Focal (incl secondarily
generalised)
Generalised
Focal + generalised
Undetermined*
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Table 4.6: Initial seizure (s)    
 Seizure types: N (%) 
Generalised (not further classified) 2 (3.5) 
Tonic-clonic 5 (8.8) 
Tonic 2 (3.5) 
Myoclonic 3 (5.3) 
Spasms 13 (22.8) 
Focal (not further classified) 13 (22.8) 
Focal motor 12 (21) 
Focal motor with automatisms 1(1.8) 
Focal motor + secondarily generalised 1(1.8) 
Secondarily generalised 3 (5.3) 
Undetermined* 2 (3.6) 
Total cases  57 
* unable to classify (1), no agreement between raters (1) 
 
 
 
 
 
Table 4.7: Subsequent seizures:    
 Seizure types: N (%) 
Generalised (not further classified) 3 (5.3) 
Tonic-clonic 1 (1.8) 
Tonic 2 (3.5) 
Tonic + atonic 1(1.8) 
Myoclonic 2 (3.5) 
Spasms 18 (31.6) 
Focal (not further classified) 11(19.3) 
Focal motor 5 (8.8) 
Focal motor with automatisms 1(1.8) 
Focal + secondarily generalised 1(1.8) 
Secondarily generalised 9 (15.9) 
Focal + generalised (multiple types) 2 (3.6) 
Undetermined* 1 (1.8) 
Total cases  57 
*no agreement between raters   
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Table 4.8: Evolution of initial seizure types (n=20) 
Initial seizure(s) Subsequent seizures N 
Secondarily generalised Focal 1 
Secondarily generalised Generalised 1 
Focal (1 focal motor) Secondarily generalised 6 
Undetermined* Spasms 1 
Focal (2 focal motor) Spasms 4 
Focal motor Multiple  types 1 
Tonic Focal + generalised 1 
Myoclonic Focal 1 
Tonic-clonic Focal 1 
Tonic-clonic Tonic 1 
Undetermined** Tonic + atonic 1 
Tonic-clonic Undetermined* 1 
*no agreement between raters, ** unable to classify   
 
 
4.2.3 Axis 3: Epilepsy syndromes 
 
Following consensus discussion all but 3 cases could be categorised in one of the 
epilepsy syndrome groups. Specific syndrome diagnosis, however, could not be 
allocated in a third of children (19, 33%; see also table 4.9: Epilepsy syndrome 
groups and table 4.10: Specific epilepsy syndromes). 
 
The majority of cases in this cohort were categorised under 2 syndrome groups: 
epileptic encephalopathy (39%, 95% CI 27 - 52%), symptomatic focal (28%, 95% CI 
18 - 41%) or probably symptomatic focal epilepsy (10%, 95% CI 5-21%; see also 
table 4.10). Amongst the epileptic encephalopathies, West syndrome was the 
commonest specific epilepsy syndrome diagnosis [16 of 22 cases, others: 2 Ohtahara 
syndrome (2), Severe Myoclonic Epilepsy in Infancy (3), Undetermined (1)]. Only 
16% (95% CI 8.5 - 27%) of cases were classified as idiopathic. The majority of these 
were idiopathic focal epilepsies. 
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The values for Kappa were 0.48 and 0.5 for the classification of the epilepsy 
syndrome group and specific epilepsy syndromes respectively indicating moderate to 
poor agreement between the two paediatric neurologists refering (see table 4.11 and 
4.12 for 95% Confidence intervals of κ).  
 
Differences between the two raters in categorising a number of cases are illustrated 
by two examples: 
- Infants with infantile spasms and cortical abnormalities on magnetic 
resonance imaging were classified under epileptic encephalopathy by rater B 
but as symptomatic focal epilepsy by rater A 
- Rater B classified cases as idiopathic focal that were classified by rater A as 
probably symptomatic focal. 
 
Reasons why cases could not be classified under specific epilepsy syndromes  
included lack of information (e.g. no data on neuroimaging, or EEG data) or  the 
clinical presentation (especially history of seizure manifestations) was felt not to be 
in keeping with any of the in the ILAE classification listed syndromes in this age 
group. 
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Table 4.9: Epilepsy syndrome groups: 
  N % 
Epileptic encephalopathies 22 38.6 
Symptomatic focal 16 28.1 
Probably symptomatic focal 6 10.5 
Symptomatic generalised 1 1.8 
Idiopathic focal 8 14 
Idiopathic generalised 1 1.8 
Undetermined* 3 5.3 
Total 57 100 
*Unable to classify   
 
 
 
 
Table 4.10: Specific epilepsy syndromes: 
 N % 
West syndrome ( 8 symptomatic) 16 28 
Ohtahara syndrome 2 3.5 
Dravet syndrome (Severe myoclonic 
epilepsy in infancy) 3 5.3 
Neocortical epilepsies* 13 22.8 
Mesial temporal lobe epilepsy with 
hippocampal sclerosis 1 1.8 
Benign infantile seizures (non 
familial) 2 3.5 
Benign myoclonic epilepsy in infancy 1 1.8 
Undetermined** 19 33 
Total 57 100 
*”other types defined by location and aetiology” 
** Unable to classify (16); No agreement between raters (3) 
 
   
Table 4.11: Classification of epilepsy syndrome groups after baseline assessment 
 Rater B 
 Rater A  
Epileptic 
encephalopathy 
symptomatic or 
probably 
symptomatic focal Idiopathic focal 
Not able to 
classify 
Idiopathic 
generalised Total 
Epileptic 
encephalopathy 13 2 1 0 0 16 
  
Symptomatic or 
probably symptomatic 
focal 
5 18 3 3 0 29 
  
Idiopathic focal 0 0 4 1 0 5 
  
Not able to classify 1 2 1 1 2 7 
Idiopathic generalised 0 0 0 0 0 0 
Total 19 22 9 5 2* 57 
Kappa (n=55)* 
 
0.48 (95% CI 0.3 – 0.66) 
* 2 cases classified by rater B as idiopathic generalised epilepsy were excluded to calculate Kappa 
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Table 4.12:  Classification of specific epilepsy syndromes  after baseline assessment 
 Rater B 
Rater A 
BIS  
(non 
familial) BME♦ SMEI MTS NAC   
Neocortical 
 epilepsies* 
Ohtahara  
syndrome 
West 
 syndrome Total 
BIS 
(non familial) 1 0 0 0 3 0 0 0 4 
BME 0 0 0 0 0 0 0 0 0 
  
SMEI 0 0 0 0 2 0 0 0 2
♦ 
  
MTS 0 0 0 1 0 0 0 0 1 
  
NAC 0 1 0 0 11 1 1 0 14 
  
Neocortical 
epilepsies* 
0 0 0 0 9 8 0 5 22 
  
Ohtahara 
syndrome 
0 0 0 0 1 0 0 0 1 
  
West syndrome 0 0 0 0 0 0 0 13 13 
Total 1 1♦ 0 1 26 9 1 18 57 
Inerrater 
agreement Kappa
♦ = 0.5 (95% CI 0.34 - 0.66) 
BIS = Benign Infantile seizures, BME = Benign myoclonic epilepsy, SMEI = Severe myoclonic epilepsy in infancy, MTS =  
Mesial temporal lobe epilepsy with hippocampal sclerosis, NAC= Not able to  classify; * ‘Other types defined by location and 
aetiology’; ♦ cases excluded for calculation of kappa 
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4.2.4 Reclassification of Epilepsy syndromes  
Thirty two cases, that underwent follow up evaluation approximately 12 months after 
the initial evaluation were reclassified. As outlined in the methods Chapter (section 
3.2.3) this involved two steps in order to investigate consistency of classification and 
also to evaluate possible changes of the diagnosis overtime with new information 
becoming available.  
 
4.2.4.1 Step 1:  Consistency of classification  
 
Each rater’s reclassification based on information available after baseline assessment 
was compared to the first classification following consensus discussion. The tables 
4.13 a) and b) show classification results of epilepsy syndrome groups. The majority 
of cases were classified in the same syndrome groups and κ values (Rater A: κ= 
0.87; Rater B: κ = 0.84) indicated very good agreement. In particular there was no 
change of more narrowly defined syndrome diagnoses such as epileptic 
‘encephalopathy’ and ‘symptomatic focal’ epilepsy when cases were rated a second 
time. Differences involved cases initially classified under ‘idiopathic focal’, ‘not able 
to classify’ or ‘probably symptomatic focal’: Rater A – changed from ‘not able to 
classify’ to ‘idiopathic focal’ (1 case) and ‘probably symptomatic focal’ to 
‘idiopathic focal’ (1 case); Rater B – change from ‘idiopathic focal’ to ‘idiopathic 
generalised’ (3 cases).  
 
Although first and second classification of specific epilepsy syndromes showed good 
concordance there was more variability (see table 4.14 a) and b). Rater A allocated 
specific syndromes to a number of cases that were in the first classification 
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categorised as ‘not able to classify’. These included diagnoses such as benign 
infantile seizures (3), Generalised (Genetic) Epilepsy Febrile Seizures + (1) and 
Neocortical epilepsies ‘other types defined by location and aetiology ‘(4). Rater B 
appeared to be more consistent in allocation of specific syndromes as reflected in the 
higher kappa value (Rater A: κ= 0.69, rater B = 0.83, see also table 4.15 b). Similar 
to the reclassification of syndrome groups there was little variability when cases with 
more narrowly defined specific syndromes such as West syndrome were reclassified. 
   
 
 
Table 4.13 a):  Reclassification of epilepsy syndrome groups – Rater A 
Reclassification  based on information available after initial assessment 
First 
Classification 
(after consensus) 
Epileptic 
encephalopathy 
Symptomatic 
focal 
Probably  
symptomatic 
focal Idiopathic focal 
Idiopathic 
generalised NAC Total 
Epileptic 
encephalopathy 11 1 0 0 0 0 12 
  
Symptomatic focal 0 11 0 0 0 0 11 
  
Probably 
symptomatic focal 
0 0 2 0 1 0 3 
  
Idiopathic focal 0 0 0 3 0 0 3 
  
Idiopathic 
generalised 
0 0 0 0 1 0 1 
  
NAC 0 0 0 1 0 1 2 
Total 11 12 2 4 2 1 32 
Kappa 0.87 (95% CI 0.7-1) 
 
NAC = Not able to classify 
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Table 4.13 b):  Reclassification of epilepsy syndrome groups – Rater B 
Reclassification  based on information available after initial assessment  
First Classification 
(after consensus) 
Epileptic 
encephalopathy Symptomatic focal 
Probably 
symptomatic 
focal 
Idiopathic 
focal 
Idiopathic 
generalised NAC Total 
Epileptic 
encephalopathy 12 0 0 0 0 0 12 
Symptomatic focal 1 10 0 0 0 0 11 
Probably symptomatic 
focal 0 1 2 0 0 0 3 
Idiopathic focal∗ 0 0 0 0 3 0 3∗ 
Idiopathic generalised 0 0 0 0 1 0 1 
NAC 0 0 0 0 1 1 2 
Total 13 11 2 0 5 1 32 
Kappa 0.84 (95% CI 0.68 -1) 
∗Cases excluded for calculation of Kappa 
NAC = Not able to classify 
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Table 4.14 a):  Reclassification of  specific epilepsy syndromes – Rater A 
 Reclassification  based on information available after initial assessment  
First 
Classification 
(after 
consensus) 
West  
syndrome Ohtahara syndrome 
Neocortical  
epilepsies* NAC MTS GEFS+
♣ SMEI BME 
BIS 
  (non 
familial) 
Total 
West 
syndrome 10 0 0 0 0 0 0 0 0 10 
  
Ohtahara 
syndrome♣ 
0 0 1 0 0 0 0 0 0 1♣ 
  
Neocortical 
epilepsies* 
0 0 7 0 0 0 0 0 0 7 
  
NAC 0 0 4 1 0 1 0 0 3 9 
  
MTS 0 0 0 0 1 0 0 0 0 1 
GEFS+ 0 0 0 0 0 0 0 0 0 0 
  
SMEI 0 0 0 0 0 0 1 0 0 1 
  
BME 0 0 0 0 0 0 0 1 0 1 
  
BIS (non 
familial) 
0 0 0 0 0 0 0 0 1 1 
Total 10 0 12 1 1 1♣ 1 1 4 31 
Kappa♣ 0.69 (95% CI 0.5-0.87) 
MTS =  Mesial temporal lobe epilepsy with hippocampal sclerosis, SMEI = Severe myoclonic epilepsy in infancy, GEFS+ = Generalised epilepsies 
with febrile seizures plus, BME =  Benign myoclonic epilepsy in infancy, BIS =  Benign infantile seizures, NAC = Not able to classify,*other types 
defined by location and aetiology ;♣ Cases excluded for calculation of Kappa 
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Table 4.14 b):  Reclassification of  specific epilepsy syndromes – Rater B 
Reclassification  based on information available after initial assessment  
First Classification 
(after consensus) West 
syndrome
Ohtahara 
syndrome
Neocortical 
epilepsies* MTS SMEI BME 
BIS  
(non 
familial) 
NAC Total 
West syndrome 10 0 0 0 0 0 0 0 10 
 
Ohtahara syndrome 0 1 0 0 0 0 0 0 1 
 
Neocortical 
epilepsies* 
1 0 7 0 0 0 0 0 8 
 
MTS 0 0 0 1 0 0 0 0 1 
SMEI 0 0 0 0 1 0 0 0 1 
 
BME 0 0 0 0 0 1 0 0 1 
 
BIS (non familial)♣ 0 0 0 0 0 0 0 1 1
♣ 
 
NAC 0 0 3 0 0 0 0 6 9 
 
Total 11 1 10 1 1 1 0 7 32 
Kappa 0.83 (95%CI 0.67- 0.98) 
MTS =  Mesial temporal lobe epilepsy with hippocampal sclerosis, SMEI = Severe myoclonic epilepsy in infancy, BME =  Benign 
myoclonic epilepsy in infancy, BIS =  Benign infantile seizures, NAC = Not able to classify 
* other types defined by location and aetiology; ♣ Case excluded for calculation of Kappa 
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4.2.4.2 Step 2:  Classification of syndromes after 12 months review  
Clinical data and investigation results obtained at the 12 months reassessment were 
considered by the raters, who were also instructed to indicate whether the new 
information lead to revision of the initial epilepsy syndrome diagnosis. The syndrome 
diagnosis was changed in only a small number of cases: Rater A revised the initial 
diagnosis in 3 and Rater B in 4 cases (9% and 12 % of the follow up cohort 
respectively, see table 4.15 for details). Additional information resulted in allocation 
of syndrome diagnoses in 3 cases that were initially not classifiable or indicated 
evolution of the epilepsy syndrome (West syndrome to focal symptomatic epilepsy). 
For example rater A categorised two cases that were ‘not classifiable’ after baseline 
assessment under ‘Seizures not necessarily requiring a diagnosis of epilepsy’: one 
child remained seizure free without antiepileptic treatment throughout the follow up 
period; the other child had several febrile seizures whilst on anti epileptic medication. 
Case 11 demonstrated clinical evolution from West syndrome to focal symptomatic 
epilepsy (following remission of spasms and seizure free period focal seizures 
recurred). With the exception of one case (ID 11) there was no concordance between 
the raters with respect to the cases in which the diagnoses were revised. 
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Table 4.15: Change of epilepsy syndrome diagnosis after 12 months review  
Rater A 
ID Initial 
syndrome 
group  
Initial 
specific 
syndrome 
Syndrome group after 
 12 months review 
Specific Syndrome after 
12 months review 
11 Epileptic 
encephalopathy 
West 
syndrome 
Symptomatic focal Neocortical epilepsies 
55 NAC NAC Seizures not necessarily 
requiring a diagnosis  of 
epilepsy 
Febrile seizures 
87 NAC NAC Seizures not necessarily 
requiring a diagnosis  of 
epilepsy 
Isolated cluster of seizures 
Rater B 
ID Initial 
syndrome 
group  
Initial specific 
syndrome 
Syndrome group after 
12 months review 
Specific Syndrome after 
12 months review 
2 NAC NAC Idiopathic generalised Idiopathic generalised 
epilepsies with variable 
phenotypes (?) 
11 Epileptic 
encephalopathy 
West syndrome Symptomatic focal  Neocortical epilepsies 
35 Epileptic 
encephalopathy 
West syndrome Symptomatic focal  Neocortical epilepsies 
73 Epileptic 
encephalopathy 
West syndrome Symptomatic focal  Neocortical epilepsies 
 
 
The tables 4.16 a) and b) give details of the epilepsy syndrome diagnoses allocated by 
rater A and B after the 1 year review. Discrepancies between the raters are especially 
obvious with respect to the specific epilepsy syndrome diagnoses. Rater B was unable 
to allocate a specific syndrome diagnosis in 9 cases (28% of the review cohort), whilst 
rater A classified all cases. Most differences were observed with the classification of 
the less severe epilepsies (idiopathic types or children with infrequent seizures).  
 
   
Table 4.16 a): Reclassification of epilepsy syndrome groups after 12 months review 
Rater B Total 
 Rater A  Epileptic 
encephalopathy 
Symptomatic or 
probably 
symptomatic 
focal 
Idiopathic 
generalised 
Idiopathic 
focal 
Seizures not 
necessarily 
requiring 
diagnosis of 
epilepsy 
 
Epileptic encephalopathy 
  
  
8 (24%) 1(3%) 0  0 0 9 (27%) 
  
Symptomatic or probably 
symptomatic focal 
  
  
2 (6%) 14 (42%) 0  0 0 16 (48%) 
  
Idiopathic generalised 
  
  
0 1 (3%) 1(3%) 0 0 2 (6.1%) 
  
Idiopathic focal 
  
  
0 
 
0 
 4 (12%) 0 0 4 (12%) 
  
Seizures not necessarily 
requiring diagnosis of 
epilepsy  
  
0 
 
0 
 2 (6%) 0 0 2 (6%) 
Total 
  10 (30%) 16 (48%) 7 (21%) 0 0 33 (100.0%) 
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Table 4.16 b): Reclassification of specific epilepsy syndromes after 12 months review 
Rater A Rater B  
 WS SMEI OS 
Neocortical 
epilepsies*  MTS GEFS+ 
IGE  
variable 
phenotypes BME BIS 
Isolated 
seizures/ 
febrile 
seizures NAC Total 
WS 
  8 (25%) 0 0 1(3%) 0 0 0 0 0 0 0 9 (28%) 
 SMEI  
  
0 
 1(3%) 0 0 0 0 0 0 0 0 0 1(3%) 
 Neocortical 
epilepsies*  
  
0 
 0 1(3%) 9(28%) 0 0 0 0 0 0 3(9.4%) 
13 
(40.6%) 
 MTS   0 0 0 0 1 (3%) 0 0 0 0 0 0 1(3%) 
  
GEFS+ 
  
0 0 0 0 0 0 0 0 0 0 1(3%) 1(3%) 
IGE  variable 
phenotypes 0 0 0 0 0 0 0 0 0 0 0 0 
 BME  
  0 0 0 0 0 0 0 1 (3%) 0 0 0 1(3%) 
 BIS 
  0 0 0 0 0 0 1(3%) 0 0 0 3 (9.4%) 4(12.5%) 
 Isolated 
seizures / 
febrile seizures
0 0 0 0 0 0 0 0. 0 0 2 (6%) 2(6%) 
NAC 
0 0 0 0 0 0 0 0 0 0 0 0 
 
Total 
  
8(25%) 1(3%) 1(3%) 10 (31.3%) 1(3%) 0 1(3%) 1(3%) 0 0 9 (28%) 32 (100.0%) 
WS=West syndrome, OS=Ohtahara syndrome, SMEI=Severe myoclonic epilepsy in infancy (Darvet syndrome); MTS =Mesial temporal lobe epilepsy 
with hippocampal sclerosis;  BME=Benign myoclonic epilepsy in infancy; GEFS+= Generalised (Genetic) epilepsies with febrile seizures plus; 
BIS=Benign infantile seizures (non familial); IGE= Idiopathic generalised epilepsy; NAC=Not able to classify 
   
4.2.5 Underlying aetiologies (Axis 4) 
Underlying aetiologies could be determined in 29 children (51% of the cohort). 
Details are provided in table 4.17.  Infants presenting with recurrent unprovoked 
seizures owing to CNS  insults, such as infection or perinataly acquired injuries 
including hypoxic ischaemic brain injuries,  resulting in a static encephalopathy were 
categorised under acquired - remote symptomatic aetiologies (ILAE Commission, 
1997).  
Developmental brain malformations were the largest aetiological category (n=12, 
21%), see also figure 4.8. Cortical malformations were extensive involving both 
hemispheres in 5 infants and 2 additional infants had multilobar unilateral lesions 
(focal cortical dysplasia). Eight infants in the subgroup with developmental brain 
abnormalities (68%) presented with seizures in the first six months of life including 4 
(33%) with epilepsy onset in the neonatal period. Eight children in this subgroup 
(68%) experienced daily seizures at the time of evaluation. Acquired - remote 
symptomatic aetiologies (details see table 4.17) were the second largest aetiological 
group in this cohort (16%). Only one of 9 (11%) infants presented with seizure onset 
in the neonatal period. Epilepsy onset in the neonatal period was also observed in 3 
of 4 (75%) children with confirmed or strongly suspected metabolic disorders. Of the 
two children with probable mitochondrial disorder one child had low complex IV on 
assays performed on muscle tissue and skin fibroblasts. The other child had low 
concentration of all four respiratory chain enzymes in muscle tissue. Ongoing 
molecular genetic tests have so far not yet determined a specific genetic diagnosis in 
both cases. 
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One infant with a chromosomal abnormality associated with an increased risk for 
epilepsy, Trisomy 21, presented with recurrent unprovoked seizures following 
pneumococcal meningitis and was therefore categorised under acquired remote 
symptomatic epilepsies. 
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Table 4.17: Aetiologies identified in the North London infancy epilepsy cohort   
Categories N (% ) Details (number of cases) 
Developmental brain 
abnormality 
  
  
  
  
  
  
  
  
  
12 (21) Unilateral multilobar focal cortical 
dysplasia  (2) 
Polymicrogyria (4): 
 Bilateral polymicrogyria (mesial 
frontal, parietal, occipital lobes) 
 Bilateral polymicrogyria + right  
periventricular heterotropia 
 Bilateral polymicrogyria + 
hemimegalencephaly 
 Bilateral polymicrogyria + 
cerebellar hypoplasia, small brain 
stem 
Tuberous sclerosis (3) 
Lissencephaly 
Microcephaly + absent corpus callosum 
Occipital arterial venous malformation 
Other 1 (2) Probable Mesial Temporal Sclerosis 
Aquired remote 
symptomatic:  
9 (16%)  
        
         Infection 
 
 
5 (9) 
 
Viral encephalitis (2) 
Pneumococcal meningitis 
Neonatal meningitis/sepsis (2) 
 
        Perinataly acquired 4 (7) Hypoxic ischaemic brain injury (3) 
Extreme prematurity with intraventricular 
haemorrhage 
 
Metabolic disorder 
  
  
4 (7) Molybdenum Cofactor Deficiency 
Biotinidase deficiency 
Probable mitochondrial disorder (2)* 
Chromosomal 
abnormalities / Ion 
channel gene mutations 
  
  
4 (7) Chromosomal abnormalities (2) 
 monosomy 1p36 
 isodicentric Chr 15 
SCN1A mutation (2)** 
 
Unknown 28 (49) 
 
 
* Low respiratory chain enzymes in 2 patients: 1 low complex IV in muscle tissue 
and skin fibroblasts, 1 with low complex I, II, III and IV on muscle biopsy. 
** missens mutation c.1088C>G, p.Thr363Arg,  whole SCNA1 gene deletion . 
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 Figure 4.8: Aetiologies identified in the North London infancy epilepsy cohort (n = 57) 
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4.2.6 Neuroimaging and associated structural brain abnormalities  
 
4.2.6.1 Imaging practice and protocols  
Neuroimaging was performed in 55 children (96% of the total cohort) of which 54 
underwent magnetic resonance (MR) imaging and one child computed tomography 
(CT). Eight infants had both (CT and MR scans). Images of 52 children (94%) were 
obtained and independently reviewed by two experienced neuroradiologists as 
described in the methods chapter (section 3.1.2.2.4). This included 65 MR images of 
51 children. Repeat scans were performed for 12 (23%) children including 2 infants 
who had 3 MR scans. 
 According to information provided by copies of imaging request forms, imaging 
reports or clinical correspondence (clinic letters, discharge summaries) the 
indications for requesting magnetic resonance imaging was established. The majority 
of the MR images (51, 78.5%) were requested to investigate epilepsy / afebrile 
seizures. Other indications that may have preceded diagnosis of epilepsy included 
suspected brain abnormality not associated with epilepsy (4, 6%), CNS infection (5, 
8%), peri-natal hypoxic ischaemic brain injury (3, 4.6%), status epilepticus (1) and 
for one infant with epilepsy controlled on antiepileptic drugs – “investigation of 
global developmental delay" in the context of a preceding abnormal CT scan. 
 
MR images were performed in several institutions, using systems with magnetic field 
strengths from 0.5 to 1.5 tesla and different imaging protocols. The protocols applied 
for the acquisition of 36 MR scans (55% of the reviewed images) complied with the 
generic principle of combining T2 weighted images in two planes supported by T1 
weighted images in two planes as recently suggested by Saunders (Saunders et al., 
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2007). T1 weighted images in two planes were available for 50 (77%) and T2 
weighted images in two planes in 47 (72%) MR scans. Seventeen scans (26 %) did 
not include coronal T2 weighted sequences (T2 weighted techniques including fluid-
attenuated inversion recovery [FLAIR] images). Sequences recommended to 
investigate epilepsy (especially focal epilepsy) such as 3-D volume T1-weighted 
acquisition were obtained for 19 (29%) MR scans and coronal T2 weighted images 
tilted to lie perpendicular to the hippocampi for 14 (22%).  
The image quality was judged by the neuroradiologists to be ‘good’ (48, 71%) or 
‘acceptable’ (12, 18.5%) for the majority of scans. Images of 7 MR scans (11%) 
were insufficient, including 4 scans that were obtained using fast acquisition 
techniques and one that acquired only a single plane sequence (axial T2 weighted 
image, see also appendix 9 for examples of 'insufficient' quality images ). Of the 7 
MR scans with images of insufficient quality five were repeated. Three of the repeat 
MR scans provided positive diagnostic information.  
The neuroradiologists stated that repeat MR imaging was indicated after 13 scans 
(20%) because of insufficient image quality (7), in order to evaluate the evolution of 
signal changes over time (4) or to achieve better definition of a brain malformation 
(3).  Repeat imaging after 23 scans (25%) was felt to be only appropriate if seizures 
persisted and / or epilepsy surgery was considered.  
Of the 14 MR scans, that were repeat images, 7 provided new diagnostic 
information, 2 showed evolution of previously seen abnormalities and 5 did not 
demonstrate any positive findings.   
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‘Local’ reports were compared with the findings of the two neuroradiologists. Eleven 
of 57 (24%) available local reports differed from the report provided by the two 
reviewers. Two of the 11 ‘local’ reports came from the same institution in which the 
two collaborating neuroradiologists were based. Diagnoses that differed significantly 
from the local reports, which stated images were essentially normal, included 
‘tuberous sclerosis’ and ‘bilateral polymicrogyria’.  
 
4.2.6.2 Neuroimaging - Findings 
The findings of the neuroimaging review were categorised under ‘aetiologically 
relevant’, ‘not aetiologically relevant or uncertain’ and ‘normal - no positive 
findings’ (see table 4.18). The details of the imaging findings for each subject are 
listed in appendix 9, which also contains examples of MR images demonstrating 
developmental and acquired brain lesions. ‘Aetiologically relevant’ were structural 
abnormalities that are commonly reported in children with epilepsy, whilst 
neuroimaging appearances of ‘uncertain aetiological relevance’ are commonly 
observed in children presenting with a broader range of neurological and 
neurodevelopmental problems.  
 
Aetiologically relevant abnormalities were seen on the images of 27 (52%) children. 
Of these the imaging appearances were in keeping with acquired lesions in 55% and 
with developmental brain malformations in 41%. Neuroimaging findings of 9 (17%) 
children were of uncertain aetiological relevance. These included delayed 
myelination, lack of white matter bulk, thin corpus callosum or arachnoid cysts. 
Details of the neuroimaging findings for each subject are listed in appendix 9.  
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Table 4.18: Neuroimaging findings in the North London infancy epilepsy cohort, N=52  
                   The details of the imaging findings for each subject are listed in the appendix 9. 
   N (%) 
Aetiologically 
relevant findings 
 Details (n) 27 (52) 
 Developmental 
malformations: 
 
 
Unilateral multilobar focal cortical 
dysplasia  (2) 
Polymicrogyria (4): 
 Bilateral polymicrogyria (mesial 
frontal, parietal, occipital lobes) 
 Bilateral polymicrogyria + left  
periventricular heterotropia 
 Bilateral polymicrogyria + 
Hemimegalencephaly + left closed 
lip schizencephaly 
 Bilateral polymicrogyria + 
cerebellar hypoplasia, small brain 
stem 
Tuberous sclerosis (2) 
Lissencephaly 
Microcephaly + absent corpus callosum 
Occipital arterial venous malformation 
 
11 
 Acquired brain 
lesions 
Secondary to CNS infections, hypoxic 
ischaemic injury, metabolic disorders or 
seizure activity 
15  
 Other Probable mesial temporal sclerosis 1 
Not aetiologically 
relevant or 
uncertain 
 Details (n) 11 (21) 
 Incidental / 
immaturity 
Arachnoid cyst (2) 
Delayed myelination, lack of white matter 
bulk, small chiasm and/or thin corpus 
callosum  (7) 
9 
 Uncertain − Suspicious localised area of signal 
abnormality on T2 weighted 
image, (insufficient image quality)  
− Asymmetry of white matter signal 
in temporal lobes, one 
hippocampus slightly smaller  
 
2 
No positive 
findings (normal) 
 
  14 (27) 
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4.2.7 EEG data 
Eighty nine EEG recordings of 48 children were reviewed (1 recording for 19 [40%] 
subjects, 2 for 18 [37%], 3 for 10 [21%] and 4 for 1 child).  
At least one recording that included sleep was available for 35 (73%) children. 
Photic stimulation was performed in recordings of 32 (66%) subjects. Overall photic 
stimulation was performed in 42 (47%) of the reviewed EEG recordings.  
 
Fourteen (16%) of the reviewed recordings were normal. Interictal discharges were 
seen in 56 (63%) recordings and were focal or lateralized in 26 (see table 4.19 for 
details). Background activities with excess of slow activity were observed in a third 
of the recordings (unspecific background abnormalities, see table 4.19) and gross 
abnormalities with absence of age appropriate activities in 38 (43%).  Six (7%) 
recordings demonstrated typical appearances of hypsarrhythmia. The term 'modified 
hypsarrhythmia' was not applied, instead the features of the EEG were described 
(e.g. grossly abnormal background activities and distribution of interictal 
discharges).      
 
Twenty eight (31%) EEGs included ictal recordings. Details of the ictal onset are 
given in table 4.19. The onset of almost two thirds of the recorded seizures was focal 
or lateralized. Three of the 5 seizures with undetermined onset and all ictal events 
with generalized onset were infantile spasms. 
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Table 4.19: Findings of EEG review (89 records of 48 subjects) 
 N (%) 
 
Background activities: 
     Normal 
     Unspecific abnormalities* 
     Grossly abnormal** 
            Burst-suppression pattern 
     Unable to comment 
 
 
 
22 (25) 
27 (30) 
38 (43) 
7 
2 (2) 
 
Interictal discharges:     
                       Focal 
                       Unilateral 
                       Bilateral 
                       Multifocal 
 
 
56 (63) 
18 (32) 
8 (14) 
18 (32) 
13 (23) 
     
 Hypsarrhythmia 
 
 
6 (7) 
 
Ictal recordings: 
  Seizure onset: - focal                        
                         - bilateral 
                         - unilateral 
                         - generalised 
                         - undetermined 
 
 
28 (31) 
12 (43) 
3 (11) 
4 (14) 
4 (14) 
5 (18) 
 
Normal recordings 
 
 
14 (16) 
* excess of slow activities with some age appropriate activities 
present 
** no age appropriate background activities present 
 
 
4.2.8 Developmental function  
 
4.2.8.1 Developmental function close to diagnosis (Bayley III) 
Forty nine children were assessed after a median time interval of 9 weeks 
(interquartile range 5 - 15) following the diagnosis of epilepsy. Clinical data of this 
cohort are summarized in table 4.20. At the time of evaluation over a third 
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experienced daily seizures and all but five children were taking at least one 
antiepileptic drug. 
 
Table 4.20: Clinical details of cohort that was assessed with the  Bayley III  
F/ M  22/27 
Median age of seizure onset [months] (interquartile range) 5 (2.2 - 8.7) 
Median age when assessed [months] (interquartile range) 9.5 (5.6 - 17.4) 
History of neonatal seizures 12 
Frequency of seizures n (%) 
Daily 
Weekly 
Monthly 
Seizure free: < 1 month 
                      1-3 months 
                       > 3 months 
 
18 (37) 
4 (8) 
3 (6) 
6 (12) 
14 (29) 
4 (8) 
Number of anti epileptic drugs taken at evaluation n (%): 
None 
1 
2 
3 
 
 
5 (10) 
24 (49) 
15 (31) 
5 (10) 
 
The means of the composite and scale scores fall in the borderline or extremely low 
range (see table 4.21). The scores are widely distributed as illustrated in figure 4.9 a) 
and the majority of the values are more than 1 standard deviation (sd) below the 
mean of the standardisation sample. The distribution of scores is skewed towards the 
lower values and fairly similar across the three major domains: cognition, motor and 
language. Values in the bottom quartile cluster around the lowest obtainable scores 
for cognition, receptive language -, fine motor- and gross motor subscales.  The 
distribution of ‘cognition’ and ‘fine motor’ scale scores and is very similar with the 
median falling more than 2 sd below the mean of the standardisation group (see 
figure 4.9 b).  
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Table 4.21: Bayley III scores at baseline assessment,  n = 49 
Scores 
 
Mean sd Range 
Cognition 
 
72.1 20.7 55 - 115 
Language Composite 
 
68.7 17.9 47 - 106 
Motor Composite 
 
67.7 22.6 46 - 127 
Expressive language (scale score) 
 
4.7 3 1 - 11 
Receptive language (scale score) 
 
4.7 3.4 1 - 11 
Fine Motor (scale score) 
 
4.6 4.2 1 - 15 
Gross Motor (scale score) 
 
4.6 3.5 1 -14 
 
 
Figure 4.9 a): Distribution of Bayley III composite scores at baseline assessment 
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 Figure 4.9 b): Distribution of Bayley III scale scores at baseline assessment 
Gross MotorFine MotorReceptive 
Language
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Language
Cognition
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The Bayley III adaptive behavior questionnaire was completed by carers of 32 
children (65% of subjects assessed with the Bayley III). Descriptive statistics of the 
composite scores are detailed in table 4.22. 
 
Figure 4.10 (a and b) illustrates the distribution of the scores for the adaptive 
behavior domains (Social, Conceptual, Practical), general adaptive composite (GAC) 
and the Bayley III composite scores of this subgroup.   Although the clustering of 
scores at the bottom of the scale is not observed in the adaptive behavior composite 
scores the distribution of the GAC scores in relation to the standardisation sample is 
similar to cognitive, language and motor composite scores. The majority of scores 
are 1 sd and the median is more than 2 sd below the mean of the standardisation 
sample. Thus the carers perception of developmental function in the home 
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environment (Bayley Adaptive Behavior Scale scores) was in keeping with the 
Bayley III assessment. 
 
Table 4.22: Bayley III: Adaptive Behavior Scale Composite Scores  
                   at baseline assessment (n = 32) 
Composite scores Mean sd Range 
Social Domain 79.6 19.4 48 - 130 
Conceptual Domain 78.5 20.8 49 - 132 
Practical Domain 84.1 20.7 52 - 136 
General Adaptive Composite 77.4 23.5 40 - 140 
 
Figure 4.10 a): Distribution of Bayley III: Adaptive Behavior Scale Composite 
                         Scores  
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Practical DomainConceptual DomainSocial Domain
140
130
120
110
100
90
80
70
60
50
40
Bayley III: Adaptive Behavior Scale (n=32)
Average*
-2 sd*
+1 sd*
-1sd*
 
*Standardisation sample
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Figure 4.10 b): Distribution of Bayley III composite scores (subgroup with 
                          available Bayley III: adaptive Behavior Scale Scores)  
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4.2.8.2 Parental perception of developmental function prior to seizure onset 
 
The Vineland Adaptive Behavior Scales Survey Form (VABS) was completed for 39 
subjects, 79.6 % of the 49 children that were also assessed with the Bayley III scales. 
As explained in the methods chapter (section 3.2.2.2) the VABS data were not 
obtained for 8 children with seizure onset in the neonatal period and data for 2 
subjects were missing. 
 
Descriptive statistics of the 4 domains and the Vineland Adaptive Behavior 
Composite (VABC) are detailed in table 4.23 and figure 4.11 illustrates their 
distribution in relation the standardisation sample. The range of scores is wide 
reflecting the heterogeneity of the cohort. Motor skill scores (derived from 
behaviours observed prior to seizure onset) were lower compared to the other 
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domains. Fifty percent of the VABC sores in this cohort were ranked at or lower than 
the 31st percentile of the age matched standardisation sample. Twenty-five percent 
of children had VABC scores that ranked between 2 to 1 sd below the age matched 
standardisation group.  
 
Table 4.23: Results of Vineland Adaptive Behavior Scales - Survey Form (n=39) 
Domains 
 
Mean Sd Range 
Daily Living Skills 
 
98.5 14.2 62 - 122 
Socialization 
 
94.4 12.2 74 - 117 
Communication 
 
94 11.7 70 - 116 
Motor Skills 
 
86.5 10.7 61 - 116 
Adaptive Behavior Composite 91.2 12.2 61 - 116 
 
Figure 4.11: Distribution of  Vineland Adaptive Behavior Scale domains  
                    (n = 39) 
Adaptive Behavior 
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4.2.8.3 Predictors of the developmental status close to diagnoses (at 
baseline assessment) 
 
In order to explore the relationship between developmental status close to diagnosis 
and clinical factors, neurophysiology and neuroimaging the Bayley III subscale data 
(obtained at enrolment) were reduced for further analysis.  As described in the 
method chapter a single factor (Developmental Raw Score Factor [DF]) was 
generated using principal component analysis of the raw subscale scores. The 
proportion of the total variance explained by the DF was 93.7% (see appendix 10 for 
further details: component matrix with proportions of variance for each subscale raw 
score that can be explained by the factor). 
 
Explorative univariate analyses of covariance with DF as dependent factor and age at 
testing as covariate revealed significant relationships between lower developmental 
function and the following factors: ‘more than 20 seizures or cluster of seizures prior 
to the Bayley III assessment’, ‘abnormal neurological examination’, ‘aetiologically 
relevant neuroimaging findings’, ‘presence of interictal discharges on EEG ’and 
‘grossly abnormal EEG background abnormalities’ (see table 4.24 for details). The 
developmental function as reported by the carers prior to seizure onset (VABC score) 
was significantly related to the results of the Bayley III assessment (DF) following 
diagnosis of epilepsy. There was no significant relationship with the age of seizure 
onset, number of anti epileptic drugs taken at the time of assessment and 
predominant seizure type. 
   
Table 4.24: Results of explorative analysis – predictors of developmental function: Univariate 
                  Analyses of Covariance (dependent  factor: DF*, covariate: age at testing) 
Independent Factor n DF* mean (sd) F - ratio p-value 
Epilepsy onset 
 < 6 months 
 > 6 months  
 
27 
22 
 
-0.37 (.78) 
0.46 (1.1) 
F (1,46) = 0.89 0.35 
Number of AEDs at the time of 
evaluation 
0 
1 
2 
3 
 
 
5 
24 
15 
5 
 
 
1.31 (1.1) 
0.13 (0.89) 
-0.39 (0.82) 
-0.76 (0.65) 
 
F(3,44) = 2.84 
 
 
0.49 
Number of seizures /seizure 
clusters prior to developmental 
assessment: 
<= 20 
> 20 
 
 
15 
33 
 
 
0.68 (0.79) 
-0.37 (0.84) 
F (1,45) = 
17.69 
<0.001 
Seizure types: 
Spasms  
Generalised 
Focal and secondarily generalised  
 
15 
6 
28 
 
-0.48 (0.40) 
1.3 (0.71) 
-.016 (1.06) 
F(2,44) = 0.56 
 
0.58 
Development prior to seizure 
onset : 
VABC score** 
 
39 
 F (1,36) = 5.06 <0.001 
Neurological examination: 
Normal 
Abnormal 
 
25 
24 
 
0.73 (0.85) 
-0.76 (0.38) 
F(1,46) = 56.21 <0.001 
Neuroimaging Findings: 
Aetiologically relevant 
Aetiologically uncertain or not 
relevant 
Normal 
 
23 
10 
13 
 
-0.460 (0.92) 
0.20 (0.78)  
0.45 (0.90) 
F(2,43) = 6.23♣ 0.004 
EEG: 
Normal 
Abnormal 
 
8 
39 
 
1.04 (0.86) 
 -0.28 (0.62) 
F(1,44) = 13.57 0.001 
EEG - Interictal epileptiform 
discharges: 
Absent 
Present 
 
 
 
17 
30 
 
 
0.51 (1.1) 
-0.37 (0.73) 
 
F(1,44) = 8.51 0.006 
EEG – Background activities: 
Grossly Abnormal 
Unspecific abnormalities 
Normal 
 
 
18 
15 
13 
 
 
-0.79 (0.37) 
0.31 (0.10) 
0.53 (0.91) 
 
F (2,42) = 
4.18♣♣ 
0.022 
*DF = Developmental –Raw-Score Factor: generated from raw sores of Bayley III subscales 
by Principal Component Analysis 
**VABC = Vineland Adaptive Behaviour Composite score entered as covariate in addition 
to ‘age at testing’  
♣Contrasts ‘Neuroimaging Findings’: higher DF values with ‘normal’ compared to 
‘aetiologically relevant’ findings [t(43) = -3.51, p=0.001, r=0.5], DF values not significantly 
different with normal compared to ‘aetiologically uncertain or not relevant’ findings [t(43) = 
-1.512, p 0.138, r=0.2] 
♣♣Contrasts ‘EEG – background activities’: higher DF values with normal compared to 
grossly abnormal [t(42) = -2.89, p = 0.006, r = 0.4], DF values not significantly different 
with normal compared to unspecific background abnormalities (t (42) = -1.332, p= 0.19, r = 
0.2).
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The factors that were significantly related to the DF (‘abnormal neurological 
examination’, ‘presence of interictal discharges on EEG’, ‘grossly abnormal EEG 
background activities, unspecific EEG background abnormalities’, ‘aetiologically 
relevant neuroimaging findings’, aetiologically uncertain or not relevant 
neuroimaging findings’,> 20 seizures/seizure clusters prior to developmental 
assessment’ and ‘VABC score’) and ‘age at testing’ were entered into a stepwise 
linear regression model (backwards method). The independent significant predictors 
in the final model were ‘abnormal neurological examination’ and ‘presence of 
interictal discharges on the EEG’ as well as development prior to seizure onset 
(VABC score), that had a weaker effect compared to the other factors (see table 4.25 
for coefficients and p values). 
There was a significant relationship between neurological examination and 
neuroimaging findings (χ2 (1) = 15.2, p < 0.001) as well as neurological examination 
and background EEG activities (χ2 (1) = 17.63, p < 0.001, see also tables 4.26 a) and 
4.26 b)). 
Table 4.25: Multivariable linear Regression (model1) - Coefficients 
                   (Dependent factor DF♦)   
 B 95% Confidence 
Interval 
β p 
Constant -1.719 (-3.1) – (-0.34)  
Age at testing 0.09 0.07-0.11 0.68 < 0.01 
Interictal epileptiform 
discharges 
-0.4 (-0.71) – ( -0.14) -0.21 < 0.01 
Abnormal neurology -0.64 (-0.9) – (-0.34) -0.35 < 0.01 
VABC♦♦ score 0.012 0 – 0.02 0.17 0.051 
Note R2=0.87 
♦ Dependent factor: Developmental –Raw-Score Factor: generated from raw sores of 
Bayley III subscales by Principal Component Analysis 
♦♦ VABC = Vineland Adaptive Behavior Composite 
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4.26 a): Relationship between neuroimaging findings and neurological examination
  Neurological examination 
  Normal Abnormal Total 
Normal or not 
aetiologically relevant 
findings 
20 5 25 
Neuroimaging: 
Aetiologically relevant 
abnormalities 
7 20 27 
Total 27 25 52 
χ2 (1) = 15.2, p < 0.001 
 
 
 
4.26 b): Relationship between EEG background activities and Neurological 
examination 
  Neurological examination 
  Normal Abnormal Total 
Normal or abnormal not 
otherwise specified 
23 6 29 
EEG Background 
activities 
Grossly abnormal 3 15 18 
Total 26 21 47 
χ2 (1) = 17.63, p < 0.001 
 
 
Because both epileptic activity and structural brain abnormalities may manifest in 
abnormal neurology the relationship of neuroimaging, EEG and prior seizure activity 
to the developmental function were explored in a separate model. The following 
factors were entered in a backward linear regression analysis: ‘abnormal EEG’, 
‘aetiologically relevant neuroimaging findings’, ‘aetiologically uncertain or not 
relevant neuroimaging findings' and ‘number of seizures / seizure clusters prior (> 
=20 versus < 20)’. The final model revealed significant independent relationships of 
both abnormal EEG and aetiologically relevant neuroimaging findings to 
developmental function. Frequent seizures prior to assessment (> =20) had also 
although non significant effect (see table 4.27). 
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Table 4.27: Multivariable linear Regression (model 2)  - Coefficients 
                  ( Dependent factor DF♦) 
 B 95% Confidence 
Interval 
β p 
Constant -0.25 -0.69 – (-0.19)  
Age at testing 0.08 0.06 - 0.10 0.62 < 0.01 
Aetiologically relevant 
Neuroimaging findings 
-0.3 (-0.59) – (-0.02) 0.17 0.035 
Abnormal EEG -0.55 (-0.94) – (-0.16) -0.24 < 0.01 
Seizures prior testing♦♦ -0.29 -0.63 – 0.04 -0.15 0.085 
Note R2=0.81 
♦ Dependent factor: Developmental –Raw-Score Factor: generated from raw sores of 
Bayley III subscales by Principal Component Analysis 
♦♦ Number of seizures/ seizure clusters prior  Bayley III assessment (> =20 versus < 
20 ) 
 
 
 
 
4.2.8.4 Clinical features of the children at 1 year follow up 
Of the 49 children that underwent initial assessment with the Bayley III 32 (65% of 
the initial cohort) were retested after a mean interval of 12.5 months (range 10-18 
months). Seventeen children were lost to follow up: 12 children moved out of the 
area or the carers declined further participation and 5 children died during the follow 
up period (case fatality: 9% (95% CI 4 - 19)).  Three of the later group had 
developmental brain malformations with neurological impairment; one was 
diagnosed with Ohtahara syndrome and one with SMEI (SCN1A missense mutation). 
Known causes of death included aspiration pneumonia in two cases and status 
epilepticus in the infant with SMEI (findings on post mortem examination performed 
in this child were in keeping with clinical history of status epilepticus). The post 
mortem examination of the child diagnosed with Ohtahara syndrome did not reveal 
any cause for the sudden death. 
 
 164
   
Table 4.28 illustrates the initial clinical features and epilepsy syndrome diagnoses of 
the ‘follow up cohort’ compared to the group that was lost to follow up. Children 
with epileptic encephalopathies and idiopathic epilepsies appear to be stronger 
represented in the group that was lost to follow up. The mean age of epilepsy onset 
was earlier in the subgroup lost to follow up.  
Table 4.28: Clinical features and epilepsy syndrome diagnosis at baseline of patients 
followed up and those lost to follow up 
 Follow up assessment carried out  
n = 321 
Lost to follow up 
  n = 17 
Age at 
epilepsy onset 
[months] 
mean (sd) 
 
                 7.9 (6.2) 
 
3.8 (4.6) 
  N (%)  N (%) 
Male  20 (62.5) Male  8 (47)  
Seizure status Daily 
Weekly 
Monthly   
Seizure free < 3 months 
Seizure free > 3 months 
11 (34) 
2 (6) 
2 (6) 
13 (40) 
4 (12) 
Daily  
Weekly 
Monthly 
Seizure free < 2 
months 
 
7 (41) 
1(6) 
1 (6) 
8 (47) 
Epilepsy 
syndrome 
group 
Epileptic encephalopathy 
Symptomatic focal (11) 
or Probably symptomatic 
focal (3) 
Idiopathic focal (3) or 
generalised (1) 
NAC 
11 (34) 
14 (43) 
 
4 (12.5) 
3 (9) 
Epileptic 
encephalopathy 
Symptomatic focal 
(3) or probably 
Symptomatic focal 
(1) 
Symptomatic 
generalised 
Idiopathic focal 
8 (47) 
 
4 (23) 
 
 
 
1 (6) 
 
4 (23.5) 
Specific 
Epilepsy 
Syndrome 
West syndrome 
Ohtahara syndrome 
Neocortical epilepsies* 
Mesial temporal lobe 
epilepsy with 
hippocampal sclerosis 
BIS (non familial) 
BME 
NAC 
10 (31) 
1 (3) 
8 (25) 
1 (3) 
 
 
1 (3) 
1 (3) 
10 (31) 
West syndrome 
Ohtahara syndrome 
Dravet syndrome 
Neocortical 
epilepsies* 
BIS (non familial) 
NAC 
4 (23) 
1(6) 
2 (12) 
3 (18) 
 
1 (6) 
 
 
6 (35) 
NAC = not classified, , * defined by location and aetiology, BME = Benign myoclonic epilepsy in 
infancy,  BIS = Benign Infantile seizures; 1 Three children were not included in repeated measures 
ANOVA as data sets were incomplete: Idiopathic focal epilepsy – Benign infantile seizures (1), 
symptomatic focal epilepsy – Neocortical epilepsy (2) 
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Information about severity of epilepsy and number of antiepileptic drugs the children 
were treated with at the time of the follow up assessment is provided in table 4.29.  
 
Table 4.29: Clinical features of subjets that were re-assessed with the Bayley III
 N=32 
Age at follow up assessment [months]: mean (sd): 26.7 (8.6) 
Retest interval [Months]:  mean (sd) 12.5 (1.5) 
Seizure severity: 
Daily 
Weekly 
Monthly 
Seizure free < 6 months (21 weeks) 
Seizure free >= 6 months 
 
8 (25%) 
2 (6.3%) 
2 (6.3%) 
1 (3%) 
19 (59%) 
Number of antiepileptic drugs on: 
0 
1 
2 
 
7 (22%) 
18 (56%) 
7 (22%) 
 
 
 
4.2.8.5 Longitudinal changes of Bayley III scores and associated factors 
 
Figure 4.12 illustrates the longitudinal progress of Bayley III composite scores 
(cognition, language and motor) for each subject.  The progress between baseline and 
follow up assessment is variable showing improvement, deterioration or no change. 
A Wilcoxon signed-rank test revealed no significant differences between cognitive 
and language composite scores at baseline and follow up assessment.  The motor 
composite scores were slightly higher at follow up (mean 70.7, range sd 25.4) than at 
baseline testing (mean 67.7, sd 22.6), z = -2.07, p=0.035, r = 0.3.  The difference 
between gross motor scale scores and fine motor scale scores at baseline and follow 
up, did not reach significance on statistical analysis: 
gross motor (baseline: mean 4.6, sd  3.5; follow up mean 5.1, sd 3.9) z = -1.7, 
p=0.91; fine motor (baseline: 4.6, sd 4.2; follow up 4.9, sd 4.5) z = -1.6, p = 0.105. 
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In order to explore the effect of clinical factors, neuroimaging and EEG findings to 
the longitudinal change of individual developmental function further analysis was 
conducted in two steps. The data were reduced using separate principal component 
analyses for the Bayley III composite scores at baseline and follow up. Each 
generated a single factor: Developmental composite factor at baseline [DCF-0] and 
follow up [DCF-1] (See appendix 10 for details of total variances explained and 
component matrices]. A repeated measure ANOVA revealed no significant 
difference between DCF-0 (baseline) and DCF-1 (at follow up). There was also no 
difference  after adjustment for the following factors: ‘neurological examination’, 
‘seizure free for 6 months’, ‘presence of aetiologically relevant neuroimaging 
findings’, ‘EEG at enrolment’ and ‘number of AEDs at follow up assessment’ 
(between-group variables).   
Independent of the longitudinal effects (within subject analysis) ‘EEG’ [F (1, 21) = 
13.22, p= 0.002] and ‘neurological examination’ [F (1,21)=13.3, p = 0.002] at 
enrolment influenced significantly the DCF value (between subject analysis). 
Subjects with normal baseline EEG or normal neurological examination at enrolment 
had higher mean DCF values (average of DCF-0 and DCF-1) compared to those with 
abnormal initial EEG and abnormal initial neurological examination. 
   
Figure 4.12: Change of Bayley III composite scores within subjects over follow up period:  
Cognition (a), Language (b), Motor (c); (n = 32) 
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4.2.9 Discussion: Findings of the observational cohort study  
(North London infancy epilepsy cohort) 
 
4.2.9.1 Clinical features of the cohort 
In this section the clinical features of the North London infancy epilepsy cohort (see 
table 4.5 in section 4.2.1.2 ) are discussed in the context of published data from other 
population or community based childhood epilepsy cohorts (composed of infants and 
older children). 
  
The time interval between first and second seizure appears to be shorter in the North 
London infancy epilepsy cohort compared to other childhood epilepsy cohorts. 
Nearly all of the seizures / cluster of spasms (96%) in the ‘Epilepsy in Infancy’ 
cohort recurred within 4 weeks and the majority within one week (79%). After 
exclusion of seizure types that rarely occur as single events (such as spasms and 
myoclonic seizures), this pattern remained unchanged (recurrence aftert first seizure 
within 1 week in 72% and within 4 weeks in 95%). A smaller poportion of children 
between 1 month and 16 years registered in the childhood epilepsy cohort form Nova 
Scotia cohort5 experienced their second seizure within the  first month (70%) and the 
mean time interval between first and second generalized tonic clonic or partial 
seizure was 4.9 months (mean age at first seizure:  6.7 years, approximately 12% 
were under the age of 12 months)(Camfield et al., 1993;Camfield and Camfield, 
2003). In the ‘first seizure cohort’of children and adolescents from 1 month to 19 
                                                 
5 Children, resident in Novo Scotia (Canada) presenting with recurrent unprovoked seizures between 
1977 and 1985, were  identified retrospectively through an EEG department of the single tertiary 
pediatric centre for the province (Camfield et al., 1996). 
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years of age ascertained by Shinnar et al from an inner city population6 the mean 
time interval of recurrence was 9.6 months with a median of 6 months (mean age at 
first seizure 6.7 years) (Shinnar et al., 1990). Cases with absence seizures, myoclonic 
seizures and infantile spasms were excluded in the latter.  
The relatively shorter time interval of seizure recurrence in infants would in keeping 
with the notion of increased propensity of the immature brain for seizures. 
 
In the North London infancy epilepsy cohort the proportion of patients with 
preceding neonatal seizures was higher compared to childhood epilepsy cohorts. A 
history of neonatal seizures was observed in a quarter of cases, including 14% of 
children with seizure onset in the neonatal period. A similar proportion of cases with 
neonatal seizures has been recently reported from a hospital based cohort children 
with epilepsy onset under 2 years (23%) (Altunbasak et al., 2007). Only 2.6% (16 of 
613) of children with newly diagnosed epilepsy in the Connecticut childhood  
epilepsy cohort (epilepsy onset at age 1 month to 15 years) had neonatal seizures 
(Berg et al., 1999c). Results of a large retrospective population based cohort study 
from Novo Scotia that investigated the relation of pregnancy and neonatal factors to 
subsequent development of childhood epilepsy were recently published (Whitehead 
et al., 2006). Neonatal seizures regardless of cause and pre-eclampsia were factors 
that were associated with the highest risk for the development of childhood epilepsy. 
The authors calculated the population attributable fractions for the risk factors. "The 
population attributable fraction is most commonly defined as proportional reduction 
in average disease risk over a specified time interval that would be achieved by 
                                                 
6 Children and adolescents with a first unprovoked seizure seen at  Montefioe Medical Centre, Bronx 
Municipal Hopita Centre, North Central Bronx Hopsital or private practices of authors were 
propectively enrolled (between October 1983 and September 1987 ) and followed (n=283, mean 
follow-up period: 30 months,   63% > 2 years) (Shinnar et al., 1990). 
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eliminating the exposure(s) of interest from the population while distribution of other 
risk factors in the population remains unchanged." (Rockhill et al., 1998).  In case 
there are no other confounding exposer(s) of interest this can be calculated as 
follows: (Cumulative proportion of total population developing disease over 
specified time [IPt] - cumulative proportion of unexposed persons who develop 
disease over interval [IP0 ]) / Cumulative proportion of total population developing 
disease over specified time [IPt] (Rockhill et al., 1998). 
The population attributable risk of 'neonatal seizures' was relatively small with 5.3%. 
This means according to the quoted definition that, the average risk for childhood 
epilepsy could be reduced by 5.3 % if exposure to neonatal seizures were to be 
eliminated or only 5.3% of childhood epilepsy cases could be prevented following 
elimination of exposure to neonatal seizures, assuming these were causal. There was 
no significant association of childhood epilepsy with labour and delivery events. The 
population attributable fractions of other prenatal and neonatal factors ranged in this 
study from 2% to 8% (e.g. prenatal CNS anomalies: 2.8%, small for gestational age 
7.4 %, neonatal metabolic disorders 5.7%). Although prenatal and neonatal factors 
(including neonatal seizures) contribute to the risk of developing epilepsy later in 
childhood they occur relative infrequent in the childhood epilepsy cohort and other 
factors (e.g genetic factors or later aquired brain injuries) that were not investigated 
here may have a larger weight. In the infancy epilepsy cohort, however,  neonatal 
seizures may be more relevant for the risk to develop epilepsy. To confirm this 
hypothesis a poplation based case control study design would be required.  
 
Febrile convulsions have an age dependent distribution with the majority occuring in 
the first 2 years of life (Verity et al., 1985;Sillanpaa et al., 2008). Therefore it is not 
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suprising that the proportion of subjects with a history of febrile convulsions in the 
North London infancy epilepsy cohort (21%) is higher compared to childhood 
epilepsy cohorts (10.3 – 16 %), that include infants and older children (Berg et al., 
1999c;Camfield and Camfield, 2003;Arts et al., 2004;Larsson and Eeg-Olofsson, 
2006).  
 
One or more episodes of status epilepticus (SE) were reported in 7 (12%) of subjects 
enrolled in the North London infancy epilepsy cohort at baseline assessment, close to 
diagnosis. Similar or higher figures (12-17%) have been documents in hospital 
/specialist setting based infancy epilepsy cohorts (seizure onset under 1 year) 
(Chevrie and Aicardi, 1978;Cavazzuti et al., 1984).  These proportions are higher 
when compared to data from childhood epilepsy cohorts around the time of diagnosis 
/ enrolment (8.1% - 9.1%) (Berg et al., 1999b;Stroink et al., 2007). The notion that 
young children may be of particular risk is further supported by the observation that 
the incidence of convulsive SE (CSE) in childhood is highest in the youngest age 
group (< 1 year) (Chin et al., 2006) and by the follow up data of the Connecticut 
childhood epilepsy cohort showing a significant independent relationship of the risk 
for CSE with young age at epilepsy onset,  previous CSE and symptomatic aetiology 
(Berg et al., 2004a).  Four of the 7 cases with history of SE in the North London 
infancy epilepsy cohort had symptomatic focal epilepsies and 3 epileptic 
encephalopathy syndromes (2 testing positive for SCN1A mutations and 1 Ohthahara 
syndrome). Both the community based Connecticut and the hospital based Dutch 
childhood epilepsy cohorts demonstrated that the majority of cases of CSE occur at 
or prior to the diagnosis of epilepsy (and that an episode of CSE increases the risk 
for future episodes (Berg et al., 2004a;Stroink et al., 2007). 
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The proportion of children with developmental impairment preceding seizure onset 
in the North London infancy epilepsy cohort was relative high (39%) reaching values 
that have been previously reported from hospital or specialist clinic based settings 
(38-53%) (Chevrie and Aicardi, 1977;Matsumoto et al., 1983c;Battaglia et al., 1999). 
In addition neurological abnormalities at enrolment were observed in a significant 
proportion of children, giving further the impression that preexisting brain pathology 
was common in this population based infancy cohort.  
 
The observed proportion of consanguineous marriages in the North London infancy 
epilepsy cohort (16%) may well be a reflection of the particular ethnic composition 
with different traditions of the surveyed inner city population.  Consanguineous 
marriages are common in certain countries (North and sub-Saharan Africa, the 
Middle East, West, Central and South Asia) with 20 to > 50% compared to < 1% in 
most parts of Europe and North America of marriages between couples related as 
second cousins or closer (Bittles, 2008). The composition of the surveyed inner-city 
target population with relative high proportion of residents belonging to the non 
white ethnic groups (36%) as well as ethnic composition of the infancy cohort has 
been discussed previously (see sections 4.1.5; 4.1.6.2 ).  Consanguinity is a potential 
risk factor for infancy onset epilepsy because autosomal recessive traits / disorders 
are more likey to be expressed. Ideally an age matched normal control group 
ascertained from the same population would be required to establish whether the 
relative high  proportion of  consanguineous marriages in the North London infancy 
epilepsy cohort is related to an increased risk for infancy onset epilepsy.  Masri et al 
applied a case control design to investigate risk factors of for infancy onset epilepsy 
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(Masri et al., 2008). They acsertained an age matched 'normal' control group (n=111) 
from attenders of the general paediatric clinic of their institution (Jordan University 
Hospital) for comparison with their retrospective specialist clinic based cohort of 
children with epilepsy onset in the first year of life (n=55, attenders of the neurology 
clinic). Consanguinity was one of the significant risk factors (60% parental 
consanguinty in the patient group versus 30% in the control group). The authors have 
not provided further information about the patient population that attends the clinics 
at their institution. Thus, there are limitaions to which their findings can be applied to 
the general population as ascertainment bias cannot be assessed.  
 
The case fatality of 9% observed in the North London infancy epilepsy cohort during 
the here described study period (see section 4.2.8.4)  is similar to the figures reported 
previously from hospital and community based infancy epilepsy cohorts (7-10%) 
(Chevrie and Aicardi, 1978;Matsumoto et al., 1983c;Battaglia et al., 1999;Rantala 
and Ingalsuo, 1999;Datta and Wirrell, 2000). In comparison to the infancy epilepsy 
cohorts the documented proportions of deaths in childhood epilepsy cohorts range 
from 1.9-3.7% (Callenbach et al., 2001;Camfield et al., 2002;Berg et al., 2004b). 
Similar to the observations in the childhood epielpsy cohorts the deaths in the North 
London infancy epilepsy cohort occurred in children with neurological impairments 
and a diagnosis of a severe epilepsy syndrome. This included also one case that met 
criteria for definite sudden unexpected death in epilepsy (SUDEP)(Tomson et al., 
2008).   
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4.2.9.2 Distribution of seizure types at enrolment, classification (Axis 2) 
and interrater agreement  
Contrary to the reports from early hospital/specialist clinic  based infancy epilepsy 
cohorts focal and secondarily generalised seizures were the commonest seizure types 
in the North London infancy epilepsy cohort documented at enrolment (Chevrie and 
Aicardi, 1978;Matsumoto et al., 1983a;Czochanska et al., 1994). Spasms were less 
frequent compared to some of these earlier studies occurring in around a third of 
infants. A similar proportion of infantile spasms were reported from a retrospective 
population based Finnish infancy epilepsy cohort (seizure onset between 28 days and 
24 months (Rantala and Ingalsuo, 1999) and one hospital based series (Matsumoto et 
al., 1983a). As mentioned in the introduction, Korff and Nordli analysed video-
telemetry data from infants (aged 1 -12 months) investigated in a specialist setting 
(epilepsy centre) (Korff and Nordli, Jr., 2006). The majority of seizures (101 events 
in 69 children) were classified as focal seizure types (76%) including spasms with 
features suggesting focal onset (28 of 76). Only 23 events were classified as 
generalised and 13 of these were spasms. Although bias of this series of infants 
investigated by Korff and Nordli towards more severe and lesional epilepsy cannot 
be excluded, these observations support the impression that the majority of seizures 
in children under two years are focal.  
 
Explanations for the differences in proportions of seizure types between the various 
discussed infancy epilepsy cohorts include selection bias associated within various 
settings and that classification was based in most cases on description or clinical 
observation. There are limitations to which the electrographical correlate can be 
predicted accurately based on observation (Nordli, Jr. et al., 1997;Korff and Nordli, 
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Jr., 2006), descriptions of seizure manifestations may vary in content and quality,  
and application of the international seizure classifications (ILAE, 1981, 2001) to 
seizures occurring in infancy without modification is difficult. These limitations 
became apparent in the North London epilepsy in infancy study because in a 
significant proportion of cases the raters were not able to classify seizure types as 
listed in the 2001 ILAE proposal beyond gross categories such as ‘focal’ or 
‘generalised’ (see tables 4.6 and 4.7 in section 4.2.2).  Using large categories there 
was good inter-rater agreement between the two paediatric neurologists, who both 
had a special interest in epilepsy.  
 
Data in the literature show that inter-rater agreement with respect to seizure types 
was mostly moderate. In one study ratings of a paediatric neurologist with 3 junior 
doctors in training were compared when applying the 1981 ILAE classification to 
seizure description in records of children newly diagnosed with epilepsy (Ottman et 
al., 1993). There was only poor or fair agreement and kappa scores improved when 
cases with insufficient information were removed. Six paediatric neurologists 
classified first seizures of children enrolled in the Dutch Study of Epilepsy in 
Childhood into 5 seizure categories, eg simple partial, complex partial, generalised 
etc, based on information from a questionnaire completed by a paediatric neurologist 
at enrolment (Stroink et al., 2004). There was moderate agreement when they used 
their own judgement (average kappa score 0.46) with some improvement of kappa 
scores when additionally specific criteria were used (average kappa 0.57).  
Inter – rater agreement remains only moderate even when the bias introduced by 
seizure descriptions is removed and seizures are rated based on video recordings. In a 
recently published study 3 epileptologists independently classified 138 seizures by 
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analysing video tapes (obtained during video-telemetry sessions) of 60 patients (aged 
between 2 and 59 years, median age 26 years) whilst comparing the ILAE 1981 
classification with a semiologic seizure classification (Parra et al., 2001). Average 
kappa scores for the ILAE 1981 seizure classification were 0.41(agreement in 39% 
of cases) and for the semiologic seizure classification were 0.56 (agreement in 63%).  
 
The reviewed data from the literature as well as observations from the North London 
Epilepsy in Infancy Study show that seizure classification, especially in infants, 
based on clinical description is only limited possible and frequently unreliable with 
the exception of certain types such as epileptic spasms that have more narrowly 
defined motor manifestaions and frequency patterns.  Video EEG can achieve more 
accurate classification, however, in everyday clinical practice there are limitaions to 
the availability of this resource and seizures may occur too infrequently.  Thus the 
suggestions of the ILAE task force in  the 2001 ICE proposal to apply seizure types 
as diagnostic entities, whith therapeutic and prognostice implications where a 
diagnosis of a specific electro-clinical syndrome cannot be obtained, is at least in the 
infancy group not practical (Engel, Jr., 2001). A classification of the type of epilepsy 
with relevance for patient management and prognosis requires especially in this early 
onset group a descriptive approach that incoporates information about aetiology, 
neurological as well as developmental status prior and after seizure onset, seizure 
severity and response to antepileptic treatment.  
 
4.2.9.3 Distribution of epilepsy syndromes (Axis 3) at enrolment  
Although for a third of infants in this cohort following baseline assessment a specific 
epilepsy syndrome could not be allocated the vast majority could at least be 
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categorised in one of the epilepsy syndrome groups that were suggested in the 2001 
ILAE proposal. Specific epilepsy syndromes could not be determined because of 
insufficient information or mismatch of clinical data with the descriptions of the 
syndromes. For the classification of cases enrolled in the North London Epilepsy in 
Infancy Study we accepted two ‘levels’ of epilepsy syndrome diagnoses (first level: 
epilepsy syndrome group – second level: specific epilepsy syndrome if possible) and 
thus we were able to allocate an axis 3 description to the majority of infants. 
Akiyama et al applied the 2001 proposal in a different way when they reclassified 
their large prevalence childhood epilepsy cohort (Akiyama et al., 2006). They were 
only able to identify an axis 3 diagnosis in 12% using solely the list of specific 
epilepsy syndromes without considering epilepsy syndrome groups. The majority of 
their cohort was described by seizure type (axis 2) as suggested in the 2001 proposal.  
 
Contrary to our expectations only a relatively small proportion of cases in the North 
London infancy epilepsy cohort were identified with idiopathic epilepsy syndromes 
(9, 16%), mostly focal idiopathic epilepsy.  Allocation of specific epilepsy 
syndromes in this 'idiopathic group' was difficult and only achieved in 3 of 9 cases 
(benign non-familial infantile seizures (2),  BME (1)). Compared to later childhood, 
in the idiopathic epilepsy group specific syndromes with onset in infancy (outside the 
neonatal period) are less well delineated. Only two syndromes are currently included 
in the ILAE syndrome list (Benign myoclonic epilepsy in infancy and benign 
infantile seizures [BIS]- familial and non familial forms). (This issue will 
bediscussed further in the following section 4.2.9.4.) 
More than two thirds of infants enrolled in the in the North London infancy epilepsy 
cohort presented with epilepsy syndromes associated with guarded long term seizure 
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outcome and developmental impairment. There are no population based data in the 
literature to compare these results as already discussed in the introduction. 
Comparison with hospital / specialist setting based cohorts of children with epilepsy 
onset under the age of 2 years is difficult because of the application of different 
syndrome classification systems, 1989 ICE in most studies (Commission on 
Classification and Terminology of the International League Against Epilepsy, 
1989;Caraballo et al., 1997).    
 
Despite the collaborative population based design of this study to avoid referral bias 
under-ascertainment of clinically less severe epilepsy presentations cannot be 
completely ruled out. Reasons may include failure of notification but also possible 
failure of mild clinical presentations to meet inclusion criteria. 'Benign infantile 
seizures' [BIS], for example,  have been described as a spectrum of conditions with 
variable severity of seizure presentations, some of which may be regarded as 
‘seizures not necessarily requiring a diagnosis of epilepsy ‘, a category listed in the 
2001 ILAE proposal (Engel, Jr., 2001;Specchio and Vigevano, 2006;Okumura et al., 
2006).  In pedigrees from families with SCN2A mutations for example some infants 
presented with a single seizure or single seizure cluster (Berkovic et al., 2004). Such 
cases may not meet inclusion criteria (recurrent seizures), when a single cluster of 
seizures within 24 hours is regarded as one event. In addition the age of onset of one 
recently described familial form overlaps with the neonatal period (benign neonatal 
infantile seizures, (Herlenius et al., 2007). Such cases may not be enrolled if these 
present with neonatal seizures only. BIS associated with gastroenteritis would not 
meet inclusion criteria because seizures are situation related rather than unprovoked.  
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In appendix 11 details of 4 cases are given that were initially enrolled in the North 
London infancy cohort but subsequently excluded because inclusion criteria were not 
met.  
4.2.9.4  Classification of epilepsy syndromes: inter-rater agreement, intra-rater 
consistency, and stability of diagnoses after1 year follow up  
The inter-rater agreement for epilepsy syndrome groups and specific epilepsy 
syndromes was only moderate or even poor referring to the issues discussed in the 
methods chapter (section 3.2.5.2). This is a striking result considering that both raters 
were paediatric neurologists with an interest in epilepsy and highlights the diagnostic 
difficulties when applying the syndrome group or specific syndrome diagnosis list of 
the 2001 proposal in the infancy epilepsy group.  
Berg et al reported a high level of agreement (application of weighted kappa) 
between three child neurologists, who independently classified cases enrolled in the 
Connecticut childhood epilepsy cohort using the 1989 ICE (Commission on 
Classification and Terminology of the International League Against Epilepsy, 
1989;Berg et al., 1999a). This was achieved because the raters agreed a priori rules 
on the application of the ICE. In the North London epilepsy in infancy study both 
paediatric neurologists applied the ILAE 2001 proposal according to their own 
judgement, a situation which more closely reflects the ‘reality’ of clinical practice.  
Berg et al observed slightly lower, although not statistically significant, Kappa values 
in the < 2 year old group (0.78-0.82) compared to children 2 years and older (0.83-
0.85). In the < 2 year old group, similar to the observations in the North London 
epilepsy in infancy study,  common discrepancies related also to the classification of 
cases as symptomatic focal epilepsies or infantile spasms (if these occurred as 
manifestation of a secondarily generalised syndrome). Epileptic spasms can be 
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generated by a focal lesion and as such be understood as secondarily generalised 
manifestation of symptomatic focal epilepsy. This aetiological approach may be 
justified as catastrophic onset focal symptomatic epilepsy (without epileptic spasms) 
may well present with developmental regression or arrest similar to that observed in 
West syndrome/infantile spasms. The electroclinical delineation of this aetiologically 
and clinically heterogeneous syndrome (West syndrome/infantile spasms) is not 
without controversies (Lux and Osborne, 2006).  A recent consensus proposal 
suggests defining two main groups: a) West syndrome as essential combination of 
specific EEG feature (hypsarrythmia) and seizure type (clusters of epileptic spasms) 
with variable presence of developmental impairment before or after onset, and b) 
‘Infantile Spasms without hypsarrythmia’ (Lux and Osborne, 2004).  In order to 
justify such grouping further research needs to determine which other characteristics 
including clinical presentation; underlying aetiology and outcomes differentiate these 
two groups of patients with infancy onset epileptic spasms.  
 
 The second area of discrepancy in the North London Epilepsy in Infancy Study 
arose between ‘idiopathic focal’ and ‘probable symptomatic focal’ epilepsy. Both 
‘syndrome groups’ are less narrowly defined with overlapping features and negative 
neuroimaging. Information about the further clinical progress is often required. 
 
Intra-rater consistency for syndrome groups was high when cases were reclassified 
after a time interval. However there was more intra-rater variability with respect to 
specific epilepsy syndromes. Change of  ‘not able to classify’ (NAC)  to ‘neocortical 
epilepsy’ in several cases within the focal symptomatic epilepsy group by both raters 
may indicate increased familiarity with the ‘formal’ classification process compared 
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to the initial rating. Other changes particularly related to NAC cases within the 
idiopathic group. This involved alteration of the initial classification from focal and 
generalised idiopathic (rater B), and NAC to specific ‘idiopathic’ syndrome’ 
diagnoses (including BIS and GEFS+, rater A).  The diagnostic uncertainty that 
involves especially infants presenting with milder clinical presentations and normal 
interictal EEG becomes apparent. The initial diagnoses in this group are variable 
between experts and less consistent.  
 
After a relatively short follow up interval (12 months) additional information did 
result in a change of syndrome diagnosis in only a small portion of cases (9-10%), 
that were followed (n=32). Berg et al reported changes in syndrome diagnosis 2 
years following enrolment in the Connecticut childhood epilepsy cohort in a slightly 
higher proportion of cases (∼14%). This may be due to the longer follow up period 
compared to this study. Similar to the observations by Berg et al reasons for change 
of syndrome diagnoses in this infancy epilepsy cohort was either evolution of the 
syndrome (West syndrome to focal symptomatic epilepsy) or further information 
lead to allocation of syndrome in cases that could not be diagnosed before. 
Variability of diagnoses over time affected especially infants with mild epilepsy 
presentations in the idiopathic group. As previously observed most discrepancies 
between raters occurred on the level of specific epilepsy syndrome diagnoses in this 
group.  Two cases were classified under ‘seizures not necessarily are requiring a 
diagnosis of epilepsy’ by one rater for example whilst the other rater determined 
idiopathic generalised epilepsy not further classifiable. 
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This again demonstrates the overlap of syndrome categories in the ICE. Children 
meeting criteria for BIS and presenting with rare seizures or a single seizure cluster 
may not require a diagnosis of epilepsy. The latter judgment is impossible to make at 
the onset. Although some authors report that early diagnosis for example of BIS  may 
be possible in a significant proportion ultimately a follow up period is required to 
confirm this (Okumura et al., 2000).  
 
At onset an epilepsy syndrome diagnosis is possible in most infants. Infants with 
milder seizure presentations (rare seizures or seizure cluster often triggered by 
illnesses), with normal neuroimaging and interictal EEG, however, are difficult to 
pigeonhole in the current syndrome list of the ICE. An epilepsy  syndrome lead 
approach to guide management and derive prognosis can not be applied in this group. 
Thus, a descriptive approach using the multi axial system of the 2001 ILAE task 
force proposal and omitting axis 3 (specific electroclinical syndrome ) may be more 
appropriate.  
 
4.2.9.5 Application of International Classification of Epilepsies and 
Epilepsy Syndromes in Infancy 
The 1989 ICE grouped epilepsies and electro-clinical syndromes according to mode 
of onset of seizures and aetiological category. This resulted in a situation as 
discussed in the introduction that some entities were narrowly defined (e.g. infantile 
spasms/West syndrome or benign myoclonic epilepsy in infancy) whilst others were 
rather unspecific providing little information (cryptogenic focal epilepsy). The 
diagnostic scheme proposed in 2001 provided more flexibility. Epilepsy syndromes, 
however, were grouped in a similar dichotomous fashion as in the 1989 ICE with 
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introduction of additional groups including 'epileptic encephalopathies'. Although by 
applying 'epilepsy syndrome groups' and 'specific epilepsy syndrome' diagnosis most 
infants enrolled in the North London infancy epilepsy cohort could be classified, 
certain less narrowly defined categories such as 'idiopathic focal / idiopathic 
generalised' and 'probable symptomatic focal' provided little information and there 
was more inter-rater disagreement with variability over time. Determination of the 
mode of seizure onset based on clinical description in this age group is difficult as 
are  assumptions with respect to outcome at outset when the aetiology is unknown 
(cases categorised under idiopathic or probable symptomatic).  It is questionable 
whether such diagnoses are useful beyond the description of certain key clinical 
characteristics (e.g. seizure type, neuroimaging findings, developmental status, and 
response to medication).  
 
There was also overlap between syndrome groups defined by aetiological category 
plus mode of seizure onset such as symptomatic focal and the epileptic 
encephalopathy group as observed in cases with infantile spasms / West syndrome in 
the presence of structural brain abnormalities. Presence of encephalopathy associated 
with frequent seizures or near continuous epileptiform activity on EEG is not 
confined to the specific electroclinical syndromes grouped under epileptic 
encephalopathies but can also occur with 'focal symptomatic epilepsies'. On the other 
hand encephalopathy may not be part of the clinical presentation of some infants 
meeting criteria for one of the syndromes grouped under epileptic encephalopathies 
(e.g. infantile spasms/West syndrome). 
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The identification of genetic aetiologies in a number of epileptic encephalopathy 
syndromes including Dravet syndrome (SCN1A), infantile spasms (CDKL5, ARX ) 
and Othahara syndrome (STXBP1, Saitsu et al, 2008) resulted in further overlap of 
the epileptic encephalopathy syndromes with idiopathic syndrome group. Genetic 
aetiology is part of the definition of the latter syndrome group according to the 2001 
proposal. The 'idiopathic' syndrome group in infancy onset epilepsies becomes thus 
rather heterogenous with regards to outcomes and its further justification is 
questionable. The term 'idiopathic' that infers a 'benign' prognosis because the 
majority of patients diagnosed with syndromes associated with onset in later 
childhood and adolescence respond to anti-epileptic medication, becomes 
misleading. 
 
In the latest update the commission on classification and terminology of the ILAE 
has addressed some of these issues (see draft document available on www.ilae-
epilepsy.org/visitors/centre/ctf/ctfoverview.cfm; commission report July 2009,(Berg 
et al., 2010)).  The use of 'syndrome' should be restricted to a list of entities that are 
defined by a 'reliably identifiable cluster of  electro-clinical characteristics', 
essentially the list of specific epilepsy syndromes organised according to peak age of 
onset (neonatal period, infancy, childhood, adolescence-adult).  Description of 
epilepsies solely according to mode of seizure onset and aetiological category 
(idiopathic, symptomatic, cryptogenic) in the fashion of the 1989 ICE is discouraged. 
Instead epilepsies that do not meet criteria of the specific epilepsy syndromes should 
be organised in the first instance according to underlying cause or according to key 
characteristics if cause is unknown (seizure type, age at onset, interictal focus). 
Proposed groupings are:  
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electro-clinical syndromes, constellations (electroclinical-features in combination 
with specific lesions or causes, e.g. Rasmussen's encephalitis, mesial temporal lobe 
epilepsy with hippocampal sclerosis, gelastic seizures with hypothalamic 
harmatoma); epilepsies secondary to specific structural or metabolic lesions or 
conditions, epilepsies of unknown cause.  
 
The commission proposes further changes to the terminology of the aetiological 
categories listed in the 1989 ICE: 'structural/metabolic' instead of 'symptomatic', 
'genetic' or 'presumed genetic' instead of 'idiopathic', 'epilepsy of unknown cause' 
instead of 'cryptogenic'.  
 
The commission retained  the 'epileptic encephalopathy' concept with the notion " 
that certain forms of epileptic activity lead to severe cognitive and behavioural 
impairment above and beyond what might be expected from underlying pathology 
alone". Part of this concept is the idea that cognitive impairment associated with such 
forms of epileptic activity is potentially reversible with effective treatment. Further 
more suppression of epileptic activity early in the course could prevent negative and 
irreversible interference with maturation processes in the immature brain and thus 
improve neurodevelopmental and cognitive outcomes. The term 'epileptic 
encephalopathy' is according to this proposal no longer restricted to specific  
syndromes, but can now also be applied to individuals that present with 
encephalopathic features or worsening of these after the onset of epilepsy. The 
proposal also acknowledges that not all cases diagnosed with an epileptic 
encephalopathy syndrome (group of syndromes with a high risk for individuals to 
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develop cognitive or behavioural deterioration associated with epileptic activity) 
manifest cognitive or behavioural impairments. 
To prove the epileptic encephalopathy concept in the context of infancy onset 
epilepsies is difficult because of the complex most likely reciprocal relationships 
between epileptic activity and underlying brain abnormalities. 
 
As discussed in the introduction (section 2.1.1) historically the development of an 
epilepsy classification system based on electro-clinical characteristics was sensible 
because of the heterogeneity of the underlying conditions, which were frequently 
unknown. Over time the diagnostic tools including neuroimaging have become 
increasingly sophisticated and more widely available. In conjunction with the 
contributions of neurogenetics new aetiological entities have also been discovered. 
The syndromic approach has proved useful for clinicians to guide their choice of 
investigations and anti-epileptic medication as well as prediction of prognosis in the 
context of more narrowly defined electro-clinical syndromes. Review of the literature 
and results from the North London epilepsy in infancy study, however, shows that 
with the exception of West syndrome/infantile spasms other specific electro-clinical 
syndromes in this age group occur relative infrequently. A significant proportion of 
patients was classified according to gross aetiological categories and seizure onset 
(symptomatic focal, probably symptomatic focal or idiopathic focal etc) an approach 
that contributes little to management and prediction of outcome in a proportion of 
patients as discussed. Because epilepsy surgery procedures can now be offered to a 
proportion of patients, epilepsy management in recent years is driven more by an 
aetiological approach especially with the notion that intervention at an earlier stage 
may result in better outcomes. It is therefore very appropriate that the most recent 
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evolution of the epilepsy classification adopts more 'specific' aetiological categories 
(i.e. 'structural/metabolic', 'genetic', 'unknown cause') with less emphasis on the mode 
of seizure onset for patients that do not meet criteria for a specific electro-clinical 
syndrome.  The new aetiological categories, however, overlap in individual cases and 
thus application may be challenging (e.g. specific genetic defects are associated with 
developmental brain abnormalities such as mutations in ARX, lis1 or DCX genes in 
patients with lissencephaly). Both should be stated - the electroclinical syndrome- if 
this can be determined and the aetiological category or if known the specific 
underlying cause to describe an epilepsy presentation appropriately.  
 A flexible organisation of epilepsies according to dimensions that are relevant for 
the specific purpose as suggested by the ILAE commission rather than a fixed 
classification system would offer a realistic option to meet the needs of research and 
clinical practice. Such a flexible approach would allow one to group non-lesional 
epilepsies according to clusters of electro-clinical features in order to conduct 
research into genetic aetiologies, or lesional versus non-lesional epilepsies to guide 
therapeutic interventions. A stronger emphasis on specific underlying causes would 
also allow research into predictors of natural progress within the specific electro-
clinical syndromes.   
 
4.2.9.6 Structural brain abnormalities and underlying aetiologies (Axis 4)  
In keeping with the recently published guidelines on management of epilepsy in 
primary and secondary care (National Institute for Clinical Excellence, 2004) brain 
MR imaging was performed with exception of only 3 in all children enrolled in this 
study.  Availability of neuroimaging (particularly MR imaging) data has contributed 
to the relatively high proportion of identified aetiologies in half of the cases in the 
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North London infancy epilepsy cohort. The identified disorders reflect the wide 
spectrum of aetiologies associated with epilepsy in this age group. Limited 
availability of magnetic resonance imaging  and discovery of ‘genetic’ epileptic 
encephalopathies, with infancy onset more recently may be factors that explain the 
lower  proportion of identified aetiologies in the  retrospective Finnish population 
based infancy epilepsy cohort (22 of 72, 31%), that was mentioned in the 
introduction (Rantala and Ingalsuo, 1999). Similar to the findings in the North 
London infancy epilepsy cohort, with 41% of known aetiologies (~ 21% of the entire 
cohort), developmental brain lesions/malformations  were the largest aetiological 
category in the Finnish infancy cohort , identified in 11 (50%). Although 
developmental brain lesions/malformations are also common aetiologies in 
childhood epilepsy cohorts as documented in a recent Swedish population based 
study with  43% of known  aetiologies (28 of 65 children,  13.6% of the total cohort: 
n=205) the proportion in relation to the whole cohort is smaller compared to the 
infancy age  group (Larsson and Eeg-Olofsson, 2006). Review of brain MR imaging 
data available from 518 (85%) children enrolled in the Connecticut childhood 
epilepsy cohort identified developmental lesions and malformations  of cortical 
development in 51% of abnormalities potentially relevant to epilepsy (41 of 81 cases 
with aetiologically relevant lesions, 8%  of cases with available MRI data) (Berg et 
al., 2009). 
 
Nearly two thirds of children with developmental cortical malformations in the North 
London study had extensive unilateral or bihemispheric abnormalities. Seizure onset 
in this group was commonly early in the first six months of life, in a third of cases in 
the neonatal period. Although the age of seizure onset is variable  amongst the 
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various forms of malformations of cortical development early onset in the first year 
appears to be a common feature especially in children with bilateral and diffuse 
abnormalities presenting to hospital / specialist based settings (Dalla et al., 
1996;Vigevano et al., 1996;Kloss et al., 2002).  In the North London infancy 
epilepsy cohort seizure onset in the neonatal period appeared also to be more 
frequent in the group of children with confirmed or strongly suspected metabolic 
conditions. The number of children with known aetiologies in this study, however, 
was too small for subgroup analysis to determine the relationship between 
aetiological categories and clinical features. 
In most population / community based childhood epilepsy cohorts the proportion of 
cases with identified aetiologies is considerably smaller: between 18 % and 36% 
(Eriksson and Koivikko, 1997;Arts et al., 1999;Berg et al., 1999c;Larsson and Eeg-
Olofsson, 2006). The higher proportion of remote symptomatic epilepsy in one 
retrospective Finish childhood epilepsy cohort (50%,  children diagnosed in the 
1960’s) can be partially explained by the way cases were categorised, in accordance 
with the 1993 ILAE commission guidelines for epidemiologic studies(ILAE, 
1993;Sillanpaa et al., 1999). Classification under remote symptomatic was based 
mainly on clinical evaluation and included cases with abnormal neurological 
examination (cerebral palsy) and / or learning difficulties.   
Despite possible under recognition of symptomatic aetiologies in the childhood 
epilepsy cohorts because of the limited  application of  modern  magnetic resonance 
imaging methods and genetic investigations, the impression that brain pathologies, 
especially structural abnormalities, are an important aetiological factor associated 
with epilepsy onset  in infancy is upheld by our observations in a population based 
setting.  
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4.2.9.7 Quality of MR imaging and yield of neuroimaging in children 
with epilepsy onset under the age of 2 years 
Despite the variability of MR imaging protocols, with a relative small proportion of 
sequences recommended to investigate ‘epilepsy’, and different magnetic field 
strength systems, the diagnostic yield was high in the North London infancy epilepsy 
cohort. Aetiologically relevant findings were documented in half and uncertain or not 
aetiologically relevant findings in a further 20 % of children imaged, giving a total of 
70% positive findings. This yield of aetiologically relevant findings is significantly 
higher when compared with the to observations from Berg et al in the Connecticut 
childhood epilepsy cohort  who initially  reported lesions related to epilepsy in 
12.7% of those imaged; 80% of the total cohort underwent neuroimaging: 63% MRI, 
32% CT, 16% MRI and CT) (Berg et al., 2000b). In a more recent study Berg et al 
reviewed MRI data available of 518 (85%) of children enrolled in the Connecticut 
childhood epilepsy cohort (Berg et al., 2009). This included research MR images of  
299 children (57%) who were able to undergo  MR scanning without sedation, 
clinical scans with various protocols available for 103 (20%) and written reports for 
113 (21%) cases. Available MR scans were reviewed independently by two 
neuroradiologists. Eighty two (16%) children had positive MRI scans with 
aetiologically relevant lesions for epilepsy. Although the yield of MRI was higher in 
the age group under 2 years in this cohort (approximately 25%)  'age under 2 years' 
was not a significant predictor for positive MR findings in a multivariate regression 
model. Abnormal neurological examination was the strongest significant predictive 
factor for positive findings on MR in this cohort. The heterogeneity of MRI data with 
probably different sensitivities for the diagnosis of lesions may partially explain the 
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lower yield of positive findings in the age group under 2 years in the Connecticut 
cohort compared to the North London infancy epilepsy cohort.  
 
A small proportion of images reviewed in the North London ‘Epilepsy in Infancy 
Study ‘were judged to be of insufficient quality. When these were repeated, just over 
half these MR scans revealed new diagnostic information (3 of 5 repeat scans). In a 
quarter of MR images reviewed, dedicated epilepsy protocol  sequences were 
recommended in order to identify a focal lesion should seizures persist or surgical 
treatment be considered. Overall 20% of the MR images reviewed in this study were 
repeat images and half these obtained new diagnostic information.  The 
recommendation by ‘NICE’ to perform MR imaging in all children with new onset 
epilepsy under the age of two years seems justified considering the high yield of 
positive relevant findings in then North London infancy epilepsy cohort (National 
Institute for Clinical Excellence, 2004;Berg et al., 2009). This high yield was, 
however, achieved with a proportion of MR images needing to be repeated with 
increased risk from sedation and additional costs. In order to achieve optimal MR 
images appropriate sedation protocols (with consideration of general anaesthetic in 
individual cases) as well as adequate/specialised sequences are required (Saunders et 
al., 2007). These were not uniformly available across institutions as demonstrated in 
the North London 'Epilepsy in Infancy Study'.  In order to minimise false negative 
MR imaging results due to inappropriate MR protocols with poor sensitivity and the 
need for repeat scans the NICE guidelines should thus also provide 
recommendations, at least basic generic principles, regarding adequate protocols for 
this particular patient group.  Choice of sequences of a standard protocol could 
follow the generic principle of combining T2 - weighted images in two planes 
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supported by T1-weighted images in 2 planes, which has been found to be useful in 
practice (Saunders et al., 2007). Coronal images (obtained to lie perpendicular to the 
hippocampus) for optimal visualisation of mesial temporal lobe structures combined 
with axial images in T2 weighted sequences and 3-D T1- weighted volume 
acquisition reconstructed in 3 planes (sagittal, axial, coronal) have been 
recommended in international guidelines for neuroimaging of children with recent 
onset epilepsy (Gaillard et al., 2009).  The stage of physiological brain maturation 
with increased brain water in children less than 2 years requires consideration and 
special sequences to achieve optimal contrast resolution in this age group are 
necessary. Dual-echo short tau inversion recovery (STIR) sequence may therefore be 
considered in preference to the conventional T2 weighted fast (or turbo) spin-echo 
sequence in children under 2 years (Saunders et al., 2007). There are, however, other 
ways to address this problem of increased brain water content in young children 
using conventional T2 weighted sequences (i.e. fast spin-echo) and it is therefore 
difficult to include such details in national guidelines beyond a general statement that 
this needs to be resolved in discussion with local neuroimaging services.  
The guidelines should also state the need for specialised MR technologies in 
individual cases with medication resistant seizures, when MR imaging is negative 
and focal epilepsy is still suspected. Standard MR imaging does not appear to be 
sensitive enough to identify focal lesions as shown in a series of 123 consecutive 
adult patients  with refractory epilepsy undergoing pre-surgical work up by von 
Oertzen et al (Von et al., 2002). In the setting of a specialist epilepsy centre, external 
standard MR scans reviewed by expert neuroradiologists failed to identify 55% of 
focal lesions recognised with dedicated epilepsy protocol scans. More recently such 
observations have also been reported from paediatric epilepsy surgery programs. 
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Salamon et al compared external and internal MRI reports of a selected series of 42 
paediatric patients that underwent epilepsy surgery with a histopathologically 
confirmed diagnosis of focal cortical dysplasia at their institution (University of 
Calfifornia, Los Angeles) (Salamon et al., 2008). Reports of external scans identified 
abnormalities in 38% (15 of 42 patients), whilst reports of internal MR images (scans 
performed at their institution) identified an extra 40% of lesions (11 subtle and 6 
obvious abnormalities).  
Application of specialised MR techniques with high sensitivity to diagnose focal 
lesions across the whole group of children with recurrent afebrile seizures may not be 
cost effective.  Some of these issues have been addressed in recently published 
recommendations by a task force of the ILAE (Gaillard et al., 2009).Von Oertzen et 
al also highlighted the importance of expertise in reporting of MR images. The 
sensitivity of MR reports for focal lesions of radiologists, who were not experienced 
in reporting of images of epilepsy patients, was lower (39%) compared to those from 
expert ‘epilepsy’ neuroradiologists (50%) (Von et al., 2002). To some extent a 
similar observation has also been made in the North London Epilepsy in Infancy 
Study, when significant brain pathologies were not mentioned in local reports in at 
least 2 cases, namely ‘Tuberous sclerosis’ and ‘bilateral polymicrogyria’. NICE 
guidelines should thus also emphasise that MR images should be interpreted by 
radiologists with sufficient experience in paediatric neuroradiology. 
 
4.2.9.8 Developmental status close to diagnosis and its predictors  
This is the first study that has used standardised validated methods to evaluate the 
developmental status in a population based infancy epilepsy cohort close to 
diagnosis. The majority of children demonstrated developmental impairment with 
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63-71% of composite scores falling below the average for the standardisation sample 
(composite scores < 80: motor 63.3 %, language 71.4 %, cognition 63.3%). Over half 
of this cohort had severe developmental impairment with Bayley scores in the 
extremely low range (>2 sd below the average of the standardisation sample) and 
similar distribution in all subscales (expressive and receptive language, fine and 
gross motor, cognition). In keeping with the observations from hospital and specialist 
clinic based cohorts after longer follow up periods only approximately a third of 
infants demonstrated developmental status in average range (Czochanska et al., 
1994;Battaglia et al., 1999;Altunbasak et al., 2007). This study shows that 
developmental/cognitive impairments are already present in approximately two 
thirds of infants close to diagnosis. The significant relationship between the DF and 
the VABC identified in our study suggests that in many of the children with 
developmental impairments the abnormalities were present prior to presentation with 
seizures.  
 
The proportion of individuals with subnormal global cognitive function is much 
higher in the infancy epilepsy cohorts compared to childhood epilepsy cohort. Berg 
et al found subnormal global cognitive function in just over a quarter of children nine 
years after enrolment in the Connecticut cohort (Berg et al., 2008a).   
 
‘Symptomatic aetiology’ has been an important predictor of adverse developmental 
/cognitive outcome of infants with seizure onset in the first 12 o r 24 months of life 
(Chevrie and Aicardi, 1978;Matsumoto et al., 1983c;Cavazzuti et al., 
1984;Czochanska et al., 1994;Battaglia et al., 1999). In the early studies 
categorisation of cases as symptomatic or remote symptomatic was based on history 
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(including preceding developmental status), neurological examination or, 
neuroimaging if available grouping subjects with known or assumed static (mostly 
structural) brain pathologies together (Chevrie and Aicardi, 1977;Czochanska et al., 
1994). As most infants in the UK with new onset epilepsy undergo neuroimaging in 
accordance with current national management guidelines data could be obtained in 
this observational study to examine the relationship of ‘structural brain 
abnormalities’ and other factors to developmental status separately. In univariate 
analyses similar factors as implicated in the hospital based infancy epilepsy cohorts 
were significantly associated with lower developmental function: developmental 
status prior to seizure onset (Vineland Adaptive Behaviour Composite, VABC), 
seizure severity prior to the developmental assessment,  abnormal neurological 
examination, aetiologically relevant findings on  neuroimaging and EEG 
abnormalities (interictal discharges, grossly abnormal background activities 
)(Matsumoto et al., 1985;Battaglia et al., 1999;Altunbasak et al., 2007).  
 
Contrary to the observations in some of the hospital based series no significant 
relationships to younger age at seizure onset (< 6 months) and seizure type was 
demonstrated (Chevrie and Aicardi, 1978;Matsumoto et al., 1983b;Cavazzuti et al., 
1984;Battaglia et al., 1999). In those series not only infantile spasms but also partial 
and secondarily generalised seizures were associated with worse outcomes compared 
to children with generalised seizures (other than infantile spasms). The difficulties to 
classify seizures in this age group with considerable inter-rater variability have been 
already discussed. Variations in seizure classification may be partially responsible 
for the observed lack of relationship between seizure type and developmental 
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function in the North London infancy epilepsy cohort. Only a small proportion of 
children was classified as having predominantly generalised seizures.  
 
Multivariable regression analysis revealed abnormal neurological examination and 
presence of interictal discharges on EEG as factors that independently predicted and 
significantly poor developmental function close to diagnosis. In addition preceding 
developmental status (VABC) had an effect, which however did not reach 
significance. It is not surprising that aetiological relevant findings on neuroimaging 
were not retained as predictor for developmental status in the model. Patients with 
abnormal neuroimaging were also likely to have abnormalities on neurological 
examination.  ‘Abnormal neurology ‘ was significantly associated  with ‘aetiological 
relevant findings on neuroimaging’ and ‘grossly abnormal EEG background 
activities’ therefore only one factor was retained after correction for the other. When 
the relationship of neurophysiology, neuroimaging findings and seizure severity to 
the developmental status was investigated in a separate multivariate linear regression 
model both ‘abnormal EEG’ and ‘aetiological relevant neuroimaging findings’ had 
significant independent effects. Incidental or uncertain neuroimaging findings were 
not significantly related to the neurodevelopmental status.   
 
These findings support the view that developmental impairment in children with 
infancy onset epilepsy is already present in a large proportion at onset and that 
epileptiform activity and structural brain abnormalities are important predictive 
factors.  This would further indicate that at or close to diagnosis the cerebral 
processes that determine developmental impairment may have already taken effect 
beyond reversibility before therapeutic interventions can be practically considered. 
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Thus the degree to which these impairments can be reversed or alleviated by early 
therapeutic interventions may be largely determined by the underlying aetiology 
which manifests itself with abnormal developmental status and epileptiform activity.  
 
4.2.9.9 Longitudinal change of developmental function and associated factors  
The developmental trajectories of children enrolled in the North London infancy 
epilepsy cohort observed over a short period of approximately 12 months following 
the diagnosis of epilepsy were variable. Some infants continued on the same level, 
others improved and some deteriorated. This may be a reflection of the heterogeneity 
of this group with respect to clinical presentation and underlying aetiologies. Across 
the whole group there was no significant common trend for either worsening or 
improvement in cognition and language composite scores.  Although there was a 
significant trend of motor composite scores to increase over the follow up period the 
difference was small (only 3 points). This may indicate that motor skills (especially 
gross motor skills) show some recovery over the follow up period, whilst this is not 
the case for cognition and language. However, the slight increase of gross motor and 
fine mptor scale scores observed over the follow up period did not reach statistical 
significance; most likely explained by the small sample size. 
 
There was no significant difference of the developmental composite factors (derived 
from the Bayley III composite scores by principal component analysis) between 
baseline (DCF-0 ) and follow up (DCF-1). Following correction for confounding 
factors such as  ‘Aetiologically significant structural brain abnormalities on 
neuroimaging’,  ‘6 months seizure free status’, ‘initial abnormal EEG’, ‘initial 
abnormal neurological examination’ and ‘number of anti-epileptic medications taken 
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at follow up assessment’ in the statistical model no significant difference of 
developmental function at baseline and follow up.  Independent from longitudinal 
changes children with normal EEG and neurological examination at enrolment 
demonstrated better developmental function compared to those with abnormal 
neurology and EEG. Thus, the initial developmental status (in the first 3 months after 
diagnosis) determined the developmental function after short term follow up.  
However, small longitudinal changes in developmental function over the relative 
short observation period may not have become significant due to sample size effects. 
Small changes in developmental function are likely to be cumulative over time and 
therefore longer observation periods may be required for longitudinal differences to 
become significant. 
 
Data to compare these findings are available in the literature.  Berg et al observed 
adaptive behaviour function of children with early onset epilepsy enrolled in the 
Connecticut childhood epilepsy cohort over 3 years (Berg et al., 2004c). The 
Vineland Adaptive Behavior Survey (VABS) was completed with carers of  children 
with newly onset epilepsy under the age of 3 years at enrolment and annually (n = 
172, 67 % under 2 years at onset, complete data sets available for 70% of subjects).  
Remote symptomatic aetiology, diagnosis with an epileptic encephalopathy 
syndrome, and intractable epilepsy at 3 years follow up were all significantly 
associated with lower adaptive behaviour function at baseline. Following adjustment 
for aetiology a diagnosis of an epileptic encephalopathy syndrome had only modest 
and marginally significant effects. After adjustment for aetiology and epileptic 
encephalopathy syndrome intractable seizures (assessed at 3 year follow up) did not 
have an effect on baseline Vineland scores. Longitudinal analysis demonstrated that 
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most children who had average (normal) adaptive behaviour function at enrolment 
continued on the same level without decline. These were individuals with non-
symptomatic epilepsy who were not diagnosed with an epileptic encephalopathy 
syndrome. Children with risk factors (symptomatic epilepsy, epileptic 
encephalopathy syndrome, intractable seizures at 3 year follow up) had lower 
function already at enrolment and demonstrated further decline during the follow up 
period (probably indicating a failure to acquire skills at an adequate rate).  
 
‘Epilepsy syndrome diagnosis’ is a description of a cluster of several factors 
including EEG characteristics, seizure type, and other clinical features, which infers 
prognostic expectations especially in the case of epileptic encephalopathy 
syndromes. Thus, strong correlations between remote symptomatic aetiology, 
epileptic encephalopathy syndrome and intractable epilepsy as reported in the study 
by Berg et al are not surprising (Berg et al., 2004c). The subgroup of children 
diagnosed with epileptic encephalopathy syndromes is by definition likely to be 
biased towards developmental impairment and therefore the argument becomes 
circular. Taking this issue into account as well as the fact that adaptive behaviour 
based on perception of carers and a formal neuropsychological assessment are not 
equivalent but related measures, the study from Berg at al is in keeping with the 
observation made in the North London Epilepsy in Infancy Study that developmental 
function at diagnosis determines largely the status at follow up. Although the 
cognitive outcome of children diagnosed with idiopathic or cryptogenic epilepsies is 
generally more favourable,  specific more subtle intellectual deficits such as slower 
processing speed have been identified on long term follow up in individuals with 
average intellectual function (Berg et al., 2008b).    
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Data from a population based setting confirm the observations from specialist 
settings that epilepsy onset in the first 2 years of life is associated with a higher risk 
for developmental/cognitive impairment compared to epilepsy onset in later 
childhood and that this is strongly related to the underlying, in the majority 
structural, brain pathologies manifesting with seizures in this age group. The 
observations of Berg et al, who documented subnormal cognitive function on long-
term follow up in a quarter children enrolled in the Connecticut childhood epilepsy 
cohort (epilepsy onset 1 month to 15 years ) have been mentioned in the introduction 
and previous section (Berg et al., 2008a). In the Connecticut childhood epilepsy 
cohort multivariable logistic regression analysis demonstrated that developmental 
and acquired brain pathology (remote symptomatic aetiology) was the factor 
associated with the highest risk for global cognitive impairment, followed by young 
age at onset (< 5 years), ongoing antiepileptic treatment and lastly epileptic 
encephalopathy syndrome diagnosis. The latter combines some of the effects of the 
other factors. Even within the subgroups defined by aetiology (symptomatic versus 
idiopathic/cryptogenic epilepsy) or syndrome diagnosis (focal symptomatic and 
idiopathic generalised epilepsy) children with early epilepsy onset (<5 years) were 
more likely to be cognitively impaired compared to subjects with later onset (> 5 
years). Despite of the overlapping effects of the factors, the data from the 
Connecticut childhood epilepsy cohort support the idea of an additional independent 
adverse effect of seizure activity in young age on cognitive outcome. In a separate 
study, age at epilepsy onset was the best predictor of intellectual dysfunction in a 
cohort of children with temporal lobe epilepsy undergoing pre-surgical evaluation. 
Children with epilepsy onset in the first year of life had a particular high rate of 
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intellectual impairment (82% versus 32% in the rest of the study population) 
(Cormack et al., 2007).  From this observation in a hospital based cohort of children 
with focal brain lesions it can however not be excluded that early age of seizure onset 
and degree of cognitive impairment are also determined by the underlying brain 
abnormality itself.  
 
Tuberous sclerosis (TS) has been used as model to investigate the relationships of 
underlying brain pathology, epileptic activity, cognitive function and autistic 
spectrum disorder. Tuber load, location of tubers, early seizure onset and 
presentation with epilepsy were all found to be relevant risk factors for autistic 
spectrum disorder (Bolton, 2004;O'Callaghan et al., 2004). Bolton et al reported that 
location of tubers in the temporal lobe appeared necessary but was not sufficient to 
explain outcome with autism in a mixed TS cohort of patients attending a specialist 
clinic and referrals form an epidemiological study. Data were obtained from a 
retrospective case note review. The following significant and independent neuro-
epileptic predictors were additionally determined: 'age of seizure onset in the first 3 
years of life' and 'presence of temporal lobe discharges'. Although the authors found 
a significant relationship between history of infantile spasms and autism, this factor 
became not significant in a multivariate regression analysis when the other two 
neuro-epilptic predictors were entered. Most likely because of the overlap of these 
factors (early seizure onset and history of infantile spasms). In a different study 
O'Callaghan et al investigated the relationship between tuber load, history of infantile 
spasms and IQ in a population based cohort of patients with tuberous sclerosis 
(O'Callaghan et al., 2004). Patients without a history of infantile spasms had 
significantly higher median IQ values compared to those with a history of infantile 
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spasms. In a multivariable regression model both factors tuber load and infantile 
spasms had significant and independent effects on IQ (whereby in the model tuber 
load explained 33% and infantile spasms 15% of the variance of the IQ values). This 
result would add more support of the notion that epileptic activity in very early age 
has an additional negative impact on cognitive outcome beyond the underlying brain 
pathology. 
Early interventions to achieve seizure control could thus have most impact on 
developmental and cognitive outcome in the subgroup of infants with unknown 
aetiology and signs of developmental impairment with onset of the seizure disorder. 
The impact of a lag of treatment on developmental outcome has been investigated in 
a number of studies in children with infantile spasms of unknown aetiology 
(cryptogenic, normal development prior to onset) and Down's syndrome with 
controversial results. Several studies suggest that longer time period to start of 
treatment or cessation of spasms is associated with poorer developmental outcome 
(Eisermann et al., 2003;Kivity et al., 2004;Hamano et al., 2007;O'Callaghan et al., 
2011). The numbers of children included are relative small and the design is often 
retrospective with the exception of 2 studies (Eisermann et al., 2003;O'Callaghan et 
al., 2011). Two other studies (one prospective intervention study, the other 
retrospective case note review) could not find a relationship between treatment lag 
and developmental outcome in the subgroup with cryptogenic infantile spasms 
(Glaze et al., 1988;Partikian and Mitchell, 2010).  
The impact of time to start of antiepileptic treatment and developmental status at 
enrolment and 12 months follow up has not been investigated in the North London 
infancy epilepsy cohort and this could be subject of further data analysis.   
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Both closely interrelated factors 'underlying brain pathology' and 'epileptic /seizure 
activity' have adverse effects on developmental/cognitive outcome in this early age 
group. The magnitude of their independent effects is difficult to disentangle in 
human observational studies and experimental animal studies are required to shed 
more light on these complex relationship (Holmes, 2005). The negative impact of 
brief recurrent seizures on the normal immature brain has been documented in 
animal rodent models. Exposure to seizures at an very early age was associated with 
cognitive dysfunction especially spatial memory at later age (Sayin et al., 
2004;Karnam et al., 2009). Following exposure to hypoxia, trauma, status epilepticus 
or febrile seizures at very young age a cascade of events on a molecular and a 
cellular level is triggered with the result that rodents present later with spontaneous 
seizures. Such processes involve interference with the normal age dependent 
expression of receptor subunits with impact on balance of excitatory glutamatergic 
and inhibitory GABAergic neurotransmission, induction of abnormal dendtritic 
sprouting  and alteration of synaptic pruning as well as neurogenesis (Rakhade and 
Jensen, 2009). The result is not only epilepsy but also cognitive dysfunction as 
shown in rodent pubs exposed to febrile seizures (Dube et al., 2009).  
 
5 CHAPTER 5: LIMITATIONS AND CONCLUSIONS 
This study aimed to obtain population based data on children under the age of 2 years 
with newly onset epilepsy. In particular the purpose was to determine frequency of 
epilepsy onset in this age group, associated structural brain abnormalities, types of 
epilepsy and whether these can be classified according to the international 
classification system of epilepsies and epileptic syndromes (2001 proposal). In 
addition the neurodevelopmental status of children enrolled in this observational 
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incidence cohort was examined using standardised evaluation tools with the aim to 
determine predictors of neurodevelopmental function close to diagnosis and factors 
related to longitudinal change.  
 
The literature review in section 2.2 concluded that data available in the literature 
pertaining clinical presentation and outcome of infants with newly onset epilepsy 
may not be representative of the general population. Much of the information has 
been obtained retrospectively and if prospectively collected, data origin from hospital 
or specialist settings may be biased to more severe types of epilepsy.   In addition 
application of modern neuroimaging techniques (MRI) was limited at the time most 
infancy epilepsy series were published with possible under documentation of 
associated structural brain abnormalities as a consequence. 
 
In the population survey part of this study active and passive notification systems, 
providing two sources of ascertainment, were successfully applied to determine an 
ascertainment adjusted incidence of new onset epilepsy in children under the age of 2 
years of 56.3 – 88.5 (95% CI) / 100.000 children under 2 years/ year. These figures 
overlap with confidence intervals of incidence estimates calculated from data of 
other comparable studies (Camfield et al., 1996;Kurtz et al., 1998). The case 
numbers enrolled in the North London Epilepsy in Infancy Study were small and 
therefore the confidence interval is relatively wide. A two source capture recapture 
method was applied taking into account that this approach would not permit 
adjustment for case heterogeneity and list dependence in the statistical model. 
Because positive dependency between the two sources in this study could be 
assumed and in accordance with the argument made by Brenner, the two source 
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capture recapture method was used rather than a traditional case registration 
approach in order to reduce the degree of case underestimation associated with the 
latter (discussed in paragraph 4.1.1.4)(Brenner, 1995). The completeness of case 
ascertainment as determined in this study (76 %) is likely to be an overestimate. This 
figure, however, is comparable with completeness of ascertainment estimated by 
Chin in NLSTEPSS, who applied similar notification systems in the same 
geographical area using 3 sources and log-linear capture-recapture modelling (Chin, 
2005;Chin et al., 2006).  
 
In keeping with the findings of previous studies the incidence of new onset epilepsy 
falls steeply in the second year of life (Hauser et al., 1993;Camfield et al., 
1996;Kurtz et al., 1998). The risk of new onset epilepsy in the first year of life is 
almost 3 times higher compared to the second year  when data of two other 
comparable studies and the 'North London Infancy in Epilepsy in Infancy Study' are 
fitted with poisson regression models (2.88; 95% CI 2.15-3.9; p < 0.0001) (Camfield 
et al., 1996;Kurtz et al., 1998). These observations in human populations would be 
compatible with the findings in animal rodent studies of susceptibility of the 
immature brain for seizures. 
 
The survey in the North London Infancy in Epilepsy Study was conducted in a 
densely populated inner city area of North London with marked ethnic diversity. 
Population genetic factors associated with different ethnic back grounds are likely to 
be a relevant compounding factor for infancy onset epilepsy. Results of this study are 
supportive of this hypothesis. Without taking information regarding socioeconomic 
background into account Asian children under the age of 2 years were 3 times more 
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likely to present with epilepsy compared to white children. Further evidence has 
emerged from childhood epilepsy cohorts (Shamansky and Glaser, 1979;Annegers et 
al., 1999) and hospital based series of infantile onset epilepsy with high prevalence 
of consanguinity (Masri et al., 2008).  Chin and other authors documented ethnicity 
as a significant independent risk factor for convulsive status epilepticus  in childhood 
(Chin, 2005;Chin et al., 2006;Raspall-Chaure et al., 2007).  
 
Clinical features of the population based infancy epilepsy cohort that differed from 
childhood epilepsy cohorts included shorter recurrence interval after the first seizure 
(even after exclusion of cases with infantile spasms and myoclonic seizures), higher 
proportion of cases with a history of neonatal seizures (25% vs. 2.6%) and status 
epilepticus (12% vs. 9.1%). The case fatality in The North London 'Epilepsy in 
Infancy Study' was 9%. Most infants that died during the observation period in the 
North London 'Epilepsy in  Infancy Study' had neurological impairment (associated 
with symptomatic epilepsy)  and severe types of epilepsy in keeping with 
observations from community based childhood epilepsy cohorts (Berg et al., 2004b). 
 
Data from the North London infancy epilepsy cohort demonstrate a high rate of 
identified underlying aetiologies (51%) compared to most childhood epilepsy cohorts 
(18-36%). Developmental as well as acquired structural brain abnormalities are the 
most common causes for epilepsy in this early age group in a population based 
setting. This is in keeping with the observation that over a third of infants enrolled in 
this study presented with a history of developmental impairment preceding the onset 
of their seizures and almost half had some abnormalities on neurological examination 
at baseline evaluation.  The diagnostic yield of magnetic resonance imaging was high 
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in this infancy epilepsy cohort despite of the variability of image quality and 
different imaging protocols obtained from various centres.  A proportion of MR 
scans were repeated. This observation supports recommendations of  current national 
and international guidelines  but also reveals a need for standardised magnetic 
resonance imaging protocols to minimise risks associated with sedation and repeat 
imaging as well as costs (National Institute for Clinical Excellence, 2004;Gaillard et 
al., 2009). The sensitivity of neuroimaging reports by expert neuroradiologists versus 
non -expert radiologists for abnormalities has to be considered in this context. 
 
Findings of the North London 'Epilepsy in Infancy Study' suggest that over two 
thirds of infants with new onset epilepsy in a population based setting present with 
epilepsy types / syndromes associated with poor or guarded prognosis (epileptic 
encephalopathies 39%, focal symptomatic epilepsy 28%) and only approximately a 
third have syndromes compatible with milder or uncertain course (idiopathic focal 
and generalised 16%, probable symptomatic focal 10%). Under ascertainment of 
milder presentations with single seizures or single seizure cluster (spectrum of 
benign infantile seizures) may have occurred because either cases failed to meet 
inclusion criteria or may not have been identified as infants with (probable) new 
onset epilepsy. Although such cases do not necessarily require a diagnosis of 
epilepsy (Engel, Jr., 2001), this may have to be determined in retrospect when infants 
remain seizure free or subsequent seizures occur only in relation to febrile illnesses 
as  also demonstrated in this study. 
 
Infants enrolled in this study were classified according to the list of epilepsy 
syndrome groups and specific epilepsy syndromes (electro-clinical syndromes) as 
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suggested in the 2001 ILAE proposal (Engel, Jr., 2001). Most cases could be 
categorised into epilepsy syndrome groups. A specific epilepsy syndrome diagnosis 
however, could not be allocated in over a third of children at enrolment similar to 
findings in a large community based childhood epilepsy cohort (Berg, 2003). 
Inter-rater agreement between two paediatric neurologists, who classified cases 
independently  was only moderate and lower compared to a study in which a priory 
rules on application of the ICE had  been agreed (Berg et al., 1999a). Disagreement 
occurred between West syndrome/infantile spasms and focal symptomatic epilepsy 
(with infantile spasms as secondarily generalised seizures) demonstrating the overlap 
between epileptic encephalopathy syndromes and syndrome groups defined by 
aetiology with mode of onset.  Other areas of disagreement related especially to 
cases without known aetiology in less narrowly defined syndrome groups (defined 
according to aetiology and mode of seizure onset) such as 'idiopathic focal / 
generalised' or 'probable symptomatic focal'. Such diagnoses were less consistent 
within raters and also more variable over time. Classification according to mode of 
seizure onset is especially difficult in infants when this is based on clinical 
description of events. Such syndrome group diagnoses in cases without known 
aetiology that do not meet criteria for a specific electro-clinical syndromes, provide 
little additional information (Berg, 2003). For these cases a descriptive approach by 
using the other axes of the diagnostic scheme (seizure types, aetiology and 
impairments) would be more appropriate. The list of seizure types in the 2001 
proposal is however difficult to apply in infants. A descriptive approach for cases 
that do not fit into the defined electro clinical syndromes rather than using syndrome 
groups defined by aetiological category and mode of seizure onset has also been 
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suggested in the most recent ILAE task force proposals (draft document: www.ilae-
epilepsy.org/visitors/centre/ctf/ctfoverview.cfm; version July 2009).  
 
The North London 'Epilepsy in Infancy Study' is the first study that obtained 
prospectively data relating to the neurodevelopmental status of infants with new 
onset epilepsy in a population based setting using standardised assessment tools 
(Bayley III Scales of Infants and Toddler Development). Over two thirds of infants 
demonstrated developmental impairments that were already present close to 
diagnosis (in the majority within 3 months). Cognition, language and motor function 
as evaluated by the Bayley III were affected in similar way without much difference 
between these domains. Independent negative predictors of the developmental 
function at enrolment were abnormal neurological examination and presence of 
interictal discharges on the EEG. When investigating relationships of investigation 
results (neuroimaging, neurophysiology) and seizure severity prior to assessment 
with developmental function at enrolment in a separate linear regression model both 
aetiologically relevant neuroimaging findings and abnormal EEG were strong 
independent negative predictors of developmental function close to diagnosis.  
 
Overall in the group of children followed up there was no significant longitudinal 
change of acquisition of developmental skills over the period of approximately 12 
months. After correction for confounding factors developmental function at initial 
assessment did not differ from follow up evaluation. The developmental function at 
follow up was determined by the function at epilepsy onset.  
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Limitations of this part of the study have been discussed above and include small 
numbers of subjects that underwent evaluations at the two time points, findings only 
applicable to the relative short reassessment interval and possible bias due to patients 
being lost to follow up at the mild as well as severe end of the ‘epilepsy syndrome 
spectrum’.   
 
In this observational study investigations including neuroimaging and 
neurophysiology have not been conducted according to a standardised protocol as 
this would be the case in an experimental or interventional trial design. Subtle 
structural brain abnormalities, rare genetic or metabolic conditions may have not 
been recognised in this cohort. However a major strength of this study is the 
reflection of current practice in investigation and management of infants presenting 
with new onset epilepsy in North London. 
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6 CHAPTER 6:  FUTURE DIRECTIONS 
In order to adequately document course and outcome of children presenting with 
recurrent seizures in the first two years of life in a community setting a prospective 
study with longer follow up period is required. This would allow the investigation of 
the complex relationships between aetiology, natural history of the epileptic disorder, 
impact on education, cognitive and psychosocial outcome.  
 
Diagnostic difficulties at the onset concern particularly infants at the clinically milder 
end of the spectrum, who present few seizures or a single seizure cluster. Factors 
predicting long-term outcome would be especially helpful in this group in order to 
tailor the diagnostic work up at onset more cost effectively and provide adequate 
information to families.  
 
Psychiatric disorders are more commonly associated with childhood epilepsy (37%) 
compared to other chronic conditions in the general population as shown in a recent 
epidemiological study (Davies et al., 2003). Associated hyperactive as well as 
pervasive developmental (autistic) disorders were particularly increased in epilepsies 
complicated by learning difficulties and neurological problems (Davies et al., 2003). 
The infancy onset epilepsy group is therefore likely to be especially at risk because 
of the high prevalence of cognitive and neurological impairments that were also 
documented in the North London 'Epilepsy in infancy Study'. A significant 
proportion of infants with West syndrome/infantile spasms were diagnosed with 
autistic spectrum disorders on follow up in several observational studies (Riikonen 
and Amnell, 1981;Jambaque et al., 2000;Askalan et al., 2003;Saemundsen et al., 
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2008). Other types of infancy onset epilepsies are also associated with a higher risk 
for autistic spectrum disorder as suggested by the data from a recent  retrospective 
population based study carried out in Iceland   (7% autistic spectrum disorders in 
children with unprovoked seizures in the first year of life excluding infantile spasms 
versus 0.5 -1% in the general population) (Baird et al., 2006;Saemundsen et al., 
2007).  
Long-term follow up of children enrolled in the North London infancy epilepsy 
cohort will provide an opportunity to obtain data about frequency and risk factors of 
mental health problems including behavioural impairments and autistic disorders 
associated with epilepsy onset in the first 2 years of life.  In the currently ongoing 
follow up phase of the North London 'Epilepsy in Infancy Study' subjects are 
assessed 3 years after enrolment. Data are collected on the clinical course of the 
epilepsy, neurological status, and standardised tools are used to assess social 
communication, behavioural and attention difficulties, general cognitive function, as 
well as memory.  Assessment of children enrolled in this cohort is challenging 
because of the heterogeneity of neurodevelopmental function and association with 
motor as well as sensory impairments. Therefore in addition to the standardised 
neuropsychological tests novel neurophysiological methods involving event related 
potentials (ERP's), that do not require motor or verbal responses, are also applied to 
measure memory and social-communication processing. ERP methods have been  
increasingly applied in studies investigating the normal development of social 
processing in young children and abnormal course in children with autism /autistic 
spectrum disorders (Dawson et al., 2005;Grossmann and Johnson, 2007;Wong et al., 
2008).   
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Future data collection in the North London infancy epilepsy cohort should also focus 
on health related quality of life.  Adequate instruments (parental reports versus 
patient questionnaires) need to be considered in this group with high cognitive and 
neurological impairments (Ronen et al., 2003;Soria et al., 2007;Waters et al., 2009). 
Such information is however paramount to decide on the best therapeutic 
management strategies and provide appropriate support to patients and their families. 
 
Design of larger epidemiological studies enrolling children with recurrent 
unprovoked seizures under two years of age would add to the case numbers required 
to determine incidence and risk factors (for active epilepsy, medication resistance, 
mortality, cognitive, behavioural and neurological impairments) more precisely with 
smaller confidence intervals.  The North London 'Epilepsy in Infancy Study' could be 
a model for such studies that survey larger populations.  A computer based on-line 
registry could facilitate case notification and data collection. This could be part of a 
larger epilepsy patient register, a project that may be included in the portfolio of the 
clinical research network established in the UK, especially the recently launched UK 
Epilepsy Research Network (UKERN, February 2010). Issues relating to data 
confidentiality especially if the aim is to obtain longitudinal data would have to be 
adequately addressed.    
 
A larger infancy epilepsy cohort ascertained with national or international 
collaboration using electronic registries would also allow to determine frequency of 
genetic syndromes in this age group (Wallace et al., 2003;Herlenius et al., 
2007;Guerrini et al., 2007;Kato et al., 2007;Rosas-Vargas et al., 2008;Saitsu et al., 
2008;Depienne et al., 2009a). Clinical data detailing the course of the seizure 
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disorder and  developmental trajectories from larger case numbers are often lacking 
to correlate genotypes and phenotypes (Depienne et al., 2009b). The SMEI / GEFS+ 
syndrome spectrum would be an example for which genetic studies in a population 
based infancy epilepsy incidence cohort could provide data that are less biased and 
give insight into factors that determine milder phenotypic manifestations.  
 
The North London 'Epilepsy in Infancy Study' obtained prospectively population 
based data that contributed to a better understanding of the early clinical course of 
children with epilepsy onset under the age of two years. The ongoing longitudinal 
data collection in this project will provide additional information to address 
important questions relating to cognitive, behavioural and educational outcomes. 
This information may not resolve the question about the causal relationships between 
developmental disorders, underlying brain pathology and epileptic activity but can be 
the basis for the formulation of research hypothesis and design of studies to 
determine the impact of early interventions. Ultimately this approach will help to 
promote the development of better therapeutic and remediative strategies that may 
reduce the impact of associated morbidities on children and their families.  
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8 APPENDICES 
 
8.1 Appendix 1: Resident population in North London  
 
 
Resident Population in surveyed geographical area* of  North London - Census 
2001 (Office for National Statistics) 
 Males Females Total 
All ages 1,477,952 1,586,652 3,064,604 
0-1  ( <= 2 years) 42,795 40,859 83,654 
0 -15 (< 16 years) 305,473 295,451 600,924 
*15 Boroughs: Barnet, Brent, Camden, City of London, Enfield, Hackney, Hammersmith and 
Fulham, Haringey, Harrow, Islington,  Kensington and Chelsea, Newham, Tower Hamlets, 
Wandsworth, Westminster  
 
Resident Population in surveyed geographical area* of  North London  
Mid 2006 population estimates (Office for National Statistics) 
 Males Females Total 
All ages 1,598,285 1,620,525 3,218,810 
0-1  ( <=2 years) 50,161 47,929 98,090 
0 -15 (< 16 years) 310,933 298,354 609,287 
*15 Boroughs: Barnet, Brent, Camden, City of London, Enfield, Hackney, Hammersmith and 
Fulham, Haringey, Harrow, Islington,  Kensington and Chelsea, Newham, Tower Hamlets, 
Wandsworth, Westminster  
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8.2 Appendix 2: Ethnic composition of childhood population in North London and 
England and Wales  
(Mid 2006 estimates, Office for National Statistics 2009; 2010) 
 
 
North London: distribution of ethic groups in childhood population
 ( 0 - 15years)
32,5493
53% 18,762
3%
95,709
16%
119,867
20%
51,827
8%
Asian Black Others White Mixed
England and Wales: Distribution of ethnic groups in childhood population
(0-15 years)
8,736,378
86%
29,062
<1%
321,747
3%
688,682
7%
386,674
4%
Asian Black Others White Mixed
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8.3 Appendix 3: Notification Forms   
Epilepsy in infancy study 
 
Notification form                                                                               [Month] – [Year] 
Dear Dr [Name of Consultant Pediatrician] 
 
Have you seen in this month of [month] patients, who meet the following inclusion 
criteria for our study ? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please return in addressed envelope. 
Epilepsy in Infancy Study: Institute of Child Health, Neurosciences Unit, The Wolfson Centre, 
Mecklenburgh Square, London WC1N 2AP, Phone 020  7837 7618  
Investigators: JH Cross, CM Eltze, R Scott, BGR Neville 
No Cases                        Cases of epilepsy      
  
A B 
Name Address Telephone 
number 
Patient’s 
Initials  
Sex 
M/F 
Date of 
Birth 
Partial 
Postal Code 
(eg SW17) 
 
 
 
 
 
 
 
 
 
 
 
      
 
Not eligible for cohort study: 
 
⇒ Complete section B only 
⇒ Return with completed 
questionnaire 
Eligible for cohort study: 
Research team will get in contact if 
parent/carer is interested  
 
⇒ Complete sections A and B  
⇒ Questionnaire will be requested 
after consent has been 
obtained by research fellow
New / First diagnosis of 
Epilepsy 
Parents are not 
interested in cohort 
study 
Known diagnosis of epilepsy 
 
Patient 
• is between 4 weeks and 24 months old        
                           + 
• has a history of more than 2 unprovoked seizures 
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Notification form (Reminder): 
(ID)                                                                                                    [Months] [Year] 
Dear Dr [Name of Consultant Paediatrician] 
 
Thank you for assisting with our study. Unfortunately we did not receive a 
reply for [Months].  
Please indicate below, in the appropriate box, the number of cases, who meet 
the following inclusion criteria for our study that you have seen or been 
informed of in [Months] or tick the box ‘No cases seen’.  
 Patient 
 • is between  4 weeks and 24 months old        
                            + 
• has a history of 2 or more unprovoked 
seizures 
 
 
Eligible for cohort study: 
Research team will get in contact if 
parent/carer is interested  
⇒ Complete sections A and B on 
notification form 
⇒ Questionnaire will be requested after 
consent has been obtained by 
research fellow 
New/First diagnosis of epilepsy Known diagnosis of epilepsy 
 
 
 
 
 
Parents are not interested in 
cohort study 
 
 
 
 
Not eligible for cohort study:
 
 
 ⇒ Complete only section B on 
notification form   ⇒ Return with completed  
questionnaire  
 
 
 
Please tick:                 No cases seen                          Cases of epilepsy      
  
A B 
Name Address Telephone 
number 
Patient
’s 
Initials 
Sex 
M/F 
Date 
of 
Birth 
Partial 
Postal 
Code (eg 
SW17) 
 
 
 
 
 
 
 
 
 
 
 
      
 
Please complete this form and return in self addressed envelope or fax: 020 7833 9469 
Epilepsy in Infancy Study: Institute of Child Health, Neurosciences Unit, The Wolfson Centre, 
Mecklenburgh Square, London WC1N 2AP, Phone 020  7837 7618  
Investigators: CM Eltze, JH Cross, BGR Neville, RC Scott,  
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8.4 Appendix 4: Newsletters                                                  
Newsletter  May 2006 
Epilepsy in Infancy Study 
Collaborative Study of Early Onset Epilepsies in North London 
  
 Age: 4 weeks to 24 months  
 History of 2 or more unprovoked seizures 
www.epilepsyininfancy.ich.ucl.uk
Call 01342 831260 to notify 
 
Investigating:   
 
 incidence of epilepsy onset in the first 2 years of life 
 spectrum of aetiologies and syndromic presentations 
in a population based setting 
 short term outcome 
 
Period of case ascertainment: 1st September 2005 until 31st August 2007 
 
Dear Colleagues, 
 
We would like to thank you for your help with our important study and provide an 
update of our progress. Since the start of case ascertainment 51 children with a 
possible first diagnosis of epilepsy have been notified to us. Thirty five of these were 
suitable for enrolment in our prospective cohort study. Clinical evaluation and formal 
neurodevelopmental assessment (conducted by a Psychologist) has been carried out 
in 25 children so far. We have also started reviewing EEG recordings and MRI 
scans. A feed back report will be formulated after each assessment. These will be 
forwarded to the responsible Consultant Paediatrician with a copy to the parents, so 
that information can be related in the context of local care. Review of the patients 
enrolled in the prospective cohort is planned 6 and 12 months following baseline 
assessment. 
 
The period of case ascertainment has been extended to 24 months from 1st September 
2005 until 31st August 2007. We require several sources of case ascertainment in 
order to apply capture recapture methodologies for the calculation of incidence 
estimates. We would therefore be grateful if you could notify patients with a known 
and first diagnosis of epilepsy, who are between 4 weeks and 24 months old: 
• by phoning our telephone hotline 01342 831260 (24 hour automated 
service) at the time eligible patients are seen 
•  and returning the  notification form, which is send to you at the end of each 
month. 
Information sheets for parents and consultants are available on our website. 
 
Yours sincerely, 
 
 
Dr J H Cross (Principal Investigator) 
Reader & Honorary Consultant Paediatric 
Neurologist  
h.cross@ich.ucl.ac.uk 
 Dr C M Eltze 
Clinical Research Fellow in 
Paediatric Neurosciences  
c.eltze@ich.ucl.ac.uk 
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Newsletter  November 2006 
                                               
Epilepsy in Infancy Study - One year on  
Collaborative Study of Early Onset Epilepsies in North London 
  
 Age: 4 weeks to 24 months  
 History of 2 or more unprovoked seizures 
 
Investigating:   
 www.epilepsyininfancy.ich.ucl.uk
Call 01342 831260 to notify cases! incidence of epilepsy onset in the first 2 years of life 
 spectrum of aetiologies and syndromic presentations 
in a population based setting 
 longterm outcome 
 
Case ascertainment: 1st September 2005 until 31st August 2007 
 
Dear Colleagues, 
 
Thank you very much for your help with this important study. In the first year of our 
study we were notified about 79 children with an existing or possible first diagnosis 
of epilepsy. So far we have assessed 46 children of the 51 patients suitable for 
enrolment in our cohort study of newly diagnosed patients. We are in the process of 
reviewing EEG’s, MRI scans and other investigating results. Analysis of the initial 
data will commence soon. 
 
Twelve months following the base line assessment we will invite patients for a 
follow up review which will include clinical and neurodevelopment evaluation. Anna 
Merrett(Clinical Psychology Assistant) who has joined our team since March 2006, 
will also be involved in liaising with families. As for the baseline assessment, a 
feedback report will be forwarded to the responsible Consultant Paediatrician with a 
copy to the parents.  
 
We will continue case ascertainment until the end of August 2007. We would be 
grateful if you could encourage junior doctors, nursing staff and colleagues in your 
department to notify us of patients with a known or first diagnosis of epilepsy, who 
are between 4 weeks and 2 years old, by phoning our telephone hotline 01342 
831260 (24 hour automated service) at the time patients are seen. In addition, please 
return the notification form, which is sent to you at the end of each month.  
An information leaflet to introduce our study to parents and more information about 
inclusion /exclusion criteria can be downloaded from our website 
(www.epilepsyininfancy.ich.ucl.ac.uk). We will phone parents, who have given 
permission to be contacted by our team, in order to answer questions and arrange 
dates for assessments. 
  
Yours sincerely, 
Dr J H Cross (Principal Investigator) 
Reader & Honorary Consultant Paediatric 
Neurologist  
h.cross@ich.ucl.ac.uk 
 Dr C M Eltze 
Clinical Research Fellow in 
Paediatric Neurosciences  
c.eltze@ich.ucl.ac.uk 
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8.5 Appendix 5: Standard History Proforma 
Epilepsy in Infancy Study 
                                
History Proforma for Patients with Epilepsy:  
 
Date:  Patient’s initials:  
Person 
completing:  
 Date of Birth   
 
Position: 
 Sex:  
 
 
 Partial  postal code 
(eg SW17): 
 
Please, tick as appropriate: 
 Patient 
• is between  4 weeks and 24 months old1        
                           + 
• has a history of 2 or more unprovoked 
seizures2 
 
 New/First diagnosis of 
epilepsy 
 Known diagnosis of 
epilepsy 
Eligible for cohort study: 
Research team will get in contact if 
parent/carer is interested  
⇒ Call 01342 831260  
⇒ Questionnaire will be 
requested after consent has 
been obtained by research 
fellow 
 Parents are not 
interested in 
cohort study 
⇒ Call 01342 831260 
⇒ Send this questionnaire to 
above address 
Not eligible for cohort study: 
 
1 This includes patients, whose seizure onset is in the first 4 weeks of life – but who continue to have 
seizures beyond 4 weeks 
2 Seizures without any acute underlying cause such as fever, infection, trauma, stroke, electrolyte 
imbalances, intoxication. 
  
Problem List:
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Background information: 
  Comments/Details 
Birth history: 
 
 
Complications: 
 
 
 
 
  No 
 
  term (≥ 37 weeks)   premature (< 37 
weeks):……………………………………………………………. 
 
  
Yes:……………………………………………………………
…… 
  
 
Neonatal History   normal     abnormal:…………………………………………………………… 
 
 
 
Relevant past medical 
history 
  No 
 
  Yes:…………………………………………………………… 
          …………………………………………………………… 
Febrile convulsions:   No 
 
  Yes: (Age, duration, focal or generalised)…………………… 
………………………………………………………………………. 
………………………………………………………………………. 
 
 
 
 
Genetic diagnosis/ 
Chromosomal 
abnormality 
  No 
 
  Yes:………………………………………………………………… 
          …………………………………………………………………. 
 
 
 
Family History: 
Seizures (Learning 
difficulties, genetic 
conditions): 
 
 
 
Consanguinity: 
 
 
  No 
 
 
 
 
 
  No 
 
  Yes:………………………………………………………………… 
         ………………………………………………………………..  
 
 
 
 
  Yes:………………………………………………………………… 
         ………………………………………………………………… 
 
 
 
 
General Examination: 
 
 
 
 
 
 
 
 
  normal     abnormal:…………………………………………………………… 
………………………………………………………………………… 
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Headcircumference:  ……………..cm                 centile:……………….. 
 
Weight:                    ……………….kg                 centile:………………….       
Neurological 
Examination  
  normal      
abnormal:………………………………………………………
…… 
…………………………………………………………………
………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Seizure History 
Age at first afebrile seizure:  
 
Seizure Types:  Please describe clinical manifestations - ictal and postictal, triggers, 
duration and frequency (number of seizures per day)  
First afebrile seizure 
 
Timing:   awake    asleep 
 
Duration:…………………. 
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Subsequent seizure types: 
 
1. 
Age: 
Timing:   awake    asleep 
Duration:…………………….. 
Frequency:………………… 
 
2. 
Age: 
Timing:   awake    asleep 
Duration:…………………….. 
Frequency:………………… 
 
 
 
 
 
3. 
Age: 
Timing:   awake    asleep 
Duration:…………………….. 
Frequency:………………… 
 
 
 
… 
 
 
 
 
 
 
Current Seizure Types: 
1. 
Timing:    awake      asleep    
Duration:…………….……
… 
Frequency:………………… 
 
 
 
2. 
Timing:   awake       asleep     
Duration:…………….……
… 
Frequency:………………… 
 
. 
Timing:   awake       asleep     
Duration:…………….……
… 
Frequency:………………… 
 
 
… 
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Status epilepticus: 
   
 
  
No 
 
  Yes  
at first presentation:   Yes    No    Unsure 
Please specify age, duration, number of episodes: 
 
 
 
 
 
 
 
 
 
Longest seizure free period  
Antiepileptic Medication 
 
Drug  
( + maximum  dose [mg]): 
Duration Comments (side effects, reason for withdrawal): 
Initial/previous: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 248
   
Response to 
current regime: 
  Seizure free  
How long ? ……………days/weeks/months (quantify and circle as appropriate) 
  Improved but not seizure free 
  Little improvement or unchanged 
 
Developmental progress prior to seizure onset: 
Domain: Comments (concerns, loss of skills) 
Motor: 
   normal 
 
 
  delayed    regression:……………………………………………………….. 
……………………………………………………………………………………. 
 
 
 
 
 
 
 
 
 
 
 
Social 
communication 
– play 
  normal 
 
  delayed    regression:……………………………………………………….. 
……………………………………………………………………………………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Language: 
  normal  
 
 
 
 
  delayed    regression:……………………………………………………….. 
……………………………………………………………………………………. 
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Current Development  
Chronological age:  
 
Domain: Please circle (Y = Yes, N = No, DK = don’t know) if appropriate and/or comment (other 
achieved milestones, concerns or loss of skills) 
Gross Motor: 
  normal 
  delayed 
  regression 
        
Y N D
K 
Lifts head in prone 
position for several 
seconds (face makes 
approximate angle of 45o with 
surface) 
Y N DK Stands alone (> 10 
seconds) 
Y N D
K 
Head control in sitting 
position  
(holds head steady)  
Y N DK Walks well (good 
balance, falls rarely) 
  
Y N D
K 
Pull to sit – no head lag Y N DK Runs  
Y N D
K 
Sits - no support Y N DK Walks up steps 
(holding onto rail or wall 
for support, not to person) 
 
Y N D
K 
Stands holding on Y N DK Jumps up (gets both 
feet of the floor at same 
time) 
Y N D
K 
Pulls to stand from sitting 
position      
Gross Motor - 
Comments: 
 
 
 
 
 
 
 
 
Fine Motor and 
vision: 
  normal 
  delayed 
  regression 
Y N DK In supine - follows 
object from one side 
past the midline  
Y N DK Picks up 2 cubes 
one in each hand 
 
Y N DK In supine - brings hands 
together in midline (over 
chest or at mouth) 
Y N DK thumb finger grasp 
(brings together thumb 
and one or several 
fingers to pick up small 
objects) 
 
Y N DK In supine - follows 180° Y N DK scribbles 
 
Y N DK Reaches for objects (in 
sitting position)  
 
Y N DK Looks at pictures in 
book 
Y N DK transfers objects from 
one hand to other 
(without help of mouth, body 
or table) 
 
Y N DK Turns pages in 
book 
 
Comments:  
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Personal – 
Social-  Play 
  normal 
  delayed 
  regression 
Y N DK regards face  
 
Y N DK Waves bye-bye  
 
Y N DK smiles responsively 
(when talked to)  
 
Y N DK Points to share 
interest (not for 
wants/needs) 
Y N DK Regards own hand Y N DK Imitates 
(household) 
activities (eg talking 
on phone, wiping up) 
Y N DK feeds self (finger food) 
 
Y N DK Use Spoon/Fork 
Y N DK turns to name  
 
Y N DK Feeds doll 
(Symbolic play)  
Y N DK Indicates wants (by 
pointing, reaching + making 
sounds, pulling, saying 
words, putting arms up to be 
picked up) 
Y N DK Puts on clothing 
(can put on any clothing 
eg socks, shoes, jacket) 
 
Comments:  
 
 
 
 
 
 
 
 
Language: 
  normal 
  delayed 
  regression 
Y N DK vocalizes  
 
Y N DK one word 
 
Y N DK laughs  
 
Y N DK 6 words or more 
Y N DK turns to voice Y N DK combines words  
 
Y N DK single syllables 
 
Y N DK Follows one part 
command 
Y N DK DADA/MAMA (non 
specific) 
 
Y N DK Follows two part 
command 
Y N DK DADA/MAMA 
(specific) 
 
    
 
Comments:  
 
 
 
 
 
 
 
 
 
 
Sensory Impairments 
Vision   normal   concerns:……………………………………………………… 
 
 
Hearing   normal   concerns:………………………………………………………… 
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Which ethnic group does the patient belong to ? 
 
Mixed: 
  White and Black Caribbean 
  White and Black African 
  White and Asian 
  Other (please state)…………………… 
 
White: 
  British 
  Irish 
  Other (please state):………………….. 
 
Chinese or other Ethnic Group: 
  Chinese 
  Other (please state):………………..… 
 
 
Black/Black British: 
  Caribbean 
  African 
  Other (please state):………………………  
 
Asian/Asian British: 
  Indian 
  Pakistani 
  Bangladeshi 
  Other (please state):……………………….. 
 
Investigations 
  Details (you may consider enclosing anonymised copy of report) 
EEG 
 
  Yes     
No 
 
  normal     abnormal 
  results awaited 
 
 
 
 
 
 
 
 
 
 
MRI 
 
  Yes   
  No 
  normal     abnormal 
  results awaited 
 
 
 
 
 
 
 
 
CT 
  Yes   
  No 
  normal     abnormal 
  results awaited 
 
 
 
 
 
 
 
 
 
Other Investigations:  Details if abnormal: 
   normal     results awaited  
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   normal     results awaited  
   normal     results awaited  
   normal     results awaited  
   normal     results awaited  
   normal     results awaited  
   normal     results awaited  
   normal     results awaited  
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8.6 Appendix 6: Clinical evaluation proformas (baseline and 12 months) 
Epilepsy in Infancy Study: 
 
Evaluation Proforma (Baseline):  
 
Patient details: 
Name:   Local Hospital / 
Community 
Clinic: 
 
Date of Birth:    Local 
Consultant: 
 
Address:  
 
 
 Contact number/
e-mail: 
 
Contact 
Number: 
 
 
 GP: 
 
 
 
 
 
 
 
 
Date seen: 
Attended with: 
Consent signed by: 
 
Evaluation: 
Baseline (detailed history) 
Review………………….. 
Neuropsychology (Tests):……………………………………….. 
…………………………………………………………………… 
…………………………………………………………………… 
Blood sample taken 
Spare sample from local hospital requested 
 
Local EEG:  
Done (Department……………………………………………..) 
Awaiting Appointment 
Have Appointment – date:…………….; Department:…………………………. 
Digital recording requested for review  
 
Local MRI: 
Done (Department……………………………………………..) 
Awaiting Appointment 
Have Appointment – date:…………….; Department:…………………………. 
Images requested fro review: 
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Background information: 
  Comments/Details 
Pregnancy – complication: 
 
Birth: 
 
 
 
 
Complications: 
 
  No 
 
 
 
 
 
 
 
  No 
 
  Yes: 
 
  term (≥ 37 weeks)   premature (< 37 
weeks):………………………………………
…… 
 
Mode of delivery: 
Birth weight: 
 
  
Yes:……………………………………………
…………… 
  
 
 
 
 
Neonatal History   normal     
abnormal:……………………………………
……………………… 
 
 
 
 
 
Relevant past medical 
history 
  No 
  DK 
 
 
  
Yes:……………………………………………
……………… 
          
…………………………………………………
………… 
 
 
 
 
Febrile convulsions:   No 
  DK 
 
  Yes: (Age, duration, focal or 
generalised)…………………… 
…………………………………………………
……………………. 
…………………………………………………
……………………. 
 
Genetic diagnosis/ 
Chromosomal abnormality 
  No 
  DK 
  
Yes:……………………………………………
…………………… 
          
…………………………………………………
………………. 
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Family History: 
Seizures (Learning difficulties, 
genetic conditions): 
 
  No 
 
 
 
 
 
 
  
Family tree: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Seizure History 
Age of first afebrile 
seizure: 
 
 
Seizure Types:  Clinical manifestations - ictal and postictal, 
triggers, duration and frequency (number of 
seizures per day)  
 
First afebrile seizure: 
 
Timing: 
   awake       asleep    Duration:…………………… 
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Subsequent seizure types: 
Please document: Age, if occurs when awake or when asleep, duration, 
frequency for each type 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current Seizure types: 
Please document: If occurs when awake or when asleep, duration, frequency for 
each type 
 
 
 
 
 
 
 
 
 
 
 
 
 
Status epilepticus: 
   
 
  No 
 
  Yes  
at first presentation:   Yes    No    
Unsure 
Please specify age, duration, number 
of episodes: 
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Longest seizure free 
period 
 
 
 
Antiepileptic Medication 
 
Drug  
 
Maximum 
Dose [mg]): 
Duration  + Comments (side effects, 
reason for withdrawal): 
Initial/previous: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response to current 
regime: 
  Seizure free  
How long ? ……………days/weeks/months (quantify 
and circle as appropriate) 
  Improved but not seizure free 
  Little improvement or unchanged 
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Developmental progress prior to seizure onset: 
(Milestones) 
Motor: 
 
 
 
 
 
 
 
 
 
Social communication 
– play 
 
 
 
 
 
 
 
 
 
 
Language: 
 
 
 
 
 
 
 
 
 
 
 
Current Development  
Chronological 
age: 
 
 
Domain: Please circle (Y = Yes, N = No, DK = don’t know) if appropriate and/or 
comment (other achieved milestones, concerns or loss of skills) 
Gross 
Motor: 
  normal 
  delayed 
  regression 
        
Y N DK Lifts head in prone 
position for several 
seconds (face makes 
approximate angle of 45o 
with surface) 
Y N DK Stands alone (> 10 
seconds) 
Y N DK Head control in 
sitting position  
(holds head steady)  
Y N DK Walks well (good 
balance, falls rarely) 
  
Y N DK Pull to sit – no head 
lag 
Y N DK Runs  
Y N DK Sits - no support Y N DK Walks up steps 
(holding onto rail or 
wall for support, not to 
person) 
 
Y N DK Stands holding on Y N DK Jumps up (gets 
both feet of the floor 
at same time) 
Y N DK Pulls to stand from 
sitting position      
Comments:  
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Fine Motor 
and vision: 
  normal 
  delayed 
  regression 
Y N DK In supine - follows 
object from one side 
past the midline  
Y N DK Picks up 2 cubes 
one in each hand 
 
Y N DK In supine - brings 
hands together in 
midline (over chest or at 
mouth) 
Y N DK thumb finger 
grasp (brings 
together thumb and 
one or several fingers 
to pick up small 
objects) 
 
Y N DK In supine - follows 
180° 
Y N DK scribbles 
 
Y N DK Reaches for objects 
(in sitting position)  
 
Y N DK Looks at pictures 
in book 
Y N DK transfers objects from 
one hand to other 
(without help of mouth, 
body or table) 
 
Y N DK Turns pages in 
book 
 
Comments:  
 
 
Personal – 
Social-  Play 
  normal 
  delayed 
  regression 
Y N DK regards face  
 
Y N DK Waves bye-bye  
 
Y N DK smiles 
responsively (when 
talked to)  
 
Y N DK Points to share 
interest (not for 
wants/needs) 
Y N DK Regards own 
hand 
Y N DK Imitates (household) 
activities (eg talking on 
phone, wiping up) 
Y N DK feeds self (finger 
food) 
 
Y N DK Use Spoon/Fork 
Y N DK turns to name  
 
Y N DK Feeds doll (Symbolic 
play)  
Y N DK Indicates wants 
(by pointing, reaching 
+ making sounds, 
pulling, saying words, 
putting arms up to be 
picked up) 
Y N DK Puts on clothing (can 
put on any clothing eg 
socks, shoes, jacket) 
 
Comments: 
 
 
 
 
 
Language: 
  normal 
  delayed 
  regression 
Y N DK vocalizes  
 
Y N DK one word 
 
Y N DK laughs  
 
Y N DK 6 words or more 
Y N DK turns to voice Y N DK combines words  
 
Y N DK single syllables 
 
Y N DK Follows one part 
command 
Y N DK DADA/MAMA (non 
specific) 
 
Y N DK Follows two part 
command 
Y N DK DADA/MAMA 
(specific) 
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Comments:  
 
 
 
 
 
Sensory Impairments 
Vision   normal   
concerns:…………………………………………………
…… 
 
 
Hearing   normal   
concerns:…………………………………………………
……… 
 
 
 
Which ethnic group does the patient belong to ? 
 
Mixed: 
  White and Black Caribbean 
  White and Black African 
  White and Asian 
  Other (please state)…………………… 
 
White: 
  British 
  Irish 
  Other (please state):………………….. 
 
Chinese or other Ethnic Group: 
  Chinese 
  Other (please state):………………..… 
 
 
Black/Black British: 
  Caribbean 
  African 
  Other (please state):………………………  
 
Asian/Asian British: 
  Indian 
  Pakistani 
  Bangladeshi 
  Other (please state):……………………….. 
 
Examination: 
 
Headcircumference: 
Weight: 
Height/Length: 
 
Dysmorphic features: 
 
 
 
Neurocutaneus stigmata: 
 
 
Neurological examination: 
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General Examination: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investigations:  Details if 
abnormal: 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
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Epilepsy in Infancy Study 
Follow up Assessment 
 
ID: 
 
Patient details: 
Name:   Local Hospital / 
Community 
Clinic: 
 
Date of Birth:    Local 
Consultant: 
 
Address:  
 
 
 
 
 Contact number/
e-mail: 
 
Contact 
Number: 
 
 
 GP: 
 
 
 
 
 
 
 
 
Date seen:                                     Age (months): 
Time since base line assessment (months): 
Attended with: 
 
Evaluation: 
Neuropsychology (Tests):……………………………………….. 
…………………………………………………………………… 
…………………………………………………………………… 
Blood for DNA stored 
 
Investigations reviewed so far: 
 
EEGs ( Department……………………………………………..) 
MRI (Department……………………………………………..) 
 
Comments: 
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Seizure History 
 
Seizure types since baseline assessment: 
Age, if occurs when awake or when asleep, duration, frequency for each type 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Status epilepticus: 
   
 
  No 
 
  Yes  
at first presentation:   Yes    No    
Unsure 
Please specify age, duration, number 
of episodes: 
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Longest seizure free 
period 
 
 
 
Antiepileptic Medication 
 
Drug  
 
Maximum 
Dose [mg]): 
Duration  + Comments (side effects, reason 
for withdrawal): 
Initial/previous: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response to current 
regime: 
Seizure free  
How long ? ……………days/weeks/months (quantify and 
circle as appropriate) 
Improved but not seizure free 
Little improvement or unchanged 
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General Health: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Any new diagnostic information (genetic syndrome/ diagnosis, metabolic disease 
ect, results of ophthalmology or audiology examinations: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Family Tree (if not documented at baseline assessment), FH of febrile 
convulsions, Epilepsy, disabilities, learning difficulties: 
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Developmental progress since baseline assessment: 
(Milestones, any concerns ) 
Motor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Social 
communication 
– play 
 
 
 
 
 
 
 
 
 
 
 
 
 
Language 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sensory Impairments 
Vision   normal   
concerns:…………………………………………………
…… 
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Hearing   normal   
concerns:…………………………………………………
……… 
 
 
 
 
 
 
Examination: 
 
Headcircumference / centile: 
Weight / centile: 
Height/Length: 
 
Dysmorphic features: 
 
 
 
Neurocutaneus stigmata: 
 
 
Neurological examination: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General Examination: 
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Investigations:  Details if 
abnormal: 
   normal     results awaited 
 
 
   normal     results awaited 
 
 
   normal     results awaited 
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8.7 Appendix 8: Proformas for review of Neuroimaging and EEG 
 
Reporting Proforma – Neuroimaging (Early onset Epilepsy < 2 years): 
 
Reported by:   
Date: 
 
Study ID: 
Name: 
DOB: 
 
Date: 
Type:   MRI        CT 
Where performed: 
 
System:               
 
MRI Sequences: 
 
 T1 weighted:……………………………………………… 
Planes:   axial    sagital    coronal .......................... 
 
 
 T2 weighted:…………………………………………………………………. 
Planes:   axial     coronal  
  sagital  
  coronal 90◦ to long axis of hippocampus  
whole head:   Yes    No:…………… 
 
 3D T1-weighted Gradient echo dataset (MPRAGE) 
 
 FLAIR 
Planes:   axial    coronal     sagital 
 
 Other:…………………………………………………………. 
………………………………………………………………….. 
……………………………………………………………………. 
 
 
Quality of images:     good     acceptable     insufficient  
 
Comments:……………………………………………………………………… 
…………………………………………………………………………………. 
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Cortex:  Normal:    yes            no: 
Abnormalities (Extend, Localisation): 
 
  Bilateral: ……………………………………………………………………. 
 
  Unilateral:……………………………………………………………………. 
 
Description (signal characteristics): 
T1: 
T2: 
 
Comments: 
 
 
 
 
White Matter: Normal    yes   no: 
Myelination:    age appropriate            delayed 
Comments:……………………………………………………………………… 
…………………………………………………………………………………. 
 
Abnormalities (Extend, Localisation): 
 
  Bilateral ……………………………………………………………………. 
 
  Unilateral:……………………………………………………………………. 
 
Description (signal characteristics): 
T1: 
T2: 
 
Comments: 
 
 
 
 
 
 
 
 
Ventricles:   Normal    Abnormalities:……………………………………… 
 
 
 
 
 
 
 
 
 
 
Corpus Callosum:   Normal    Abnormalities:……………………………………… 
………………………………………………………………………………………… 
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Basal Ganglia: Normal:    yes            no;  
Abnormalities: 
  Bilateral:………………………………………………………………………………. 
……………………………………………………………………………………………
……………………………………………………………………………………………
…… 
  Unilateral:…………………………………………………………………………..……
…. 
……………………………………………………………………………………………
……………………………………………………………………………………………
…… 
 
Description (signal characteristics): 
T1: 
T2: 
Comments: 
 
 
 
 
Hippocampus: Normal:    yes            no:   
Abnormalities: 
  Bilateral                       Unilateral:……… 
Description (signal characteristics, size): 
T1: 
T2: 
Comments: 
 
 
 
 
Brain stem:   Normal    Abnormalities:……………………………………… 
………………………………………………………………………………………… 
…………………………………………………………………………………………………
………………………………………………………………………………… 
 
 
 
 
 
 
Cerebellum:   Normal    Abnormalities:……………………………………… 
 
 
 
 
 
Other anatomical structures:   Normal    Abnormalities:………………………………. 
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Conclusion/Diagnosis: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further images required : 
  No      Yes 
(Sequences):…………………………………………………………….. 
…………………………………………………………………………………………. 
…………………………………………………………………………………………. 
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EEG-Reporting Proforma: 
 
Study-ID: 
Name: 
DOB: 
 
Recording details: 
Date: 
EEG department: 
EEG number: 
 
Antiepileptic Medication:   no   yes: 
 
Sleep:   yes   no 
Photic stimulation perfomed   yes   no 
State of patient during recording:  
 
 
Age and state appropriate background activities: 
 
Awake:  
  present               
  only abnormal activities   
  some activities present but to slow for age  
  not able to assess 
 
Drowsiness (stage 1 sleep – disappearance of α , presence of  Vertex – waves): 
 
  present               
  only abnormal activities   
  some activities present but to slow for age  
  not able to assess 
 
 
Sleep (presence of sleep spindles and K-complexes): 
  present               
  only abnormal activities   
  some activities present but abnormal for age  
  not able to assess 
 
 
Photoparoxysmal response:     yes   no 
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 Abnormal slow activity:   No   Yes: 
 Unilateral / Focal::……………………………………………………… 
 
 Bilateral:………………………………………………………………….. 
 
 Diffuse:…………………………………………………………………. 
 
 
Epileptiform activity: 
 
  Focal 
  Unilateral (hemispheric) 
  Multifocal 
  Bilateral 
 
 
Localisation:  
 
 
 
 
 
Seizures recorded:     yes   no 
Seizure type:  
 
Ictal onset:    
  Focal:…………………………………………………………………… 
  Unilateral:……………………………………………………………….. 
  Generalisedl:…………………………………………………………………. 
  Undetermined………………………………………………………………. 
 
Conclusion:  
  Normal (age and stage appropriate activities)                   Abnormal  
 
Compatible with …………………………………………………................... 
 
Comments: 
 
 
 
 
 
 
 
 
   
8.8 Appendix 9: Details of neuroimaging findings and examples of MR images 
 
Neuroimaging – Findings ID Initials Imaging Type Review - Conclusion Aetiological Category 
4 M P MRI 
non specific signal changes on T2-weighted 
images: increased deep white matter signal 
bilaterally in parietal occipital areas, differential 
diagnosis: oedema - due to hypoxic ischaemic 
brain injury, metabolic disorder or seizure related 
Acquired non specific 
8 JS MRI 
decreased grey to white matter differentiation in  
right anterior temporal lobe, increased signal on T2 
weighted images in right hippocampus, probable 
mesial temporal sclerosis 
Other 
9 VK MRI 
asymmetrical atrophy of cortex left more than   
right (left temporal lobe atrophy) appearances 
compatible with infection or seizure related 
(coronal T2 weighted images through temporal 
lobe only) 
CNS infection 
11 JR MRI 
asymmetric Peri-ventricular leucomalacia  with 
white matter loss affecting more the right 
hemisphere, cortical atrophy right more than left , 
right Ventricular-peritoneal -shunt in situ 
Perinatally acquired /HIE 
14 ZH MRI 
extensive area of cortical dysplasia in right 
hemisphere (mesial, middle, inferior frontal lobe, 
frontal operculum, perisylvian, superior parietal 
lobe), thickened septum pellucidum (feature 
suggesting hemimegalencephaly) 
Developmental lesion 
Abnormal – aetiologically 
relevant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 NE MRI 
bilateral tubers (largest left frontal),  subependymal 
nodules, diagnostic for Tuberous Sclerosis  
 
 
Developmental lesion 
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Neuroimaging – Findings ID Imaging Initials Review - Conclusion Aetiological Category Type 
17 A K-H MRI 
maturation of changes seen in initial scan - 
asymmetrical atrophy of affected cortical and 
subcortical areas, involvement of left lentiform 
nucleus and thalamus, mild atrophy of left 
hippocampus, consistent with encephalitis 
CNS infection 
19 M D-S MRI 
bilateral symmetrical signal abnormalities  on T2 
weighted images in globus pallidum and dorsal 
pons, in addition increased white matter signal on 
T2-weighted images in left temporal - occipital area 
with decreased signal on T1-weighted images in 
same area giving appearance of thickened cortex, 
This could be seizure related. 
Metabolic/ 
neurodegenerative 
29 IT MRI 
grossly abnormal with cystic encephalomlacia, thin 
cortex with paucity of gyration (preserved in 
occipital lobe), small brain stem and cerebellum, 
basal ganglia involved 
Acquired non specific 
30 SD MRI bilateral polymicrogyria (mesial frontal/parieto- occipital), microcephaly Developmental lesion 
34 TG MRI 
bilateral asymmetric polymicrogyria (left: frontal, 
temporal, parietal right: frontal perisylvian,insular) + 
left periventricular heterotropia 
Developmental lesion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 ML MRI 
blurring of grey/white matter junction and abnormal 
white matter signal in left temporal lobe (also 
coarse gyral pattern) extending in occipital area 
and insular cortex, consistent with area of focal 
cortical dysplasia 
 
 
 
 
Developmental lesion 
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Neuroimaging – Findings ID Imaging Initials Review - Conclusion Aetiological Category Type 
40 DG MRI 
multiple developmental abnormalities:1. extensive 
bilateral hemispheric polymicrogyria, left frontal 
cortex appears thinner (which may suggest an  
Insult) 2. right hemisphere is larger with thickened 
septum pellucidum - features of hemime-
galencephaly 3. left closed lip schizencephaly  
Developmental lesion 
42 A-R M MRI 
cerebellar hypoplasia/dysplasia with abnormally 
bright signal in the hemispheres, small brain stem; 
in addition bilateral polymicrogyria in frontal 
operculum and insular cortex 
Developmental lesion 
43 MK CT 
maturation of changes seen initially, asymmetric 
atrophy,  left more than right, also involving deep 
gray matter, hypodense changes left 
periventricular white matter, enlarged ventricles 
(left more tha right), consistent with infection with  
hypoxic insult (infarction), but lesion does not 
adhere to vascular territory  
CNS Infection 
56 AM MRI 
symmetrical increased signal on T2-weighted 
images in dorsal pons, single lesion in right 
thalamus with increased signal on T2-weighted 
images, lesion in left caudate with increased signal 
on T2-weighted images,  suggestive  of metabolic 
disorder (e.g. mitochondrial cytopathy) 
Metabolic/ 
neurodegenerative 
 
 
Abnormal – aetiologically 
relevant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
57 RAI MRI 
generalised cortical swelling, periventricular cystic 
encephalomalacia and areas of periventricular 
haemorrhage, pathological enhancement of 
periventricular lining, abnormal signal in the 
thalamus bilaterally. The differential diagnosis 
includes infection  with hypoxic ischaemic injury 
and metabolic disorder. 
Acquired non specific 
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Neuroimaging – Findings ID Imaging Initials Review - Conclusion Aetiological Category Type 
58 AP MRI 
asymmetrical cortex and white matter signal 
changes (oedema and haemorrhage especially 
right deep white matter) affecting more the right 
hemisphere, basal ganglia bilaterally are also 
involved, appearances consistent with global 
vascular injury (affecting more the right 
hemisphere) hypoxic ischaemic injury  
Ischaemic/vascular 
60 DR MRI 
bilateral multiple tubers, largest in the left frontal 
lobe (calcified) and multiple subependymal 
nodules, diagnostic for Tuberous sclerosis 
Developmental lesion 
64 SH MRI 
global atrophy, delayed myelination,  consistent 
with metabolic disorder or progressive 
neurodegenerative disorder  
Metabolic/ 
neurodegenerative 
65 IY MRI anterior pachygyria, posteriorly smooth cortex, consistent with Lissencephaly Developmental lesion 
70 HY MRI 
abnormal white matter signal  on T2 weighted 
images (especially internal capsule and 
cerebellum), more consistent with leucodystrophy 
than hypomyelination 
Metabolic/ 
neurodegenerative 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 SC MRI 
bilateral cortical atrophy with increased signal in 
peri-rolandic cortex, lack of white matter bulk , thin 
corpus callosum, delay of myelination, bilateral 
signal abnormalities in basal ganglia on IR and T2 
weighted sequences, small pos and vermis atrophy 
consistent with profound hypoxic ischaemic injury 
at term  
 
 
 
 
Perinatally acquired /HIE 
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Neuroimaging – Findings ID Imaging Initials Review - Conclusion Aetiological Category Type 
76 ZA MRI 
lack of white matter bulk (volume loss),could be 
consistent with periventricular malacia, slightly 
delayed myelination, increased subcortical white 
matter signal on T2 weighted images in right 
occipital areal non specific – differential includes  
hypoglycaemia, hypoxic ischaemic injury and 
malformation 
Unable to categorise 
81 JS MRI Microcephalus vera (asymmetric) cerebellar diaschisis, coarse gyral pattern Developmental lesion 
82 HK MRI right temporal occipital aterial venous malformation supplied by posterior cerebellar artery Developmental lesion 
 
Abnormal – aetiologically 
relevant 
 
 
 
83 AP MRI 
acute changes diffuse swelling and oedema of 
cortex and white matter, deep grey matter also 
involved, (subtentorial subdural haemorrhage), 
consistent with bilateral hemispheric infarction - 
global hypoxic ischaemic injury 
Ischaemic/vascular 
 Total N (%) 26 (50%) 
5 EP MRI arachnoid cyst right lateral ventricle (trigonum) 
6 LM MRI 
delayed myelination, lack of white matter bulk, 
white matter  immaturity and increased 
perivascular spaces 
12 GH MRI mild lack of white matter bulk,  thin corpus callosum 
13 MA-H MRI mild delay of myelination 
16 NR MRI 
asymmetry of wm signal in temporal lobes (right 
more advanced / or left delayed) right 
hippocampus slightly smaller  - weak lateralising 
sign 
Incidental / immaturity/ 
uncertain 
 
33 HD MRI subarachnoid cyst over left sylvian system, no localising or lateralising features 
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Neuroimaging – Findings ID Initials Imaging Type Review - Conclusion Aetiological Category 
39 AK MRI delayed myelination 
48 00 MRI delayed myelination 
69 MA MRI 
delayed myelination. Lack of white matter bulk and 
thin corpus callosum,  small chiasm, no localising 
abnormalities 
85 MD MRI delayed myelination 
88 A K-O MRI 
suspicious area of abnormal signal (decreased on 
T2 weighted images) right posterior frontal, fronto-
parietal, insufficient imaging quality to determine 
for certain 
 Total N (%) 10 (17.5%) 
3 TW MRI normal 
7 RK MRI normal 
32 HV MRI normal 
36 AM MRI normal 
38 PMJ MRI normal 
41 MD MRI normal 
46 JF MRI normal 
51 ZM MRI normal 
52 OG MRI normal 
54 RH MRI 
fast speed imaging, limited quality scans, not 
sufficient for epilepsy pathology - no gross 
structural abnormalities  
55 JT MRI normal 
71 DM MRI normal 
84 RA MRI normal 
No abnormalities seen 
 
87 PD MRI normal 
 Total N (%) 14 (25%) 
 
CT = Computer Tomogram, MRI = Magnetic Resonance Image 
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Examples of MR imaging findings 
 
Abrevations for sequences: 
TSE: Turbo Spin Echo 
FSE: Fast Spin Echo 
IR: Inversion Recovery 
DESTIR: Double Echo Short Tau Inversion Recovery 
 
Developmental lesions / malformations: 
 
 
Diffuse bilateral hemispheric involvement: 
 
Figure 8.1 
Axial T2 (TSE) weighted (A , B) and T1 weighted (C and D) images 
showing anterior pachygyria and posteriorly smooth cortex consistent with 
Lissencephaly, ID 65, male infant, 6 months of age at the time of imaging 
A B
C C D
   
Figure 8.2: 
 
A B 
C D
 
 
 
 
 
 
 
A-D: axial T2 (FSE) weighted images showing several abnormalities: 1. 
extensive bilateral hemispheric polymicrogyria, 2. the left frontal cortex appears 
thinner, which may suggest an insult, 3. the right hemisphere is larger with 
thickened septum pellucidum, which is a feature of hemimegalencephaly, ID 40, 
male infant, 2 weeks at the time of imaging  
 
 
 
 
 
 
 
 
 
 
 
 
 283
   
 
Bilateral multi-lobar hemispheric involvement  
 
Figure 8.3: 
BA 
C D
A-D: T2 weighted (TSE) images showing bilateral asymmetric polymicrogyria 
involving frontal, temporal and parietal lobes in the left hemisphere, on the right 
frontal lobe, perisylvian and insular areas. In addition there is left periventricular 
heterotropia (demonstrated by black arrows). ID 34, male infant 3.2 months at the 
time of imaging 
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Unilateral multi-lobar  hemispheric involvement: 
 
Figure 8.4: 
A B C
A- C: axial T2 (DESTIR) images showing extensive area of cortical dysplasia in 
right hemisphere involving mesial, middle, inferior and frontal lobe, frontal 
operculum, perisylvian area as well as superior parietal lobe (black arrows). ID 14, 
female infant, 3 weeks of age at the time of imaging  
Unilateral uni-lobar involvement: 
 
Figure 8.5 
A B
 285
Axial (A) and coronal (B) T2 weighted (DESTIR) images demonstrating coarse 
gyral pattern and  blurring of grey/white matter junction and in left temporal lobe  
extending in occipital area consistent with area of focal cortical dysplasia. ID 35, 
male infant, repeat MR images performed at 4 months of age; first MR  images at 
2.7 months of age see Figure 8.6. 
   
Figure 8.6: 
 
Initial MR images of case 35 performed at 2.7 months of age  - 
axial T2 (TSE) weighted. No structural abnormalities were 
identified. The images wer of acceptable quality as judged by 
collaborating neuroradiologists. A repeat MR scan at 3 months 
of age demonstrated subtle abnormality in left temporal lobe 
extending to occipital and insular cortex  (see Figure 8.5) 
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Acquired brain lesions:  
 
Figure 8.7 
 
Axial (A and B) and coronal 
(C and D) T2 (FSE)  
weighted images 
demonstrating asymmetric 
peri-ventricular leucomalacia 
with white matter loss 
affecting more the right than 
the left hemisphere as well 
as cortical atrophy that is 
more severe on the right. ID 
11, male infant, 9 months 
corrected gestaional age at 
the time of imaging, 
premature at birth (25 weeks 
of gestation), sustained grade 
4 asymmetric 
intraventricular 
haemorrhages in first days of 
life with subsequent 
evolution to post 
haemorrhagic hydro-
cephalus. 
DC 
BA 
Figure 8.8:
Axial T2 (DESTIR) weighted (A) and axial T1 (IR) weighted (B) images showing 
bilateral cortical atrophy with lack of white matter bulk, delay of myelination and 
bilateral signal abnormalities in basal ganglia, thalami and  posterior limb of the 
internal capsule.  Sagital T1 weighted (C)  image demonstrating thin corpus callosum 
small pons and vermis atrophy. Appearances are consistent with profound hypoxic 
ischaemic injury at term. ID 73, male infant , 6 months at the time of imaging, 
required cardio pulmonary resuscitation after birth  at term and ventilation on the 
neonatal intensive care unit. 
A B C
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Figure 8.9: 
A B
C D
Axial T2 weighted (DESTIR) images (A and B) demonstrating bilateral 
symmetrical signal abnormalities  in globus pallidum and dorsal pons (white 
arrows) suggestive of metabolic disorder such as mitochondrial cytopathy. 
Increased white matter signal on axial T2-weighted (DESTIR) image (C)   in 
left temporal - occipital area and T1 weighted (IR) (D) image showing  
decreased signal in same area giving appearance of thickened cortex, which 
could be seizure related. ID 19, female infant, 9 months at the time of imaging. 
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Figure 8.9: 
A B
A and B: Axial T2 weighted (DESTIR) images showing abnormal white matter signal  on 
T2 weighted images, especially internal capsule and cerebellum, in keeping with 
leucodystrophy. ID 70, female infant, 2 months of age at imaging, significantly low plasma 
biotinidase in keeping with diagnosis of biotinidase deficiency.   
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Examples of MR images of insufficient quality  
 
 
Figure 8.10:
A CCA 
B 
Panel A and B: axial T2 weighted (Fast Spin Echo) images (A), axial T1 weighted 
(Inversion Recovery sequence) images (B), with movement artefacts of female 
patient (ID 19) at 3 months of age, abnormalities on repeat MR images at 8 months 
of age  are illustrated in figure  
Panel C: axial T2 weighted images with movement artefacts of female patient (ID 
14) at 2 weeks of age, for abnormalities on repeat MR imaging at 3 weeks of age 
see figure  8.3 
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  Figure 8.11:
DC 
BA 
Panels A-C: example of ultra fast axial T2 weighted sequence  images with 
reduced contrast to noise as obtained in 4 cases (IDs 41, 54, 56 and 84), 3 MR 
scans were repeated with positive findings in one (ID 56)  
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8.9 Appendix 10: Principal Component Analysis (Bayley III subscale raw scores)  
 
Total Variance Explained 
Initial Eigenvalues Extraction of Sums of 
Squared loadings 
Component 
(raw 
subscale 
scores) 
Total % of 
Variance
Cumulative% Total % of 
Variance 
Cumulative 
% 
Cognition 4.687 93.746 93.746 4.687 93.746 93.746 
Expressive 
language 
0.211 4.222 97.967    
Receptive 
language 
0.054 1.090 99.057    
Fine Motor 0.033 0.656 99.713    
Gross 
Motor 
0.014 0.287 100.000    
Extraction Method: Principal Component Analysis. 
 
Table of Communalities 
 Raw subscale scores Initial Extraction 
Cognition 1 0.973 
Expressive language 1 0.910 
Receptive language 1 0.911 
Fine Motor 1 0.944 
Gross Motor 1 0.950 
Extraction Method: Principal Component Analysis. 
 
Component Matrix(a) 
Component   
 Raw subscale scores 1 
Cognition 0.98 
Expressive Language 0.95 
Receptive language 0.95 
Fine Motor 0.97 
Gross Motor 0.97 
Extraction Method: Principal Component Analysis. 
a  1 components extracted. 
 
   
8.10 Appendix 11: Principal component analysis:  
Bayley III composite scores at baseline / follow up 
 
 
Total Variance Explained 
Initial Eigenvalues Extraction of Sums of Squared loadings Component  
(composite 
scores baseline) Total % of Variance Cumulative% Total % of Variance Cumulative 
% 
Cognition 2.654 88.452 88.452 2.654 88.452 88452 
Language 0.252 8.403 96.855    
Motor 0.094 3.145 100.000    
Extraction Method: Principal Component Analysis. 
 
 
Component Matrix(a) 
  Component 
 Bayley III composite scores (baseline) 1 
Cognition 0.95 
Language 0.91 
Motor 0.96 
Extraction Method: Principal Component Analysis. 
a  1 component extracted: Developmental composite factor 0 (DCF-0)  
 
 
 
 
 
 293 
   
 294 
Total Variance Explained  
Initial Eigenvalues Extraction of Sums of Squared loadings Component  
(composite 
scores follow 
up) 
Total % of 
Variance 
Cumulative% Total % of Variance Cumulative % 
Cognition 2.863 95.421 95.421 2.863 95.421 95.421 
Language 0.106 3.550 98.970    
Motor 0.031 1.030 100.000    
Extraction Method: Principal Component Analysis 
 
 Component Matrix(a) 
  Component 
 Bayley III composite scores (follow up) 1 
Cognition 0.983 
Language 0.971 
Motor 0.970 
Extraction Method: Principal Component Analysis. 
a  1 component extracted: Developmental composite factor 1 (DCF-1) 
 
 
 
 
   
8.11 Appendix 12: Cases that were excluded form the North London infancy epipesy cohort after initial enrolement 
ID Age at onset 
[months] 
Details: Reason for 
exclusion 
21 6 Female infant who experienced 4 episodes within 24 hours with the following manifestations: behavioural 
arrest, staring blankly, palor,  lip cyanosis lasting up to 3 minutes. She was commences on phenytoin and did 
not experience any further events after withdrawal of the antiepileptic medication 6 months later. Her interictal 
EEG was normal. She had a developmentally normal stepsister who experienced 2 afebrile seizures within 1 
one week at the age of 4 months and had remained seizure free ever since.  
 
Not meeting 
inclusion criteria - 
because all events 
belonging to a 
single episode 
22 1.9 Male infant with preceding history of 2 days diarrhoea and vomiting, experienced cluster of several afebrile 
seizures occurring in one day: eyes rolled back, lips blue, generally rigid, unresponsive for 1-2 minutes 
afterwards sleepy. Similar events  (4-5) were observed after admission to hospital. He was  terated with iv 
phenytoin. On admission  low blood glucose (BM - 2.9) and  metabolic acidosis (Base exess -19, bicarbonte 
11.9 mmol/L) were documented. Brain Computer tomography scans were reported to show marked brain and 
cerebellar swelling with bilateral posteriorly hypodense changes consistent with encephalitis or metabolic 
disorder.  
He recovered completely and remained seizure free for 6 months. Phenytoin was  discontinued. 
Acute symptomatic 
seizures  
37 3 A male infant who experienced two focal of  seizures lasting up to 3 minutes approximately 5 minutes apart. 
MR brain imaging and interictal EEG were normal. He has not been started on anti-epileptic medication and 
remained seizure free for 6 weeks  at the time the parents were interviewed by the researcher. 
 
not meeting 
inclusion criteria - 
because events 
belonging to a 
single episode 
66 2.5 Male infant (notified at age 8.5 months). Was admitted following normal vaginal delivery to neonatal intensive 
care unit with respiratory distress. Required 9 days of assisted ventilation (continuous positive air pressure. 
Subsequently presented global developmental delay and 4 cerebral palsy. His mother noticed from 2.5 months 
of age onwards abnormal episodic movements: punching himself with arms, shaking with legs, foaming, 
occurring in clusters every 2 days. Brain MR scan reported by local team to show periventricular leucomalacia, 
EEG was grossly abnormal. anonymised information provided by the paeditrician, who notified the case.  
lack of information 
to categorise 
paroxysmal events 
as epileptic seizures 
in this particular 
clinical context 
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